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ABSTRACT 
 
LUCIA A. LEONE: Weight-Related Disparities in Colorectal Cancer Prevention 
Behaviors 
(Under the direction of Marci K. Campbell) 
 
Although Colorectal Cancer (CRC) is the 2nd leading cause of cancer mortality, it is 
estimated that as many as 90% of CRC cases could be prevented through screening and 
healthy lifestyle, such as engaging in regular physical activity.  Obese women, who are at 
higher risk for CRC, may be less likely to engage in cancer prevention behaviors than 
normal weight women.  The purpose of this research project was to understand how 
obesity affects CRC screening and physical activity behavior in order to design 
appropriate intervention messages for decreasing CRC risk among obese women.  The 
dissertation followed three aims.  For Aim 1, national data on CRC screening were 
analyzed to better understand the combined influence of gender, weight and race on CRC 
screening practices.  We found that obese white women were 34% less likely to have had 
a colonoscopy in the past 10 years (p=0.001), but that there was no significant 
relationship between screening and weight in African American women.  For Aim 2, 
focus groups were conducted with unscreened obese women to better understand how 
weight affects compliance with screening and physical activity guidelines.  We found that 
knowledge of CRC prevention was low among obese women.  While many of the 
barriers cited were similar to those found with non-obese women, obese women had more 
co-morbidities which they may prioritize over cancer screenings tests.  Women also cited 
many weight-related barriers to physical activity.  Aim III consisted of an online 
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evaluation of weight-targeted CRC prevention messages.  White women were stratified 
by weight (obese vs. non-obese) and randomized to receive either 10 weight-targeted 
messages developed based on focus group findings or 10 generic messages about CRC 
screening and physical activity.  Women rated messages using the Elaboration Likelihood 
(ELM) Scale; there were no differences between ELM scores of women who read 
weight-targeted vs. generic messages, but obese women in both conditions reported 
higher elaboration (p=0.02) and felt that the messages were more personally relevant 
(p=0.005) and believable (p=0.047) than non-obese women did.  Together, data from 
these three aims can be used to inform the development of future CRC prevention 
interventions targeted at obese women. 
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CHAPTER I 
INTRODUCTION 
I.A. Overview 
Colorectal Cancer (CRC) is the second leading cause of cancer mortality in the 
United States.  Screening tests allow for the detection and removal of precancerous 
tumors (polyps) and can prevent CRC from ever occurring.  Since the risk of CRC 
increases with age, it is recommended that normal risk individuals begin CRC screening 
at age 50; however compliance with screening recommendations is poor.  Other risk 
factors for CRC include obesity and physical inactivity.  Weight and gender related 
disparities exist in both CRC screening and physical activity; obese women are less likely 
to be physically active and may be less likely to adhere to screening recommendations.  
Data from breast and cervical cancer screening indicate that weight-related screening 
disparities may also vary by race, but this relationship has not been examined for CRC 
screening tests.   
 Behavioral interventions have shown some effectiveness at increasing CRC 
screening and physical activity, but they may be differentially effective across weight 
groups.  Weight-targeted interventions may be needed to effectively reach obese women.  
In order to better understand and address weight, gender and race-related disparities in 
CRC screening and decrease CRC risk among obese women through increased screening 
and physical activity, I conducted research in three phases:   
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I.B. Specific Aims 
Phase I: Analyze data from the 2005 National Health Interview Survey (NHIS), a 
nationally representative sample which includes data on CRC screening behavior. 
Aim 1: Determine if disparities in CRC screening rates exist by weight, gender and/or 
race. 
 
Phase 2: Conduct focus groups with obese white and African American women age 
50 and older to better understand determinants of CRC screening and physical 
activity in this population and to inform the development of a CRC prevention 
messages for obese women. 
Aim 2: Determine why obese women may be less likely to adhere to CRC screening and 
physical activity recommendations. 
2a: Determine why women decide to be screened for cancer and how their weight affects 
their medical decisions. 
2b: Determine weight-specific barriers to physical activity. 
2c: Determine what intervention methods would be most acceptable to obese women. 
 
Phase 3:  Develop and test CRC screening and physical activity promotion message 
for obese women. 
Aim 3:  Determine if the weight-targeted messages are more comprehensible, relevant, 
acceptable, and/or motivating for obese women compared to generic messages. 
 
 
 
 
 
 
 
CHAPTER II 
LITERATURE REVIEW 
II.A. Colorectal Cancer Risk among Obese Women  
 Colorectal cancer (CRC) was responsible for an estimated 49,920 deaths in 2009 
making it the second leading cause of cancer mortality.1  Research has shown a positive 
relationship between CRC incidence/mortality and Body Mass Index (BMI).2  A recent 
meta-analysis found that obese women (BMI ≥ 30) have a 25% greater chance of getting 
CRC than women with a BMI <23.  Additionally, obesity may increase colon cancer 
mortality risk in women by as much as two-fold.2, 3  While the exact biological 
mechanisms through which obesity increases CRC risk are still debated, increased insulin 
is the best established biochemical mediator of this relationship.4  Obesity is a prevalent 
condition in the United States, particularly among older women; it is estimated that more 
than 31% of women in the United States over age 60 are obese.5  Given their high 
numbers and increased CRC risk, obese women are an important group to target for CRC 
prevention. 
II.B. Colorectal Cancer Prevention  
 Regular screening for CRC and adenomatous polyps has the potential to 
significantly reduce CRC incidence and mortality6-9 A joint taskforce on guidelines for 
screening and surveillance for the early detection of adenomatous polyps and colorectal 
cancer (CRC screening) recommend that all average risk individuals begin screening at 
age 50.10-12  In addition to screening, the American Cancer Society concluded that there 
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was convincing evidence that avoiding overweight and increasing physical activity would 
help to reduce colorectal cancer risk.13, 14  Moreover, the Surgeon General’s report on 
physical activity and health concluded that there is strong evidence suggesting a 
relationship between physical activity and colon cancer.15  It is estimated that 13-14% of 
colon cancer cases can be attributed to physical inactivity, this is greater than the 
population attributable risk for family history or any other individual lifestyle factor.16-18  
For these reasons, CRC screening and physical activities are important behaviors to target 
in a CRC prevention intervention.    
II.C. Colorectal Cancer Screening 
 Both observational and randomized controlled trials have demonstrated that 
routine CRC screening is both effective and cost-effective in decreasing CRC incidence 
and mortality11. For example, it is estimated that annual fecal occult blood testing 
(FOBT) starting at age 50 could lower mortality by up to 33%6 and regular screening 
with colonoscopy could decrease mortality by up to 65-90%.7, 8  Colonoscopy is 
recommended as both a stand-alone screening test and a follow-up to positive results 
obtained using other screening modalities.  A colonoscopy can be used to find CRC in its 
early stages (when the survival rate is higher) or to find polyps which are precancerous 
growth.  Polyps can be removed during a colonoscopy and thus prevented from ever 
becoming cancer.19, 20 Regular colonoscopy usage has been estimated to decrease CRC 
incidence by 67%.8 
CRC screening guidelines for average risk individuals begin at age 50.  Average 
risk individuals are those with no family or medical history of CRC, polyps or 
inflammatory bowel disease.  Obese individuals are generally considered average risk for 
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screening purposes; however the American College of Gastroenterology recently 
recommended that given their higher CRC incidence and mortality rates that there should 
be special efforts to ensure that screening takes place in obese and overweight patients.21 
Additionally, they suggested that initiating screening as early as age 45 may be 
recommended, but that further study is warranted.  Unfortunately, the current rate of 
adherence to CRC screening guidelines in the United States is low in general and 
particularly low in certain subgroups such as obese women.     
Screening guidelines for average risk individuals include yearly stool tests [fecal 
occult blood test (FOBT), fecal immunochemical test (FIT) or stool DNA tests (sDNA)], 
flexible sigmoidoscopy every five years, annual FOBT or FIT plus flexible 
sigmoidoscopy every five years, double contrast barium enema every five years, 
Computed Tomographic Colonography (CTC) (i.e., virtual colonoscopy) every 5 years or 
colonoscopy every ten years.11  Insurance coverage for CRC screening is available 
through most insurance plans including Medicare and is currently mandated by law in 18 
states.22  Despite insurance coverage and effectiveness evidence compliance with CRC 
screening guidelines remains low, especially when compared with screening for other 
cancers, like breast or cervical cancer.23-25  Behavioral Risk Factor Surveillance Survey 
data showed that only 23.5% of respondents reported having FOBT in the past year, and 
43.4% had a sigmoidoscopy or colonoscopy in the past ten years.26  CRC screening much 
less common than that for breast or cervical cancer;27  Among women under 65, over 
85% are adherent to pap smear guidelines and over 58% with mammogram guidelines,10 
but only 47.4% are up-to-date for CRC screening28  In addition, there is only one 
screening test recommended for each breast and cervical cancer whereas CRC has a 
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number of recommended screening tests or combinations of tests, each with a different 
screening interval; this makes compliance more difficult and makes for potentially more 
complex interventions. 
II.D. Physical Activity 
    Longitudinal studies provide evidence for a relationship between colon cancer 
risk and physical activity in women.29  Specifically women who engage in more leisure 
time physical activity have reduced risk for colon cancer, but not rectal cancer.30  For 
example, the Nurses’ Health Study found that Women who engaged in physical activity 
at a level of 21 MET-hours/week for 40 years had a 49% reduction in risk compared with 
women who only had 2 MET-hours of physical activity per week.  The relationship 
between physical activity and CRC remains, even after controlling for BMI.31  While 
there is epidemiological evidence that physical activity may reduce colon cancer 
incidence, the biological basis for this relationship is still unclear, though many theories 
exist.3233 Physical activity may decrease bowel transit time and reduce the colonic 
tissue’s exposure to carcinogens.  Physical activity is also purported to increase immune 
function; it may alter the function of macrophages and therefore affect tumor 
development.  Alternatively it may decrease prostaglandin levels.  Prostaglandins have 
been associated with colon cell proliferation and adenocarcinomas in the colon.  Lifestyle 
factors associated with colon cancer are similar to those of insulin resistance suggesting a 
relationship between colon cancer and insulin and/or IGF (Insulin like growth factor).  
Insulin and IGF increase cell proliferation and tumor growth.  Physical activity is known 
to improve insulin sensitivity and reduce levels of insulin in the blood.32   
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 Although the exact amount and type of physical activity needed to reduce cancer 
risk is not known, ACS guidelines recommend that individuals engage in at least 30 
minutes of moderate to vigorous activity each day.  They also specifically state that 
evidence is mounting to suggest that 45 to 60 minutes of physical activity on 5 or more 
days per week is optimal for reducing breast and CRC risk. 14 According to BRFSS data, 
over 50% of Americans are not even meeting national physical activity guidelines, 
defined as 30 minutes of moderate intensity activity 5 days a week or 20 minutes of 
vigorous activity 3 days per week.28  Thus, even fewer Americans are active at a level 
thought to help prevent cancer. 
II.E. Colorectal Cancer Prevention Behaviors among Obese Women 
Despite their increased risk for cancer, evidence suggests that obese individuals 
may be less likely to engage in health-promoting behaviors such as physical activity, 
healthy diet, and cancer screening tests.26, 34-37  Our own research found similar disparities 
for screening and physical activity, but not diet in a sample of rural African Americans.38 
Several studies have specifically examined the relationship between screening and weight 
(Appendix A).  Data from the Behavioral Risk Factor Surveillance Survey (BRFSS) 
showed that as weight increased, the likelihood that a person was adherent to CRC 
screening recommendations decreased for women, but not for men.26, 34  A medical 
record review of 22 practices found that both obese men and women had significantly 
lower rates of screening than non-obese.39  The Cancer Prevention II Nutrition Cohort 
found that compared to normal weight women; overweight, obese and morbidly obese 
women were all significantly less likely to have had a flexible sigmoidoscopy or 
colonoscopy.  However, three studies, one conducted in Maryland and two using NHIS 
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data have found no association between screening and weight.40-42 NHIS has one of the 
most comprehensive screening questionnaires of any nationally representative survey, 
however the two studies which have used this data set have not been designed to 
specifically examine the relationship between screening and weight.  Additionally, no 
study to date has examined this relationship stratified by both race and gender.  Research 
on mammography has indicated that screening disparities may exist for white women, but 
not other races.43-45   
While overall, the number of Americans who get no leisure-time physical activity 
is high,46 there is a negative association between physical activity and BMI, with obese 
individuals reporting substantially lower rates than normal or overweight individuals.36 
Accelerometer data also indicates that obese individuals are less likely to meet physical 
activity recommendations than normal weight individuals.  Obese individuals spent 21 
minutes less per day engaged in moderate or higher intensity activities compared to 
normal weight individuals.47  In addition, women have lower reported rates of physical 
activity than men, with obese women being the most inactive group overall.  According 
to BRFSS data 36.2% of obese women report no leisure time activity compared to 19.7% 
of normal weight women and 27.7% of obese men.28  
II.F. Physical Activity Determinants among Obese Women 
 While there is a great deal of anecdotal evidence that obese individuals face more 
barriers to physical activity, the published literature is limited.  One study in Australia 
found that there was an association between reporting being “too fat” as a barrier to 
exercise and saying that they were too shy or lazy to exercise.  Women who thought they 
were too fat were also more likely to say that they were not the sporty type.  Women 
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were more likely to report that they were too fat to exercise than men, even though there 
were more obese men in the sample.48   A study of African American women found that 
obese individuals were more likely to report that they lacked motivation to exercise.  
Normal weight individuals were also more likely to report no barriers to exercise (31%) 
than overweight (0%) or obese individuals (5%).49  Another study examined predictors of 
physical activity among overweight and obese individuals in a 6 month weight loss study.  
While there were no relationships between baseline psychosocial variables and 6 month 
physical activity levels, they did find that those who had greater self-efficacy and 
decisional balance at 6 months engaged in more activity.50, 48  Our own research found 
that obese individuals were more likely than normal weight individuals to report that they 
did not have the will power to exercise or that they felt uncomfortable with how they 
looked while exercising.38 
While research on determinants of physical activity in obese women is limited, 
we do have some understanding of the factors that affect physical activity initiation and 
continuation in older adults.  Self efficacy has been shown to be a consistent predictor of 
both exercise initiation and adherence in older populations.51-53, 53-55  Other important 
physical activity correlates include perceived behavioral control, perceived benefits, and 
perceived social support.51  While social support from friends, family and physicians had 
been shown to increase physical activity, many older adults don’t get the support that 
they need.  Older adults also face additional barriers to physical activity including fear of 
injury, physical conditioning and poor health.51-53, 53  Previous experiences with physical 
activity and attitudes towards physical activity also have an effect on initiation and 
adherence either alone or as mediators of the relationship with self-efficacy.51, 54, 54, 55  
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Based on the literature social support, self-efficacy and perceived barriers appear to have 
the largest affect of physical activity in older adults.  Qualitative research is needed to 
better understand how these factors affect physical activity participation in obese women.   
II.G. Colorectal Cancer Screening Determinants among Obese Women 
 It is not clearly understood why obese women are less likely to be adherent to 
CRC screening recommendations; no literature exists which specifically examines the 
causes of this disparity.  In order to better understand the factors which may affect CRC 
screening behaviors in obese women, we looked to a wide body of literature.  First we 
examined the psychosocial factors which have been show to correlate with screening in 
the general population.  Second we looked at the more general body of literature on 
screening and weight and thirdly we included research which detailed the experience of 
obese women in the health care system in general. 
Screening Correlates 
 Many quantitative studies have focused on correlates of CRC screening.  One of 
the strongest predictors of screening is that it was recommended by a doctor,56 so it is 
hypothesized that differential rates of doctor referral may explain some of the weight-
related screening disparities. Previous research also indicates that patient-provider 
communication may have a significant influence on screening compliance.57-59  However, 
mammography data from the National Health Interview Survey (NHIS) indicate that 
differential doctor recommendation was not responsible for lower screening rates.  
Demographic factors which are frequently reported as increasing screening compliance 
include older age,60-62 higher SES,61, 63 3 or more doctor visits in the last year,60, 62, 64 use 
of other preventive care services,58, 60, 64, 65 and insurance or access to a regular source of 
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care.61, 63, 65  Women and minorities were less likely to have had an up-to-date CRC 
screening.58, 61-64, 66  Psychosocial variables which have been cited as screening correlates 
include knowledge of testing intervals, greater perceived susceptibility, greater perceived 
support,58 and lower barriers to screening.64   
Gender Differences 
One study specifically looked at differences in screening predictors/barriers 
between men and women.  Cost of screening was reported as a barrier among women, but 
not men.  Women were also more likely to get a screening if they believed that it led to 
early detection or if they had a comparatively higher risk of getting CRC than their 
peers.60  One qualitative study examined non-adherence to screening colonoscopy found 
that women had more apprehensions about screening colonoscopies then men.  These 
included fear of pain, disagreeable preparation, concerns about modesty, and fear of 
perforation.62  Another focus group study conducted with men and women found notable 
gender differences in attitudes towards colonoscopy.  Women expressed more anxiety 
about being unclothed and exposed during endoscopic procedures than about the physical 
discomfort involved.  Women also felt that there was more emphasis placed on breast and 
cervical cancer than colon cancer.  Additionally, concerns about menopause were more 
salient among women who were just reaching screening age.67  
Other Screenings 
Similar to CRC, weight-related screening disparities exist for breast and cervical 
cancer screening; it is estimated that obese women are between 8 and 69% less likely to 
adhere to screening guidelines for mammography, pap smears or clinical breast exam.43-45  
These weight-related differences in screening rates were seen for white women, but not 
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African American or Hispanic women.43-45  In one study investigating barriers to 
gynecological screening, over 50% of morbidly obese women reported that they delayed 
seeking health care because of their weight.  Over 70% reported that their weight was a 
barrier to receiving appropriate health care.35, 43  In a recent qualitative study examining 
mammography usage, obese women reported additional barriers to screening, including 
previous bad experiences, low perceived susceptibility, discomfort, fear, poor treatment, 
provider gender.68  In addition to having more screening-specific barriers, obese 
participants may also have more co-morbidities or acute needs which doctors (or patients) 
prioritize over cancer screening tests,69, 70 however number of reported medical 
conditions has been found to correlate positively with screening compliance.59     
Healthcare-related Factors 
While obese individuals on average, have a higher number of outpatient visits.71 
they may delay preventive care.72  Reasons cited for delayed care include disrespectful 
treatment, embarrassment about being overweight, perceived negative attitudes of health 
care providers concerning their weight, dislike of unsolicited weight loss advice and 
small gowns and equipment which may not be appropriate for their size.  However, not 
all studies have found that obese women delay care.  One study conducted among 
Europeans found that overweight and obese individuals were more likely to receive flu 
vaccination, but found no relationship between weight and CRC screening.  They did 
however find lower rates of breast cancer screening and more frequent physical activity 
consultation by physicians for obese individuals.73 Another study found that obese 
patients had a significantly higher mean number of visits to both primary care and 
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specialty care clinics.  Even after controlling for health status, depression, age, education, 
income, and sex, obesity was significantly related to the use of primary care.74   
Healthcare satisfaction may be related to how often women visit the doctors and 
whether or not they choose to have screenings.  It has been hypothesized that obese 
individuals have lower satisfaction with their healthcare, but the research does not fully 
support this theory.  Wee et al. found a relationship between obesity and patient 
satisfaction (for a specific visit), but the relationship was not statistically significant after 
researcher controlled for health status, which is an important predictor of patient 
satisfaction.75  Conversely, another study found that overweight women perceived their 
healthcare experiences to be significantly more positive than their normal weight 
counterparts even though there were no reported differences in the amount of time that 
their physician spent with them.76  These findings are supported by a larger study, using 
data from the 2000 Medical Expenditure Panel Survey, which found that BMI was 
positively associated with patient satisfaction in both men and women age 55 and older; 
however this finding emerged after adjusting for health status.77  While obesity may not 
directly cause decreased patient satisfaction, it is possible that obese women who tend to 
have more co-morbidities may have lower than average satisfaction with their healthcare. 
Previous research indicates that patient-provider communication may also have a 
significant influence on screening compliance.  Focus group and baseline data from the 
WATCH (Wellness for African American’s through Churches) study was used to better 
understand the relationship between perceived patient-provider communication and 
completion of CRC screening.  WATCH was a CRC prevention intervention study 
conducted in rural churches in North Carolina.  Six focus groups (n = 45) were conducted 
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prior to the baseline survey.  Discussions focused on CRC knowledge, and perceived 
barriers/motivators to CRC screening. A theme that emerged during each groups' 
discussion about CRC screening was the quality of the participants' communication with 
their health care provider; this issue was subsequently explored using cross-sectional data 
from the baseline survey.  Among the 397 participants over age 50 who completed the 
baseline survey, 31% reported CRC screening within the recommended guidelines. 
Participants who self-rated their communication as good were more likely to have been 
screened (36%) within the recommended guidelines than were participants with poor 
communication (17%) (OR = 2.8, 95% CI 1.2, 6.4; p = 0.013).57  These results support 
the need to better understand how women and their doctors prioritize health decisions, 
such as screening. More research is needed to better understand how obese women make 
decisions about preventive services and how they relate to the health care system in 
general. 
Preliminary Research 
Our analysis of data from the WATCH study provided some further 
characterization of the relationship between weight and screening.  We analyzed baseline 
data of 813 church members who provided information on their height and weight and 
found that 78% of respondents were classified as overweight or obese.  For women age 
50 and older, there was no significant association between weight group and screening 
compliance (p=.09), however, weight was significantly associated with having had any 
CRC screening test in the past-year (n=278, p=.05).  Among normal weight women, 
44.8% reported a past year screening compared to only 22.8% of obese I (BMI 30-34.9) 
and 28.9% of obese II (BMI >35) women.   Among men age 50 and older, there was no 
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significant association between weight and having any “on-time” screening (p=.87) or 
having any past-year screening (n=100, p=.99).  Due to limited sample size, we were 
unable to control for potential confounders.   
Total scale scores for perceived barriers (F (3, 504) = .44, p=.72) and benefits (F 
(3, 650) = .25 p=.86) of screening did not significantly differ by weight group.  There 
was however, a significant association (p= .02) between weight group and the barrier 
“colorectal cancer screening tests are too expensive” with 42.9% of Obese II subjects and 
only 13.6% of normal weight subjects responding “agree a Lot.”  There was also a 
significant association (p= .04) between weight group and the barrier “My doctor or 
health care provider has never recommended a colorectal cancer screening test” with 
52.9% of Obese II participants vs. 36.4% of normal weight participants responding 
“agree a Lot.”38  These findings indicate that obese participants may be less likely to get a 
screening because it costs too much or the doctor did not recommend it.  We 
hypothesized that cost may be especially important to obese individuals who have more 
co-morbidities and thus competing health care costs.  As doctor recommendation is an 
important predictor of CRC screening, further research is needed to understand how this 
is contributing to weight-related screening barriers.  One study which examined breast 
cancer screening found that even after controlling for doctor recommendation, obese 
women still had lower rates of screening.78, 78  Aim 1 analyses will confirm if this is also 
the case for CRC screening. 
 
 
 
 
 
CHAPTER III 
INTERVENTION DESIGN 
III.A. Screening Behavior Theory 
 The overall goal of this research is to inform development of a theory-based intervention 
for increasing CRC prevention behaviors among obese women.  While multiple theories have 
been applied to screening behavior, Health Belief Model (HBM) has been used most frequently.  
Other popular theories include the transtheoretical model, the theory of planned behavior, social 
support/social networks and Social Cognitive Theory (SCT).  Based on the above review of the 
literature, several constructs from these theories have surfaced as being most salient to a CRC 
screening with obese women.  They include perceived barriers, perceived benefits, perceived 
risk/susceptibility, cues to action, patient-provider communication, social support, and self-
efficacy.  This section highlights the research supporting usage of the chosen theory and 
conceptual model.  
Perceived Susceptibility 
 Focus group data among obese women cited lower perceived susceptibility as a reason 
for low uptake of cervical cancer screening.68 Thus, obese individuals may not be fully aware of 
how much their weight increases their risk for cancer.   Perceived risk is also more strongly 
associated with CRC screening in women than in men.60  This may be related to the fact that 
CRC is often perceived as a man’s disease so women may have lower perceived susceptibility to 
start with.67  
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Perceived Barriers 
 The literature shows that there are significant barriers to all of the CRC screening tests, 
possibly even more so than screening tests for breast or cervical cancer.  As a whole, women 
report more barriers related to the unpleasantness of screening tests.  Having higher barriers is 
strongly correlated with low screening rates.64  Obese individuals report additional barriers to 
screening over and above typical barriers.38  These barriers are related to prejudice in the health 
care system, weight related personal discomfort, lack of appropriate facilities and equipment and 
higher numbers of co-morbidities.35, 72  Higher perceived barriers be largely responsible for the 
lower screening rates seen among obese women.  Specifically, we showed that obese individuals 
were more likely to report cost and lack of physician recommendation as barriers to CRC 
screening.38 
Perceived Benefits 
 Believing that screening leads to early detection of cancer or polyps is correlated with 
screening usage.  However, many individuals still express a great deal of fear over the possibility 
of finding cancer.  Misconceptions about the purpose of CRC screening tests are common among 
women.62 
Self-efficacy 
 Increasing patient self-efficacy to ask for screening is integral to any effective 
intervention that focuses on individuals or the patient-provider relationship.  One intervention 
study showed that over 50% of women needed activation cards to initiate screening 
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conversations with the doctor.  This indicated that women may have difficulty starting the 
conversation.79 
Social Support 
 Qualitative research among obese women noted the importance of social support from 
families and friends in encouraging compliance with screening tests.68  Instrumental support 
from healthcare providers and staff may also improve compliance with screening 
recommendations.  Obese women often face discrimination within the healthcare system and 
thus may not receive the same levels of social support for screening.71 
Cues to Action/Patient-Provider Communication 
Doctor recommendation for screening has been shown to one of the most important 
predictors of screening behavior, but obese individuals may not be receiving recommendations at 
the same rate as others.  Screening recommendation may serve as an important cue to action for 
–screening which may be enhanced by patient-provider communication.  While research has 
shown that better patient-provider communication is associated with CRC screening, the 
literature is mixed as to how an individual’s weight affects their relationship with health care 
providers
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Figure 3.1. Conceptual Model Guiding Aims 2 and 3 
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III.B Screening Interventions Methods 
  While CRC prevention interventions have been effective at increasing screening, 
to our knowledge there has never been an intervention that specifically targeted obese 
women.  Given their increased risk for CRC and lower rates of CRC prevention 
behaviors, they are an important group to target.  In addition, preliminary research 
indicates that obese individuals may not be adequately reached by current intervention 
strategies. 
Our research shows that, at least for physical activity, obese individuals may 
respond differently to CRC prevention interventions than normal or overweight 
individuals.  Analyses of WATCH follow-up data revealed a significant interaction effect 
(p=0.02) of weight group and intervention condition on recreational physical activity 
(RPA) METS at follow-up, but not for weight or condition alone.  Normal and 
overweight individuals receiving the Lay Health Advisor (LHA) intervention increased 
RPA more, whereas Obese I and II responded more to the Tailored Print and Video 
(TPV) intervention.  For CRC screening, the intervention-weight group interaction was 
not significant; only weight remained related to past year screening at follow-up (n= 266, 
p=0.08) with obese individuals reporting less CRC screening. Additionally, obese women 
in the LHA intervention group were less likely than normal or overweight women to 
report contact with a LHA at their church or to report participation in WATCH activities.  
This suggests that, at least for physical activity, a tailored intervention may be more 
effective than a social support intervention for promoting behavior change in obese 
women.80  We also found that even after the intervention, weight was still a significant 
predictor of whether or not a person completed a screening,80 indicating that current 
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interventions may not be adequate for overcoming weight-related screening disparities.  
These findings indicate that obese individuals may also have different preferences for 
how they receive their health information. A different study with African American 
women found variations in the efficacy of recruitment strategies based on BMI81 
however, this study found that women with higher BMIs were more likely to be recruited 
through social networks than women with lower BMIs.   
 Several of the studies have successfully employed tailored messages to increase 
screening behavior.82, 83  Tailored communications are formal individual communications 
in which the content and/or style of the materials have been created based on data 
specific to the individual and informed by health behavior theory. Theory suggest that 
tailored communications are more likely to be effective than generic materials because 
they provide personally relevant information that meets the exact information needs of 
readers and excludes irrelevant or superfluous facts.84, 85  It follows that when these needs 
are more closely met, an individual will be more likely to make desired changes in 
knowledge, belief, attitude, and to move towards behavior change.  However, some 
studies have shown that well designed targeted materials can be just as effective at 
changing health behaviors.86  The proposed research will test the acceptability and utility 
of targeting health messages to obese women.  If weight targeting proves useful, it could 
justify the use of weight-targeted messages in future intervention studies.  While 
messages for the current study will not be tailored, they will address relevant 
psychosocial and behavioral factors thought to mediate the relationship between weight 
and screening and weight and physical activity that are identified through literature 
reviews, formative research and health behavior theory.   
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III.C. Message Testing 
 Best practice for intervention design is to pre-test messages prior to conducting a 
randomized controlled trial.86, 87  Since much of the justification for the efficacy of 
targeted and tailored messages is explained by the elaboration likelihood model (ELM),88 
the message testing process will include ELM measures.  The ELM states that an 
individual with high motivation and ability to process a message will have higher 
elaboration likelihood, and thus persuasion will occur through a central route.  Persuasion 
which occurs through the central route is thought to be enduring, resistant to change, and 
predictive of future behavior.89  Conversely, when an individual has low motivation or 
ability to process a message they will have low elaboration likelihood and persuasion will 
occur through a peripheral processing route.  In this case the individual is influenced 
more by message characteristics such as source credibility and likeability.  These types of 
messages are thought to lead to more transitory behavior change.  Aim 3 will use the 
ELM to evaluate behaviorally-based messages which could be used in a future RCT 
designed to decrease CRC risk among obese women. 
III.D. Summary 
 Interventions are needed to decrease CRC risk among obese individuals.  CRC 
screening has been shown to significantly reduce CRC mortality.  Physical activity is also 
highly correlated with reduced CRC risk.  Obese women are the target population 
because they have some of the lowest rates of both screening and physical activity.  In 
addition, their weight also puts them at increased risk for CRC.  Research has shown that 
weight and physical activity are independent risk factors for CRC.  While promoting 
physical activity among obese women may produce some weight loss, the main focus of 
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the health promotion messages will not be to decrease weight unless formative research 
indicates that this would be appropriate.   Focusing on weight loss may detract from the 
main goal of this study which is to develop message which can be used in an intervention 
to reduce disparities in cancer screening and physical activity.  If effective, it may be 
possible to adapt these weight-targeted messages to be used to increase prevention 
behaviors for other cancers.  Weight-related disparities are also seen for breast and 
cervical cancer screening.  If common factors explain why obese women are not up-to-
date with screening tests, it may be possible to address correlates of multiple screening 
behaviors with one intervention. 
 
 
 
 
 
 
CHAPTER IV 
RACE MODERATES THE RELATIONSHIP BETWEEN OBESITY AND 
COLORECTAL CANCER SCREENING 
IV.A. Abstract 
The goal of this study was to determine if the relationship between obesity and 
usage of colorectal cancer (CRC) screening in women varies when stratifying by race.  
Using nationally representative data from the 2005 National Health Interview Survey, we 
examined the relationship between obesity and CRC screening for white and African-
American women ages 50 and older. Screening usage variables indicated if a woman was 
up-to-date for any CRC screening test, colonoscopy, or fecal occult blood test (FOBT).  
We used multivariable logistic regression models that included interaction terms to 
determine if race moderates the obesity-screening relationship.  We also calculated 
adjusted up-to-date colonoscopy rates using direct standardization to model covariates.  
The relationship between obesity and screening differed by race for any CRC screening 
test (p= 0.04 for interaction) and for colonoscopy (p=0.01 for interaction), but not for 
FOBT.  Obese white women had a lower adjusted colonoscopy rate (30.2%, 95%CI 25.9-
34.8) than non-obese white women (39.1%, 95%CI 36.1-42.2).  Obese African- 
American women, on the other hand, had a higher adjusted colonoscopy rate (41.2%, 
95%CI 31.6-51.4) than their non-obese counterparts (35.6%, 95%CI 28.3-43.6).  Overall, 
adjusted colonoscopy rates were lowest among obese white women.  In conclusion, 
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obesity is associated with lower CRC screening rates in white, but not African-American 
women.  
IV.B. Introduction 
Among women in the Unites States, colorectal cancer (CRC) accounts for 
approximately 10% of all cancers diagnosed annually and was responsible for an 
estimated 25,700 deaths in 2008, making it the third leading cause of cancer mortality.1  
Regular screening for CRC and adenomatous polyps starting at age 50 has the potential to 
significantly reduce CRC incidence and mortality.6, 7  Despite their proven effectiveness, 
utilization of CRC screening tests remains sub-optimal, especially when compared with 
screening for other cancers, like breast or cervical cancer.23-25  Among women under age 
65, over 85% are up-to-date with cervical cancer screening recommendations and over 
58% with breast cancer screening,10 but only 47.4% are meeting the CRC screening 
recommendations.28  Many barriers to CRC screening have been identified, including 
lack of physician recommendation for screening,56 lack of knowledge about testing 
options and intervals,58 and embarrassment about the testing procedure.67 
In addition, some research indicates that obesity may be a barrier to CRC 
screening in women.26, 34, 38, 39  Obesity is a prevalent condition in the United States, 
particularly among older women; it is estimated that more than 31% of women in the 
United States over age 60 are obese.5  There is a wide body of research showing a 
positive relationship between body mass index (BMI) and both colon cancer incidence 
and mortality.  One study found that morbidly obese women (BMI ≥ 40) were 49% more 
likely to get colon cancer than normal weight women.90  It is also estimated that obese 
women (BMI ≥ 30) have a 40-85% greater chance of dying from colon cancer than 
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normal weight individuals (BMI < 25).2  Because obese women are at high risk for colon 
cancer, failure to screen for CRC in this population could result in substantial morbidity 
and mortality.   
In order to decrease CRC risk among obese women it is important to understand if 
their weight is a barrier to receiving a screening that could potentially prevent them from 
ever getting colorectal cancer.  Several studies have investigated the relationship between 
CRC screening and bodyweight, but the results have been mixed.91  Two studies which 
used data from the Behavioral Risk Factor Surveillance Survey (BRFSS) showed that as 
weight increased the likelihood that an individual was adherent to CRC screening 
recommendations decreased for women, but not for men.26, 34  A medical record review 
of 22 medical practices found that both obese men and women had significantly lower 
rates of screening than their non-obese counterparts.39  Research on the Cancer 
Prevention II Nutrition Cohort, a predominately white (97%) study population, found 
that, compared to normal weight women, overweight, obese, and morbidly obese women 
were all significantly less likely to have had a flexible sigmoidoscopy or 
colonoscopy.92,93  However, three other studies have concluded that there was no 
statistically significant relationship between screening and weight.40-42  With the 
exception of Nutrition Cohort Study, the above-mentioned studies included a similar 
proportion of African Americans as is found in the U.S. population (range 9-21%).  
Despite this none of them stratified by race and gender, which could explain the mixed 
results.  Studies on screening usage for other cancer types suggest that stratifying by race 
and gender may be important.  For example, there is reasonable evidence to suggest that 
obesity is associated with lower breast and cervical cancer screening rates in white 
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women, but not for other races/ethnic groups.43-45  A similar pattern may also exist for 
women with regards to colorectal cancer screening.   
The goal of this study is to determine whether or not race moderates the 
relationship between CRC screening and obesity in women.  We hypothesize that, as was 
shown for breast and cervical cancer screening, there may be a previously unrecognized 
interaction between obesity and race that affects CRC screening rates.  If this interaction 
exists, it could explain why previous research examining the relationship between CRC 
screening and obesity in women has been inconsistent. 
IV.C. Methods 
Study Sample 
This analysis uses nationally representative data from the 2005 National Health 
Interview Survey (NHIS), which has one of the most comprehensive screening 
questionnaires of any national survey.94  NHIS is a multi-purpose health survey 
conducted by the Centers for Disease Control and Prevention’s National Center for 
Health Statistics and is the principal source of information on the health of the civilian, 
non-institutionalized, household population of the United States. The survey collects a 
variety of health related information including socio-demographic characteristics, basic 
indicators of health status, health insurance coverage, access to and utilization of health 
care services, medical conditions and history, and health behaviors.   
Detailed information on survey and sampling methods for NHIS can be found 
elsewhere.94  Briefly, NHIS uses a multistage sample design and one adult per family is 
randomly selected for an in-person interview by Census interviewers.  In 2005, the 
interviewed sample included 31,428 persons 18 years of age and older.  The final 
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response rate for adults was 69.0%,95 which is comparable to other national surveys.  For 
this analysis, individuals were excluded if they were under age 50, reported a race other 
than white/Caucasian or black/African-American, or if they had missing information on 
weight, colorectal cancer screening, or any relevant covariates. 
Measures 
Colorectal Cancer Screening.  The primary dependent variable for this analysis 
was a dichotomous variable any CRC Screening indicating whether or not a respondent 
reported being up-to-date with CRC screening. We classified an individual as being up-
to-date with CRC screening if he or she reported having a Fecal Occult Blood Test 
(FOBT) within the year prior to the interview, flexible sigmoidoscopy (flex sig) within 
the past 5 years, or colonoscopy within the past 10 years.  In addition to the primary 
screening variable, we looked separately at whether a respondent reported being up-to-
date for each of the following individual screening modalities: colonoscopy, any 
endoscopy (flex sig or colonoscopy) and FOBT.  For example, for the colonoscopy 
outcome, we only looked at whether or not an individual reported having a colonoscopy 
in the past 10 years and did not include any other screening modalities. 
The screening variables were created based upon responses to the following 
survey questions about CRC screening test completion 1.) “The following questions are 
about the blood stool or occult blood test, a test to determine whether you have blood in 
your stool or bowel movement. The blood stool test can be done at home using a kit. You 
smear a small amount of stool on cards at home and send the cards back to the doctor or 
lab. Have you EVER HAD a blood stool test, using a HOME test kit?”  2.) “Have you 
EVER HAD a sigmoidoscopy, colonoscopy, or proctoscopy? These are exams in which a 
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health care professional inserts a tube into the rectum to look for signs of cancer or other 
problems.”  For participants who answered yes to one or both of these questions, follow-
up questions ascertained exactly which test the respondent had and the approximate date 
of their last test.  Data on a particular test was coded as missing if the individual 
answered “don’t know” or refused the question.  If data on either endoscopy or FOBT 
was missing for a respondent, then the data was coded as missing for primary CRC 
screening variable. Screening data were available for 86% of female respondents age 50 
and older.   
Data were only collected for the respondent’s most recent endoscopic test 
(colonoscopy or flexible sigmoidoscopy) and her most recent FOBT.  For these tests, 
respondents were asked if the test was “part of a routine exam,” “because of a problem,” 
or for an “other reason.”  We completed analyses both including and excluding tests that 
were not reported to be part of a routine examine (i.e., diagnostic vs. screening).  
Although screening rates across the board were slightly higher when diagnostic tests were 
included, the trends remained the same.  For the results presented in this paper, diagnostic 
tests are included in the screening rate estimates since a test administered for diagnostic 
purposes still “counts” towards whether or not an individual is considered up-to-date with 
CRC screening guidelines. 
Obesity.  The primary independent variable for this analysis was the dichotomous 
variable obesity status (i.e., obese vs. non-obese).  We calculated each respondent’s BMI 
as weight in kilograms divided by height in meters squared based on responses to self-
reported questions on height and weight.  For the dichotomous obesity status variable we 
classified individuals as either obese (BMI ≥30) or non-obese (BMI 18.5-29.9).  Because 
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it was not clear whether the relationship between BMI and CRC screening would exhibit 
a threshold or graded pattern, we also examined results for trends using a BMI group 
variable.  For the BMI group variable, individuals were classified as underweight (BMI < 
18.5), normal weight (BMI 18.5–24.9), overweight (BMI 25.0–29.9), obese I (BMI 30.0–
34.9), obese II (BMI 35.0- 59.9) or obese III (BMI ≥ 40).   
Race/Ethnicity:  The original NHIS race variable included 6 possible categories:  
White only, Black/African-American, American Indian/Alaskan Native, Asian only, race 
group not releasable, and multiple races.  We converted race to a dichotomous variable, 
using only the first two racial groups (White and African-American); all other categories 
were excluded from the analysis.  These two racial sub-groups were examined because 
they have the highest CRC incidence rates of any racial sub-group.96  We coded ethnicity 
as a dichotomous variable (Hispanic vs. Non-Hispanic) based on participants’ responses 
to the question “[Do you] consider [yourself] Hispanic/Latino?”  Since there were no 
differences in the proportions of Hispanics in each of the race and obesity categories, we 
did not stratify analyses by ethnicity.  Additionally, separate analyses completed 
excluding Hispanics showed similar trends, thus we retained them in the final analyses. 
Other Covariates.  Several potential demographic, behavioral, and healthcare-
related confounders were included in the analyses because previous literature indicated 
that they might be associated with CRC screening.  Sociodemographic variables 
examined included age, education, and marital status.   Due to the high percentage of 
missing data for personal income (64%), NHIS created an imputed income variable using 
a variety of sociodemographic indicators.97  The original imputed income variable had 11 
categories, however for this analysis we collapsed it into 4 categories ($0-$24,999, 
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$25,000-$54,999, $55,000-74,999, and $75,000 and up).  Behavioral variables included 
smoking status (daily smoker, occasional smoker, former smoker or never a smoker), 
alcohol usage (never, former drinker, light drinker, or moderate/ heavy drinker) and 
recreational physical activity.  Physical activity was expressed as MET (metabolic 
equivalents) minutes per week.  This figure was calculated as (3 METs x moderate/light 
minutes/week) + (7 METS x vigorous minutes/week).  Recreational activity was then 
categorized as no activity/unable to exercise (0 METS), some activity (1-<675 MET 
minutes/week) or meets/exceeds the surgeon general’s recommendation (≥ 675 MET 
minutes/week).98  We coded both reported physician recommendation for screening 
(either FOBT or any endoscopic test) and insurance coverage as dichotomous (yes/no) 
variables.  Number of visits to a health care provider was ascertained using the question 
“During the past 12 months, how many times have you seen a doctor or other health care 
professional about your own health at a doctor’s office, clinic or some other place?  Do 
not include times that you were hospitalized overnight, visits to hospital emergency 
rooms, home visits, dental visits or telephone calls.”  A past-year visits variable was then 
created using the following categories: 0, 1, 2-3, 4-5, 6 or more.  Participants were also 
asked about co-morbidities: “Have you EVER been told by a doctor or other health 
professional that you had [condition]?”   We used a sum of all yes answers for the 
following conditions to determine the number of co-morbidities: hypertension, 
myocardial infarction, coronary heart disease, other heart disease, emphysema, stroke, 
asthma, any kind of cancer, ulcer, diabetes or arthritis.  Number of co-morbidities was 
then categorized as 0, 1, 2-3, 4-5 and 6 or more.   
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 Statistical Analyses 
All analyses were conducted using SAS v9.1.3 to account for the multistage 
sampling structure used by NHIS (Procedures: SURVEYFREQ, SURVEYMEAN, 
SURVEYLOGISTIC).  We limited all analyses to women age 50 and older, since this is 
the age at which screening is first recommended for normal risk individuals.  
Additionally, we used NHIS sampling weights for all analyses to create U.S. population 
estimates.  We used Rao-Scott chi-square99 to test for relationships between any CRC 
screening (up-to-date or not) and each of the covariates for both races and then separately 
for white and African-American women.  Rao-Scott chi-square tests were also used to 
examine the relationship between obesity status (obese vs. non-obese) and all covariates.   
All covariates found to be associated (p<0.1) with either screening or obesity 
status were entered into a multivariable logistic regression model with screening as the 
dependent variable.  We created four separate regression models for each of the screening 
variables (Any CRC screening, colonoscopy, endoscopy and FOBT) to test the 
significance of the interaction term (obesity status X race) while controlling for possible 
confounders.    A step-wise elimination procedure was used to create a logistic regression 
model of the relationship between each screening outcome variable and the interaction 
term while holding the race and obesity status variables constant in the model.  We 
eliminated potential confounders if they had a p-value > 0.1 and did not change the 
estimate of the interaction term by more than 10%.  The regression model was also run 
using the BMI group variable, and results were found to be similar; thus for simplicity 
further analyses were performed using the obesity variable.    
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We calculated adjusted odds ratios of the relationship between obesity and 
colonoscopy, stratified by race, using multivariable logistic regression to control for 
confounders.  Both unadjusted and adjusted screening rates, including 95% confidence 
intervals, are reported for selected sub-groups.  Adjusted colonoscopy rates for each 
weight and race group were calculated by direct standardization to the demographic 
characteristics of the study population using the coefficients from the multivariable 
model.100 
IV.D. Results 
Descriptive Statistics 
Since NHIS is designed to be nationally representative, demographic 
characteristics of this population should reflect those of White and African-American 
women age 50 and older in the United States (Table 4.1).  The average age of this 
population is 64.5 (95%CI 64.2-64.8) and the mean BMI is 32.0 (95%CI 31.5-32.5).  
Overall, 28.3% (95%CI 27.1- 29.6) of women were obese and 51.7% (95%CI 50.1-52.9) 
were up-to-date with any CRC screening.  Obesity was more prevalent in African-
American women than in white women (33.0% vs. 24.9%, p<0.0001).  All measures 
capturing screening rates were significantly higher for white women (Table 1).  Using 
combined data from all women, a statistically significant non-linear relationship was seen 
between the primary CRC screening variable and the following variables: age, marital 
status, alcohol usage, and smoking status (Table 4.2).  Women ages 70-79, married 
women, light drinkers and former smokers had the highest screening rates in their 
respective categories.  There was also significant positive association between screening 
and the following variables: reported physician recommendation for screening, past-year 
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healthcare visits, number of co-morbidities and recreational physical activity.  We did not 
find any differences in reported rate of physician recommendation for screening between 
obese and non-obese women overall or when stratifying by race (data not shown).   
Additionally, there were no statistically significant differences in CRC screening rates 
between insured and uninsured women (50.8% vs. 51.8%, p=0.6).   
Unadjusted Screening Rates   
Unadjusted screening rates, stratified by obesity status and race, are shown in 
Table 4.3.  When white and African-American women were combined, there was little 
overall difference in the proportion of women up-to-date with any CRC screening by 
obesity status. We did identify a difference in the percent of obese women who were up-
to-date for colonoscopy (p=0.02), compared with the percent of non-obese individuals 
who were up-to-date.  Colonoscopy rates for obese women were 3.9 percentage points 
lower than those for non-obese women (95%CI  0.7, 7.2).  In the unadjusted analysis, the 
relationship between obesity status and CRC screening differed according to race, but 
again only for the colonoscopy variable.  Among whites, obese women were less likely to 
be up-to-date for colonoscopy compared with non-obese women (40.3% vs. 44.7%, 
p=0.01).  Conversely, among African-American women, there was no statistically 
significant relationship between obesity and colonoscopy usage (35.3% for non-obese 
women vs. 38.1% for obese women, p=0.51). 
Obesity-Race Interaction 
Multivariable logistic regression models indicated that race moderates the 
relationship between up-to-date CRC screening and obesity for all screening tests except 
FOBT alone.  There was a statistically significant association (p = 0.04) between the 
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interaction term (obesity status X race) and the primary CRC screening variable (any up-
to-date screening) when controlling for reported physician recommendation, past-year 
medical visits, number of co-morbidities, education, smoking status, physical activity, 
and age.  The interaction term was also significant in the models which had up-to-date 
colonoscopy (p=0.01) and up-to-date endoscopy (p=0.02) as their dependent variables.  
When past-year FOBT was used as an outcome variable, neither race, obesity, nor the 
interaction term were found to be significantly related to screening, after controlling for 
potential confounders.   
Race-Stratified Regression Analyses 
Multivariable logistic regression models were created to look at the relationship 
between colonoscopy usage and the selected covariates in white and African-American 
women separately (Table 4.4).  The models were similar for the three screening outcomes 
which were associated with the interaction term (any CRC screening, colonoscopy, and 
endoscopy); however only race-stratified adjusted odds ratios for up-to-date colonoscopy 
are reported since this is the screening test with usage most strongly associated with 
obesity status.  Even after controlling for potential confounders, obesity was still 
significantly related to colonoscopy usage in white women (p=0.001).  Among white 
women, the odds of being up-to-date for colonoscopy was 33% lower for obese women 
compared to non-obese women (OR=0.67, 95%CI 0.53-0.86).  There was a non-
significant trend among African-American women indicating that obesity actually 
increased the odds that a woman was up-to-date with a colonoscopy.   
Physician recommendation for screening was the most significant predictor of 
colonoscopy for both races.  White women who reported receiving a recommendation for 
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screening from their physician had a much higher odds of having an up-to-date 
colonoscopy than those who did not receive a recommendation (OR=59.72, 95%CI 
47.10-75.72).  The association was even greater for African-American women 
(OR=145.58, 95%CI 75.69-283.86).  Among whites, having an up-to-date colonoscopy 
was also significantly (p<0.05) associated with older age, a greater number of co-
morbidities, and a greater number of medical visits.  Among African-American women, 
colonoscopy was significantly associated with a higher number of past-year medical 
visits (p=0.01). 
Adjusted colonoscopy rates were created to examine differences between obese 
and non-obese white and African-American women after accounting for possible 
confounders included in the regression model for up-to-date colonoscopy (Figure 4.1).  
Obese white women had an adjusted colonoscopy rate of 30.2% (95%CI 25.9-34.8) 
which was significantly lower than the 39.1% (95%CI 36.1-42.2) colonoscopy rate seen 
in non-obese white women (p=0.001).  Obese African-American women, on the other 
hand, had a higher adjusted colonoscopy rate (41.2%, 95%CI 31.6-51.4) than their non-
obese counterparts (35.6%, 95%CI 28.3-43.6), but these differences were not statistically 
significant (p=0.16).  Overall, adjusted colonoscopy rates were lowest among obese white 
women. 
IV.E. Discussion 
Our analysis found that race moderates the relationship between obesity and colon 
cancer screening usage.  Among white women, being obese reduced the chances that a 
woman was up-to-date with CRC screening.  The opposite, however, was true for 
African-American women, for whom obesity was associated with higher screening rates.  
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This screening disparity appears to be driven by the lower rates of colonoscopy seen 
among obese white women since the interaction between obesity and race affected 
whether or not a woman was up-to-date for any type of screening test and colonoscopy or 
flexible sigmoidoscopy, but was not related to past-year FOBT usage.  Similar to past 
research on screening correlates, reported physician recommendation had the largest 
affect on reported screening rates, however obesity was still related to screening even 
after controlling for reported recommendation and other factors.  The relationship 
between CRC screening and health insurance has been inconsistent across studies.101  In 
this analysis, whether or not a woman reported having health insurance was not related to 
being up-to-date with CRC screening.  
Previous studies which have examined the relationship between screening and 
weight have shown mixed results.  Three of these studies were limited to a specific 
geographic area and/or did not include high numbers of African Americans.39, 40, 92  Even 
studies which used more nationally representative data from BRFSS, were not able to 
differentiate between colonoscopy and flexible sigmoidoscopy, which have different 
screening timeframes and thus were not accurately able to classify women as up-to-date 
for colonoscopy or not.26, 34, 102  One advantage of using data from NHIS is that it is 
sampled and weighted to be representative of the U.S. population.  It also has one of the 
most comprehensive screening questionnaires of any nationally representative survey.  
Unlike BRFSS and other surveys, NHIS is able to differentiate between flexible 
sigmoidoscopy and colonoscopy.  Additionally, NHIS is interviewer administered and 
allows respondents to answer in multiple formats to indicate when they had their last 
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screening, which improves data accuracy.  NHIS also included questions about many 
covariates including doctor recommendation for screening.   
Only two previous studies have looked at the relationship between weight and 
screening using NHIS data, both of these used data from 2000.  While both studies 
controlled for relevant confounders, they did not stratify their results by gender or race.  
Seeff et al. found no differences between normal, overweight or obese individuals for 
rates of past year-FOBT or endoscopy in the previous 10 years. A study by Wee et al. 
found a statistically significant relationship between screening and BMI, similar to our 
results, but this relationship was attenuated in the adjusted model.  The present study 
improved upon previous research on CRC screening and weight by using a 
comprehensive nationally representative data set, examining each recommended 
screening modality within its recommended time frame, and stratifying results by race 
and gender.  The literature on how weight affects breast and cervical cancer screening 
rates in women indicate that stratifying by race is appropriate and necessary.  Similar to 
our findings with colonoscopy, previous research has shown that obese white women 
have lower rates of mammography and pap smears than non-obese white women, but 
there was no relationship between these screening tests and obesity in African American 
women.43-45 
Despites its many advantages, using NHIS data did present a few limitations.  
First, because it is meant to be representative of the U.S. population, it has much smaller 
number of African-Americans and other minority groups compared to whites.  Small 
numbers in the African-American group limit the power of the analysis as compared to 
that done with white women.  Another limitation of NHIS is that it does not include 
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questions on Barium Enema, a recommended screening test, so some women who have 
had this test may be improperly classified.  We do not believe this will appreciably affect 
the data since barium enema has steeply declined over the last decade and is now rarely 
used to screen for colon cancer; approximately 0.05 % of the Medicare population 
received a barium enema in 2005.103  
Future research is needed to better understand why obese white women are less 
likely to get screened than their non-obese counterparts.  Findings from the breast and 
cervical cancer screening literature provide some insights.  In one study investigating 
barriers to gynecological screening, more than half of morbidly obese women reported 
that they delayed seeking health care because of their weight and over 70% reported that 
their weight was a barrier to receiving appropriate health care.35, 43  In a recent qualitative 
study examining mammography usage, obese women reported additional barriers to 
screening, including previous bad experiences, discomfort, fear, poor treatment by 
providers, and low perceived susceptibility to cancer.  They also stated that having a 
female doctor would increase their likelihood of having a screening.1
                                               
1 Personal communication with Jeanne Ferrante (New Jersey-Robert Wood Johnson Medical School) 
regarding unpublished focus group data. 
  It has been 
suggested that obese individuals may have lower screening rates because they have more 
co-morbidities or acute needs which may be prioritized over cancer screening tests.69, 70  
Conversely, our data supports previous studies which have actually shown a positive 
relationship between screening and number of reported medical conditions.59  
Nevertheless, these theories do not fully explain why weight-related screening disparities 
may differ by race.    
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It is possible that racial differences in screening are related to differences in body 
image and body esteem.  Previous research has indicated that obese women may delay 
preventive care because they are embarrassed or fear disrespectful treatment because of 
their weight.72  Many obese women also are deterred from going to the doctor because 
they do not want to receive unsolicited weight loss advice and they are made 
uncomfortable by small gowns and equipment which may not be appropriate for their 
size.  These issues may be particularly salient for women who have poor body image or 
body esteem.  This could explain why obese African-American women, who tend to be 
more accepting of a larger body size than their white counterparts,104 do not have lower 
screening rates than non-obese African-American women.   
Body image-related issues may also explain why obesity appeared to affect rates 
of endoscopic tests, particularly colonoscopy, but not of FOBTs.  The invasive nature of 
the colonoscopy and the fact that it must be performed in a clinical setting (as opposed to 
at home which is the case with FOBT), may explain why screening rates are lower for 
obese women, but not men. One focus group study found that men and women had 
similar views about FOBT testing, but noted gender differences in attitudes towards 
colonoscopy.67  Women expressed more anxiety about being unclothed and exposed 
during endoscopic procedures.  These feelings could be enhanced in higher weight 
women, especially if they have poor body image.   
While the present study provides further evidence that obesity affects screening 
behavior in women, especially for more invasive tests like colonoscopy, it is still unclear 
why these disparities exist.  Qualitative research is needed to better understand how 
weight affects a woman’s decision to get a cancer screening.  Once the source of  weight-
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related screening disparities are better understood, we can improve screening promotion 
and education to better meet the needs of women with the lowest screening rates.  
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Figure 4.1 Race Stratified Adjusted* Colonoscopy Rates for Women Age 50 and Older by Obesity Status. 
 
*Adjusted colonoscopy rates for each weight and race group were calculated by direct standardization to 
the demographic characteristics of the study population using the coefficients from the multivariable 
model.100   
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 Table 4.1 Characteristics of White and African-American Women Age 50 and Older in the U.S. 
 
White and 
African-
American 
(n=7,469) 
White Only 
(n=6,459) 
African-
American 
Only 
(n=1,010) 
P-value* 
Screening 
 Up-to-date for Any CRC  
 Screening 
 Up-to-date Colonoscopy 
 Up-to-date Endoscopy 
 Up-to-date FOBT 
 
 
51.7% 
42.3% 
45.3% 
15.4% 
 
 
52.5% 
43.0% 
46.0% 
15.7% 
 
 
44.8% 
36.1% 
39.2% 
12.7% 
 
 
0.0004 
0.002 
0.002 
0.046 
Hispanic/Latino Origin 23.9% 23.8% 25.4% 0.34 
Age 
  50-59 
 60-69 
 70-79 
 80+ 
 
40.9% 
26.9% 
19.2% 
13.0% 
 
40.3% 
26.9% 
19.4% 
13.5% 
 
46.4% 
26.9% 
17.5% 
9.2% 
 
 
 
 
0.001 
BMI Group 
 Underweight 
 Normal Weight 
 Overweight 
 Obese I 
 Obese II 
 Obese III 
 
2.1% 
37.3% 
32.8% 
16.6% 
6.7% 
4.4% 
 
2.3% 
39.1% 
32.3% 
16.1% 
6.3% 
3.9% 
 
1.1% 
21.7% 
37.4% 
21.0% 
10.1% 
8.6% 
 
 
 
 
 
 
<0.0001 
Marital Status 
 Married/Living w/Partner 
  Divorced/Separated 
 Never Married 
 Widowed 
 
56.4% 
15.3% 
4.7% 
23.7% 
 
59.0% 
13.9% 
3.9% 
23.1% 
 
34.0% 
26.8% 
10.9% 
28.2% 
 
 
 
 
<0.0001 
Education 
 Less than High School 
 High School/ GED 
 Some College/ Associates  
 College Degree 
 Graduate/ Professional  
 
37.4% 
22.2% 
22.2% 
12.8% 
5.7% 
 
36.9% 
22.5% 
22.1% 
12.7% 
5.8% 
 
38.5% 
20.1% 
22.8% 
13.9% 
4.7% 
 
 
 
 
 
0.46 
Personal Income 
 $0-$24,999  
 $25,000-$54,999  
 $55,000-$74,999  
 $75,000 and up 
 
46.5% 
33.9% 
9.2% 
10.4% 
 
46.7% 
33.5% 
9.0% 
10.7% 
 
44.4% 
37.3% 
10.1% 
8.1% 
 
 
 
 
0.26 
Health Insurance Coverage 83.7% 83.6% 84.5% 0.52 
Past Year Medical Visits 
 0 
 1 
 2-3 
 4-5 
 6 or more 
 
7.9% 
11.6% 
24.8% 
18.4% 
37.4% 
 
7.8% 
11.8% 
24.7% 
18.2% 
37.5% 
 
8.0% 
10.1% 
25.2% 
19.9% 
36.7% 
 
 
 
 
 
0.62 
Physician CRC Screening 
Recommendation 
 
56.4% 
 
58.6% 
 
50.4% 
 
0.0002 
Self- Reported Health Status 
 Excellent 
 Very Good 
 Good 
 
33.9% 
29.3% 
26.3% 
 
33.9% 
29.4% 
26.3% 
 
33.7% 
28.7% 
26.6% 
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 Fair 
 Poor 
7.6% 
2.9% 
7.6% 
2.8% 
7.5% 
3.4% 
 
0.93 
Co-Morbidities 
 0 
 1 
 2-3 
 4-5 
 6 or more 
 
21.9% 
27.3% 
36.1% 
11.6% 
3.1% 
 
22.4% 
27.6% 
35.5% 
11.4% 
3.0% 
 
17.4% 
24.7% 
40.6% 
13.8% 
3.6% 
 
 
 
 
 
0.002 
Alcohol usage 
    Never 
 Former 
 Light 
   Moderate/ Heavy 
 
32.2% 
20.0% 
36.6% 
11.3% 
 
30.8% 
19.2% 
37.9% 
12.1% 
 
44.1% 
26.5% 
25.7% 
4.0% 
 
 
 
 
<0.0001 
Smoking Status 
   Daily 
    Occasional 
 Former 
 Never 
 
11.4% 
2.2% 
26.5% 
59.8% 
 
11.3% 
2.1% 
27.1% 
59.5% 
 
12.5% 
3.8% 
21.8% 
61.9% 
 
 
 
 
<0.0001 
Recreational Physical Activity 
(MET minutes/week) 
 None/Unable to exercise 
 <675  
 >675 
 
 
47.5% 
30.0% 
22.5% 
 
 
45.6% 
30.7% 
23.7% 
 
 
63.6% 
24.8% 
11.7% 
 
 
 
 
<0.0001 
 * P-value calculated using Rao-Scott Chi-Square test of the relationship between race and the selected 
variable 
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Table 4.2 CRC Screening Rates for White and African-American Women Age 50 and Older: Percent Up-
to-date for Screening by Selected Demographic and Health Characteristics. 
 
 
White and 
African-American 
(n=6,412) 
White 
(n=5,566) 
African-American 
(n=846) 
Ethnicity 
   Hispanic 
   Non-Hispanic 
 
52.4%  
51.5%  
p=0.58 
 
52.9%  
52.1%  
p=0.66 
 
44.7%  
44.5%  
p=0.96 
Age 
  50-59 
 60-69 
 70-79 
 80+ 
 
42.5%  
58.2%  
60.4%  
55.7% 
P<0.0001 
 
43.0%  
58.2%  
61.3%  
56.6%  
p<0.0001 
 
37.7%  
56.1%  
49.8%  
39.7%  
p=0.0009 
BMI Group 
 Underweight 
 Normal Weight 
 Overweight 
 Obese I 
 Obese II 
 Obese III 
 
50.5%  
51.9%   
54.0%   
50.4%  
52.5%  
48.7%  
p=0.52 
                                     
52.4%  
 52.8%  
54.8%  
50.7%  
53.6%  
49.2%  
 p=0.54             
                                   
18.8%  
37.5%  
48.0%  
48.3%   
45.9%  
46.8%  
 p=0.27                       
Marital Status 
 Married/Living with  
 Partner 
  Divorced/Separated 
 Never Married 
 Widowed 
 
 
52.9%  
48.6%  
44.4%  
52.4%  
p=0.01 
                                                                   
 
53.3%  
48.6%  
47.4%  
53.9%  
p=0.04 
 
46.9%  
48.8%  
35.8%  
42.1%  
p=0.23 
Education 
 Less than High School 
 High School/ GED 
 Some College/ Associates  
 College Degree 
 Graduate/ Professional  
 
51.7%  
49.1%  
52.5%  
55.8%  
46.6%  
p=0.06 
 
52.6%  
50.0%  
52.7%  
58.0%  
45.9%  
p=0.02 
 
44.3% 
40.1%  
50.6%  
39.6%  
53.3%  
p=0.37 
Personal Income 
 $0-$24,999  
 $25,000-$54,999  
 $55,000-$74,999  
 $75,000 and up 
 
49.3%  
51.2%  
54.4%  
56.1%  
p=0.20 
 
49.8%  
52.3%  
54.1%  
56.9%  
p=0.22 
 
45.1%  
42.3%  
56.4%  
45.5%  
p=0.61 
Health Insurance 
 Covered 
 Not Covered 
 
 
50.8%  
51.8%  
p=0.60 
 
51.7%  
52.7%  
p=0.62 
 
43.0%  
44.5%  
P=0.78 
Past Year Medical Visits 
 0 
 1 
 2-3 
 4-5 
 6 or more 
 
18.0%  
39.3%  
49.7%  
58.0% 
61.4%  
p<0.0001 
 
18.1%  
40.5%  
51.1%  
59.6%  
61.4%  
p<0.0001 
 
17.5%  
27.2%  
37.2%  
46.7%  
61.2%  
p<0.0001 
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Physician CRC Screening 
Recommendation  
 No 
 Yes 
 
 
12.5%  
87.5%  
p<0.0001 
 
 
12.9%  
86.2%  
p<0.0001 
 
 
9.2 % 
85.8 % 
p<0.0001 
Self- Reported Health Status 
 Excellent 
 Very Good 
 Good 
 Fair 
 Poor 
 
51.9%  
52.0% 
51.0%  
49.8%  
59.2%  
p=0.42 
 
52.7%  
52.6%  
51.9%  
51.2%  
59.3%  
p=0.63 
 
44.7%  
47.2%  
42.9% 
38.1%  
58.7%  
P=0.55 
Co-Morbidities 
 0 
 1 
 2-3 
 4-5 
 6 or more 
 
36.9%  
50.6%  
57.3%  
62.3%  
58.1%  
p<0.0001 
 
37.4%  
52.0%  
58.3%  
63.1%  
59.1%  
p<0.0001 
 
31.3% 
36.5% 
49.5%  
56.4%  
50.4%  
p=0.002 
Alcohol usage 
    Never 
 Former 
 Light 
   Moderate/ Heavy 
 
44.9%  
52.4%  
56.1%  
55.2%  
p<0.0001 
 
46.5% 
52.3%  
56.4% 
55.4%  
p<0.0001 
 
35.4%  
52.8%  
52.2%  
49.8%  
p=0.0004 
Smoking Status 
   Daily 
    Occasional 
 Former 
 Never 
 
36.3%  
43.7%  
59.0%  
51.8%  
p<0.0001 
 
36.0%  
49.1%  
59.1%  
52.8  
p<0.0001 
 
38.1%  
18.7%  
57.4%  
43.2%  
P=0.004 
Recreational Physical Activity 
(MET minutes/week) 
 None/Unable to exercise 
 <675  
 >675 
 
 
44.3% 
57.9% 
58.8% 
p<0.0001 
 
 
45.3% 
58.3% 
58.5% 
p<0.0001 
 
 
38.4% 
53.8% 
64.1% 
p<0.0001 
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Table 4.3 Race Stratified Unadjusted CRC Screening Rates for Women Age 50 and Older by Obesity 
Status. 
 
 White and African-American Women White Women 
African-American 
Women 
 Non-Obese Obese Non-Obese Obese Non-Obese Obese 
Up-to-date for Any 
CRC Screening, % 
(95% CI) 
52.9 
(51.1-54.6) 
50.6 
(47.9-53.3) 
53.7 
(51.8-55.5) 
51.2 
(48.1-54.2) 
44.1 
(38.6-49.5) 
47.4 
(41.1-53.7) 
p=0.17 p=0.16 p=0.44 
Up-to-date 
Colonoscopy, % 
(95% CI) 
43.9 
(42.1-45.7) 
40.0 
(37.3-42.7) 
44.7 
(42.8-46.5) 
40.3 
(37.3-43.2) 
35.3 
(29.8-40.9) 
38.1 
(31.9-44.3) 
p=0.02 p=0.01 p=0.51 
Up-to-date 
Endoscopy, % (95% 
CI) 
46.7 
(45.0-48.5) 
43.6 
(40.9-46.3) 
47.5 
(45.6-49.3) 
44.0 
(41.0-47.0) 
38.8 
(33.4-44.3) 
41.0 
(34.8-47.2) 
p=0.06 p=0.06 p=0.61 
Up-to-date Fecal 
Occult Blood Test, 
% (95% CI) 
15.2 
(14.0-16.4) 
15.9 
(14.0-17.8) 
15.4 
(14.2-16.7) 
16.5 
(14.4-18.7) 
12.5 
(9.2-15.8) 
12.4 
(8.4-16.4) 
p=0.53 p=0.39 p=0.96 
Note: Non-obese = BMI 18.5-29.9, Obese = BMI 30+ 
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Table 4.4 Adjusted Odds Ratios for Up-to-date Colonoscopy. 
 White  
(n=4,430) 
African-American 
(n=690) 
Predictor Variable Odds Ratio 
(95%CI) 
P-Value* Odds Ratio (95%CI) P-
Value
* 
Obesity 
 Non-Obese 
 Obese 
 
1.00 
0.66 (0.50-0.85) 
 
 
0.001 
 
1.00 
1.30 (0.83-2.96) 
 
 
0.16 
Age 
 50-60 
 60-70 
 70-80 
 80+ 
 
1.00 
2.00 (1.51-2.65) 
2.84 (1.80-3.53) 
2.52 (1.80-3.53) 
 
 
 
 
<0.0001 
 
1.00 
1.97 (0.90-4.30) 
2.52 (0.95-6.72) 
2.39 (0.91-6.29) 
 
 
 
 
0.08 
Physician CRC Screening 
Recommendation  
 No  
 Yes 
 
 
1.00 
59.72 (47.10-75.72) 
 
 
 
<0.0001 
 
 
1.00 
145.58 (75.69-283.86) 
 
 
 
<0.001 
Past Year Medical Visits 
 0 
 1 
 2-3 
 4-5 
 6 or more  
 
1.00 
1.01 (0.57-1.78) 
1.20 (0.71-2.04) 
1.82 (1.05-3.17) 
1.92 (1.12-3.30) 
 
 
 
 
 
0.001 
 
1.00 
1.60 (0.45-5.69) 
1.28 (0.11-3.97) 
4.73 (1.40-15.96) 
4.37 (1.29-14.80) 
 
 
 
 
 
0.01 
Co-Morbidities 
 0 
 1 
 2-3 
 4-5 
 6 or more 
 
1.00 
1.00 (0.71-1.40) 
1.31 (0.91-1.88) 
1.29 (0.82-2.04) 
2.26 (1.23-4.16) 
 
 
 
 
 
0.03 
 
1.00  
0.51 (0.20-1.28) 
0.56 (0.22-1.41) 
0.52 (0.19-1.44) 
0.89 (0.27-2.95) 
 
 
 
 
 
0.50 
Education 
 Less than High School 
 High School/ GED 
 Some College/Associates  
 College Degree 
 Graduate/ Professional 
 
1.00 
0.92 (0.70-1.21) 
1.21 (0.90-1.63) 
1.49 (1.06-2.08) 
0.82 (0.48-1.40) 
 
 
 
 
 
0.05 
 
1.00 
0.40 (0.16-0.95) 
0.97 (0.40-2.30) 
1.03 (0.42-2.56) 
1.34 (0.59-5.32) 
 
 
 
 
 
0.23 
Recreational Physical Activity  
 None/Unable to exercise 
 <675  
 >675 
 
 
1.00 
1.26 (0.97-1.63) 
1.35 (1.02-1.78) 
 
 
 
 
0.06 
 
 
1.00 
2.41 (1.12-5.17) 
1.77 (0.59-5.32) 
 
 
 
 
0.06 
* P-value based on Wald Chi-Square test 
  
 
 
 
CHAPTER V 
INCREASING COLORECTAL CANCER SCREENING AMONG OBESE 
WOMEN 
V.A. Abstract  
Obese women are at higher risk for colorectal (CRC) cancer, but are less likely to 
engage in preventive screening.  We conducted 7 focus groups with obese (BMI ≥30) 
white and African American women age 50 and older who were not currently adherent to 
CRC screening guidelines (N=31).  Topics discussed included perceived benefits and 
barriers to screening, patient-provider communication, healthcare decision making, and 
preferred sources of health information.  Overall, knowledge about CRC and 
understanding of the purpose of screening tests was low.  Most women did not recognize 
that their weight might put them at higher risk for CRC.  They cited many barriers to 
screening including cost and unpleasantness, but few benefits.  Women discussed several 
healthcare and provider-related factors which might help or hinder screening behavior; 
the importance of shared decision making and provider thoroughness was frequently 
mentioned.  Several organizational level changes, including patient screening reminders, 
were also suggested.  Public education about CRC prevention is poor, particularly among high risk groups such as obese and African American women.  Improving patient-provider communication and including information about risk factors for 
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CRC and the benefits of screening in health promotion messages may help improve screening rates.     
V.B. Introduction  
Obese women have both higher incidence and mortality rates for many cancers, 
including colorectal cancer (CRC).  Research has shown that morbidly obese women 
(BMI ≥ 40)  are 49% more likely to get colon cancer than normal weight women90  and 
that obese women (BMI ≥ 30) have a 40-85% greater chance of dying from colon cancer 
than normal weight individuals (BMI < 25).2  Despite their increased risk for cancer, 
evidence suggests that obese individuals may be less likely to engage in health-promoting 
behaviors such as cancer screening tests.26, 34, 36-38, 91  This appears to be true for all three 
recommended cancer screenings for women in the United States (breast, cervical and 
colorectal).  Particularly concerning is that compliance with screening recommendations 
for CRC is much lower than it is for breast or cervical cancer.10, 23, 24  A recent study 
found that obese white women have significantly lower CRC screening rates than non-
obese women.105  However, this association did not appear to exist for African-American 
women.   While a positive relationship between BMI and screening may only be confined 
to white women,34, 44, 45, 105, 106 improving screening rates in both white and African 
American women is important since these two groups suffer from the highest rates of 
CRC.  Unfortunately, women in both racial groups have lower CRC screening rates than 
their male counterparts,56, 61 even though CRC is the 3rd most common cause of cancer 
death for both sexes.1 
Regular screening for CRC and adenomatous polyps has the potential to 
significantly reduce CRC incidence and mortality.6, 7  The American Cancer Society 
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guidelines for screening and surveillance for the early detection of adenomatous polyps 
and CRC recommend that all average risk individuals begin screening at age 50.10  In 
order to increase CRC screening among obese women, it is important to first understand 
what is causing the weight-related disparities.  For example, obese women may have 
more or different barriers to CRC screening than non-obese women.  Unfortunately we 
could find no previous studies that specifically address factors that either help or hinder 
obese women to get screened for CRC.   
Many quantitative studies have focused on correlates of CRC screening and can 
provide some insight into the factors that may determine screening behavior.  One of the 
strongest predictors of screening is physician recommendation,56 so it is hypothesized 
that differential rates of physician referral may explain some of the weight-related 
screening disparities. However, data from the National Health Interview Survey showed 
that the likelihood of having a colonoscopy in the past 10 years was 33% lower for obese 
white women compared to non-obese white women, even after controlling for reported 
rate of physician recommendation for screening.105 Previous research also indicates that 
general patient-provider communication, independent of screening recommendation, may 
also have a significant influence on screening usage.57-59  In addition, several 
psychosocial variables are positively correlated with screening including knowledge of 
testing intervals, greater perceived susceptibility, greater perceived support,58 and lower 
barriers to screening.64   
While decreased weight could reduce obese women’s cancer risk, it is still unclear 
exactly how a women’s weight affects her decisions about cancer screening.  Qualitative 
research approaches may provide such insight.  Thus, the goal of the present study was to 
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use focus group methodology to better understand why obese women choose to engage or 
not engage in CRC screening.  By uncovering the root causes of the disparity we see in 
behavior, we will be better equipped to develop interventions to increase screening rates.   
V. C. Methods 
Recruitment 
 Women age 50 and older were recruited using mass e-mail, study flyers, and 
word-of-mouth.  Periodic recruitment e-mails announcements were sent to all affiliates of 
the University of North Carolina at Chapel Hill.  Flyers were distributed in various 
locations in Orange and Durham counties in NC (USA), including hospitals, senior 
centers, community centers, and exercise facilities.  To participate, interested women had 
to contact the study staff; women in current research databases were contacted directly.  
Each potential participant was screened for eligibility by our staff.  A woman was eligible 
if she had a BMI≥29, was 50 or older, reported her race as white or African 
American/Black and was not currently up-to-date with CRC screening recommendations 
(Stool card test within 1 year, colonoscopy within 10 years or other CRC screening test in 
the past 5 years).  Because BMI was based on self-reported height and weight, we used a 
slightly lower cutoff (29 kg/m2) than the traditional obesity cut-off (BMI≥30) since obese 
women on average tend to underreport their weight and over-report their height leading 
to an underestimated BMI.107 
Focus Groups 
The focus groups were structured to be homogeneous with respect to race.  We 
conducted a total of 4 groups with white women and 3 groups with African American 
women.  Groups ranged from 2-7 participants each and were conducted at the UNC 
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Gillings School of Global Public Health.  Upon arrival, each woman completed a consent 
form and a brief demographic questionnaire.  Prior to the discussion, we informed 
participants about purpose of the study, explained how focus groups worked, and 
answered any questions.  The discussion was led by a trained moderator and was audio 
recorded.  In addition, notes were taken by at least one note taker.  Each focus group 
lasted between 1.5 and 2 hours total.  As an incentive, women were served dinner during 
the focus group as well as given a check for $30.  
The moderator led the discussion using a semi-structured focus group guide, 
which was developed using current literature on weight, preventive healthcare, cancer 
screening, and physical activity.  Questions were guided by the Health Belief Model108 
and social support theories;109 they focused on perceived barriers and benefits to CRC 
screening and preventive care, CRC susceptibility, screening self-efficacy, and social 
support for CRC screening.  In addition, the focus groups explored patient-provider 
communication and medical decision making to better understand how physician 
recommendations for screening affect screening behaviors.  Additional questions focused 
on perceived barriers and benefits to physical activity as well as social support for being 
active.  Finally, we asked women about their preferences for receiving health information 
and specifically what would help them get a CRC screening or increase their activity.  
Analysis for the present study will be limited to data specific to CRC and screening 
(physical activity related results will be presented elsewhere).  All study procedures were 
approved by the university’s Institutional Review Board. 
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Analysis 
 Audio recordings of the focus groups were transcribed then checked for accuracy 
by a note taker who was present at the focus group.  Analysis was completed using 
Atlas.ti 5.2 qualitative analysis software.  All coders were trained by the principal 
investigator (LAL).  First, we completed a round of deductive coding focused on the 
specific theoretical constructs used to develop the focus group guide.  The first round of 
coding consisted of identifying and grouping together all discussion related to a particular 
construct (e.g., perceived barriers to screening, patient-provider communication etc.)  For 
this round, each transcript was coded by one of three initial coders.  A second coder 
reviewed each transcript and ensured inter-coder reliability.  Next, we used an inductive 
process to uncover themes within each theoretical construct.  After themes were 
identified, we combined similar themes and counted the frequency at which themes 
occurred.  Theme coding and data reduction were completed by two separate coders and 
any differences were reconciled through discussion.  To determine code frequency, each 
time that a unique comment, which could be categorized under a certain theme, was made 
we counted it as one occurrence.  Multiple comments made by one person on a single 
theme were counted as one occurrence.  In many cases there were multiple people in the 
group who agreed with the comment (as was indicated by nodding or sounds of 
affirmation); however since we could not accurately count how many people agreed, we 
did not include their affirmations in the count.  They were only included in the count if 
they made an additional comment which clearly indicated their agreement with the 
person who initiated conversation on the theme.  For each construct, we created a matrix 
to examine differences in theme frequency between the African American and white 
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focus groups.   Summaries were made of each construct, noting the most common themes 
and comparing and contrasting by race.  These summaries are presented in the results 
along with selected quotes from the transcripts which best illustrate the most common 
themes.     
V.D. Results 
Sample Characteristics: Demographics and CRC Knowledge 
Demographic characteristics of the focus group participants, separated by race, 
are shown in Table 5.1.  The average age of participants was slightly higher for white 
participants (55 years) compared with African American participants (53 years).  Overall, 
the average BMI of the sample was approximately 36 (range 28.2-46.6).  Education and 
income levels were slightly higher for the white women than they were for African 
American women.  Knowledge about colon cancer was mixed; while the majority of 
women were familiar with the concept of colon cancer screening, some were unable to 
name specific tests or its purpose.  Colonoscopy was the most frequently mentioned 
screening test, but a few women were also familiar with Fecal Occult Blood tests 
(FOBT).  In relation to primary prevention, women had limited knowledge of what they 
could do to help prevent colon cancer.  For both races, the most frequently mentioned 
risk factors were genetics and poor diet.   Women in every focus group mentioned diet 
(specifically fiber intake) as affecting colon cancer risk.   
Attitudes about Colorectal Cancer Screening 
A summary of the Health Belief Model constructs (perceived barriers, perceived 
benefits and perceived susceptibility) and their related themes and frequencies is shown 
in Table 5.2.  The most frequently cited barrier to screening for white women was cost, 
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followed by worry that the test would be unpleasant or uncomfortable.  African American 
women, on the other hand, were most likely to state that they did not have time or had 
competing priorities, including other health issues, to deal with.  Contrary to the 
discussion about barriers, few women brought up potential benefits of screening.  
However, a small number of women did mention that screening would give them “peace 
of mind” meaning that they would no longer need to wonder if something was wrong. 
We asked each woman how her risk of CRC compared to that of other women her 
age, and the majority thought that they were at lower risk.  Main reasons given by the 
white women to support this belief were lack of family history of cancer and a healthy 
lifestyle.  African American women, on the other hand, were more likely to say that they 
had faith (i.e. religious based beliefs) they would not get cancer.  Two women 
specifically stated that they believed they were at higher risk: one white had a mother 
with colon cancer and one African American woman previously had polyps removed.  
The discussion on the potential relationship between colon cancer and weight revealed 
that only three women felt weight was associated with risk for CRC.   
Delayed Care 
We started the conversation on healthcare by asking women if they had ever 
delayed preventive care such as screening and almost all women agreed that they had.  
For white women, anxiety about the procedure and concern about cost were the most 
commonly mentioned reasons.  African American women also reported that cost and 
health insurance were concerns.  Another frequently cited reason for the African 
American women was that because of other personal and medical priorities, many 
women did not have time to wait at the doctor’s office.   
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“And at that time I was supposed to go, I didn’t feel like it either, ‘cause I was 
dealing with allergies and different things like that.  I just didn’t feel like sitting 
and waiting, waiting, and waiting, you know?  After working all day, and sitting, 
waiting for the doctors, I just didn’t feel like it.” (African American Woman) 
 
Women were also asked if their weight ever caused them to delay seeking 
healthcare.  At least two-thirds of the white women agreed that they had delayed going to 
the doctor in the past because of their weight.  Some women worried that the doctor 
would chastise them about their weight.  They recalled delaying appointments until they 
had lost a few more pounds.  Others attributed their hesitancy to self-esteem issues; they 
felt uncomfortable with their bodies and did not want to undress at the doctor’s office.  
The consensus, however, was that these were mostly old concerns as they had either 
established an understanding with their physician or become more accepting of their 
weight and weight-related comments as they aged.   
 “I think it could because there’s a lot of self-esteem issues when you’re heavy, 
and there’s just not that desire to get into a gown with nothing underneath it and 
you have people looking at you.  Well, on the flip side of it, the older I get, the 
less I care what people think!”  (White Woman) 
 
“It isn’t now because I had a wonderful physician… I can talk openly about my 
weight, and that whole issue.  But it certainly has been, in the past.  And it’s not 
helpful for someone to say, ‘You’ve got to lose weight.’  But it’s been easy to be 
embarrassed or humiliated.  But it’s not a problem, now.” (White Woman) 
 
 With one exception, African American women did not generally believe that their 
weight was a reason to delay care.  A few of the African American women stated that 
they delayed doctor’s appointments or screenings because they did not like to undress, 
however, they did not attribute this dislike to their weight; some stated that this would not 
be an issue if they could be guaranteed a female physician.  Women also did not see a 
connection between weight and the decision to get screened for colon cancer; only two 
women felt that being overweight might be an impetus for more frequent screenings 
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because they were at higher risk.  One African American woman mentioned that her 
doctor recommended she be screened more often because of several indicators including 
her diet and weight; however, she was the only one who reported such a 
recommendation. 
“I think those guys that do… a bunch of them [tests] every day... to them, it’s just 
another day at work.  I don’t think they care whether you’re fat or not.”  (White 
Woman) 
 
Patient-Provider Communication 
 Although most women expressed satisfaction with their current health care 
providers, there was also extensive discussion regarding previous bad experiences with 
the healthcare system in general (i.e., problems with insurance, hospitals or past 
providers).  Most women expressed a strong desire for a relationship with their provider 
characterized by shared decision making.  They described several techniques used by 
physicians to facilitate that relationship.  The most frequently mentioned technique was 
encouraging collaborative discussions by ensuring the patient ask questions.   Women 
also emphasized the importance of agreeing upon an approach or healthcare plan with 
their physician.   
“So I’ve been really, really fortunate in having caregivers who are professional but 
very personable in whom I place a great deal of trust and who are willing and have 
joined me in looking at alternatives, and in one case, making a referral to an 
alternative practitioner.”  (African American Woman)  
 
Another important physician attribute was thoroughness.  Specifically, African American 
women were particularly concerned that a physician not jump to conclusions about their 
condition or recommend drastic treatment options prior to completing appropriate 
diagnostic tests.  They also expressed appreciation for physicians who they could rely on 
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to bring up potential health concerns or recommended screenings.  Many of the white 
women were also concerned that their physicians did not bring up important issues like 
their weight.  Those who reported receiving weight loss recommendations from their 
physicians were often discouraged or frustrated because the physician did not also 
suggest concrete action steps which could be taken to achieve weight loss. 
“Most of the things that I’ve found or called to his attention was my doing.  You 
know?  In fact, I think if he would say, “Get off your duff.  And, this is what you 
need to do.”  Next time he’d tell me all about it, it might make me a little more 
serious about it.  But, sometimes I need somebody to put a little grief on me, to 
make me do something.  But, other than that, I’m plugging along like I am, I’ll 
just keep plugging.” (White Woman) 
 
“I mean, what are they gonna tell you to do?  “Go home, don’t eat so much, and 
exercise more.”  That’s all they ever say.  That’s what they’ll tell you.” (White 
Woman) 
 
 
Factors Influencing the Decision to Undergo Screenings 
Next we asked women about their decisions to undergo screening tests and which 
factors they felt were most important in screening behavior adherence.  Since none of 
these women were up-to-date with CRC screening at the time of recruitment, the 
discussions focused on screening tests in general rather than CRC screening specifically.  
It is important to note that while we emphasized the difference between a screening and 
diagnostic test, women sometimes confused the two during the discussion.  For white 
women, doctor recommendation was the single most important factor influencing 
screening behavior.  After data reduction we found many factors to cluster around a 
single theme of necessity.  Women deemed a test medically necessary if they had a 
family history of the disease in question, perceived themselves as being higher risk 
(because of age or personal medical history), or were currently exhibiting symptoms.   
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Another common factor influencing medical decisions was personal judgment based on 
their educational background, research or reading about the test. 
“I do listen to what they say.  But then, I do do my own reading and investigation. 
Also, with the Internet now, I mean, you can read the American Medical Journal 
(chuckles)... I mean, you can research anything you want to research, and at least 
get some statistics, and baseline.  So... I always ask a ton of questions and... I’m 
very blunt: ‘What are you looking for?’” (White Woman) 
 
Like white women, African American women also made their decisions based on 
whether or not they felt a procedure was medically necessary.  The most frequently cited 
influence in the decision to undergo screening testing for the African American women 
was whether or not they had symptoms.  Unlike white women, they did not mention their 
confidence in a test’s preventive value as being an important part of the decision.  As was 
mentioned earlier, time and competing priorities also played an important part in their 
decision making process.  
“So I put my focus into seeing my eye doctor, I go there religiously that’s my 
priority… I’m not saying I don’t need to have other things checked out, too… but 
right now, I’m healthy.  I don’t have diabetes or high blood pressure.... If I had a 
stroke tomorrow, but I don’t, today. But, my priority is to be able to see.” (African 
American Woman) 
 
 
 Although overall, doctor recommendation was the single most reported influence 
on screening decision making, it did not appear to have a strong influence on the current 
CRC screening behavior of the women in the focus groups.  Out of 31 women, fifteen 
directly stated that their doctor had recommended a CRC screening compared to only 
three who reported not receiving a recommendation.  Despite this high number, none of 
these women were up-to-date with any of the CRC screening recommendations at the 
time of recruitment. 
 
  
 61 
Strategies for Increasing Screening 
We asked participants what could be done to increase CRC screening among 
women.  White women suggested various institutional changes that could increase their 
likelihood of getting screened.  For example, they suggested that providers could better 
facilitate screening by scheduling recommended tests before the end of the visit.  Some 
women felt overwhelmed by the many different tests that were recommended to them, 
particularly once they turned 50.  They thought that if a specific test was really necessary 
for them that the doctor would follow-up and assist with scheduling.  Additionally, 
reminder calls and having someone to go through the process with them (i.e., a patient 
navigator) were potentially helpful strategies for increasing screening.  It was also noted 
that better insurance coverage of preventive care would make many women less hesitant 
to get screening.  Lastly, a few women discussed the burden of the colonoscopy and felt 
that a quicker test would make them more likely to get a screening.  As was mentioned 
above, the screening conversation centered mostly on colonoscopy and some women 
were unaware of FOBT as a screening option.     
“See, if they really were thinking, instead of saying, ‘Okay, you need to go, make 
this appointment with this one, and this...’ they need to go ahead before you leave 
that office, and make those appointments for you so that they’re done!  Cause it’s 
too easy to go, ‘Oh... maybe I don’t really need to go then.’”  (White Woman) 
 
Both white and African-American women expressed surprise and concern over 
the prevalence of colon cancer and felt that education and discussion about colon cancer 
were lacking.  African American women highlighted several venues where colon cancer 
education was needed including public service announcements, community and church 
groups and schools.   
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“I think what’s so amazing is that I think of myself as pretty on top of things, and 
I get emails from medical emails, and I read them, and I research and do things, I 
know almost nothing about colon cancer.  I don’t know anything about it.  I 
didn’t...all this stuff is... I know nothing!  And so, I think that’s a real sign that 
there is not enough information being disseminated to average people.” (White 
Woman) 
 
“In my church we talk about lung cancer, we talk about cancer, cancer in general. 
We talk about diabetes…  But, no one talks about colon cancer, or any other kind 
of [cancer]... other than breast cancer in church… That’s what I call the biggies.” 
(African American Woman) 
 
We ended the conversation by asking women how they preferred to receive their 
health information.  The Internet was the most frequently mentioned source of health 
information and was preferred by most of the women.  They were generally aware that 
not all information on the Internet is reliable and some women cited specific sources that 
they trusted.  After the Internet, talking with a trained professional, such as a doctor or a 
pharmacist, was the preferred source of health information.  Print materials from the 
doctor were also seen as a reliable source of information.  We specifically asked women 
if they would prefer to receive information through either: an in-person discussion, the 
Internet/e-mail or the mail.  While it was clear that mail was not preferred, women cited 
pros and cons to both the in-person and Internet-based sources of health information.  
Several women reiterated that all possible methods should be used since a single method 
may not be capable of reaching enough people. 
V. E. Discussion 
Obese women are at higher risk for colon cancer, but current CRC screening 
recommendations do not address obesity or other lifestyle factors that have been shown 
to affect risk.  In its most recent Guidelines for Colorectal Cancer Screening, the 
American College of Gastroenterology (ACG) proposed that obesity be considered a 
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possible risk factor which would indicate earlier or more frequent screenings21.   While 
recommending that obese individuals be screened more may raise awareness about the 
importance of screening in this high risk group, we must first consider that less than half 
of this population is at present even meeting the current guidelines.  Our research 
provides several insights into how primary care and public health practitioners can shape 
messages to increase CRC screening among obese women.  
It is evident from this and other studies,57-59 that patient-provider communication 
has a strong influence on screening behavior.  Physician recommendation remains the 
strongest predictor of screening, even among obese women.105   Primary care physicians 
can play a powerful role in increasing obese women’s screening rates, but simply making 
a recommendation is not enough.  Data from our focus groups suggest that obese women 
have other co-morbid conditions (e.g., diabetes, hyperlipdemia, hypertension) that are 
being prioritized.  Most of them did not realize that their weight may also put them at 
higher risk for cancer.  It is important that conversations about CRC screening address 
lifestyle factors, such as weight and physical activity, as well as the specific purpose and 
benefits of cancer screening.  The women in our study were familiar with screening 
logistics and were able to list many negatives or barriers to screening procedures (cost, 
preparation, time involved etc.), but had little knowledge of the benefits or actual reasons 
for screening.  Many women still do not understand that it is important to be screened 
even if they do not have symptoms or a family history of cancer.  Also, conversations 
need to address how colonoscopy is used as a cancer prevention tool (rather than just 
early detection).  For example, ACG proposed using different language to describe cancer 
prevention tests versus cancer detection tests.  While colonoscopy may be the only 
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screening test that can also remove polyps, stool-based tests should not be discounted.  
Many women in the sample did not realize there were alternatives to colonoscopy that 
might better meet their lifestyle and budget.  The need to fast prior to a colonoscopy was 
a particular concern for the many diabetic women in the group.  Education about stool 
tests may be appropriate for women with significant barriers to colonoscopy. 
Participants made several practice-level and organizational-level suggestions for 
how to increase cancer screening and generally improve healthcare for obese women.  
Discussion of weight at the doctor’s office or clinic has proven to be a very tricky 
subject.  While some women expect their physician to mention it, others are upset by 
routine weighing and unsolicited weight loss advice.  Women who felt respected by their 
physician and involved in a shared decision making process were more likely to take 
his/her advice.  Discussing weight as a risk factor for diseases, such as colon cancer, may 
be better received than a general weight loss recommendation.  The participants in our 
sample of women over 50 had struggled with their weight their whole lives and had 
finally come to accept it.  They did, however, care very much about their health and most 
engaged in many health-promoting activities.  Organizational changes that make it easier 
for patients to get screened could be very effective.  Strategies that were suggested 
included making appointments for patients before they leave, sending reminders about 
recommended procedures, and having a patient navigator to explain the screening process 
in more detail.   Additionally, women felt they were more likely to complete a test or 
procedure if it could be combined with other services or if they were all offered in the 
same place. 
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While it was not an explicit goal of this study, we did uncover some differences in 
screening and healthcare-related attitudes and beliefs between white and African 
American women.  For example, African American women were more likely to attribute 
their risk for CRC to uncontrollable factors such as fate.  Unlike white participants, the 
African American women in the study did not see a connection between their weight and 
healthcare seeking behaviors.  While physician recommendation was the greatest 
screening motivator for white women, African American women were predominantly 
motivated to seek screening if they had symptoms.  In general, African American women 
appeared to feel little control over their disease risk.  Like white women, they felt there 
was a paucity of information available to them.  While greater communication about 
CRC is needed, messages which address how women’s behaviors can reduce risk may be 
most beneficial.  Even if weight-related screening disparities do not exist among African 
American women, this group still has lower rates of adherence to screening guidelines 
than white women.  Therefore it is important to uncover causes of this racial disparity.  
Further research using quantitative comparison or mixed methods is needed to confirm 
the racial differences seen in our sample. 
This is first qualitative study we are aware of which attempts to explain why some 
obese women do not get the cancer screenings tests.   While this study offers important 
suggestions for organizational changes and messages which could be used in primary 
care or public health interventions with obese women, more research is needed to fully 
understand how obesity affects screening behavior.  The current study was limited to a 
small number of women in North Carolina and may not be generalizable to women in 
other areas of the country.  This self-selected sample was highly educated and 
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representative of the university community from which the women were recruited.  The 
study is, however, strengthened by the fact that we limited enrollment to a purposeful 
sample of women who were not currently up-to-date with screening.  Recruitment of this 
population proved difficult and resulted in several focus groups with lower than ideal 
numbers of women (i.e. less than 6 participants per group).     
Despite its limitations, this research provides insight into the types of information 
and messages that may help increase screening among obese women.  These results can 
inform future interventions to promote screening among obese women and potentially 
decrease both their cancer incidence and mortality rates. 
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Table 5.1 Demographics of Focus Group Participants by Race 
Demographic 
Variables  White (n=19)  
African 
American 
(n=12)  
Average Age (Range)  55 (50-72) years  53 (50-61) years  
Average Body Mass 
Index (Range)  
36.0 (28.2-46.6)  36.5 (29.3-43.6)  
Education: % with a 
college degree or 
higher (n)  
52.6% (10)  41.6% (5)  
Median Household 
Income  
$50,000-$74,999  $30,000-
$49,999  
Marital Status: % 
married or living with 
a partner (n)  
36.8% (7)  33% (4)  
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Table 5.2 Summary of Health Belief Model Constructs and Themes  
Construct Common Themes and Frequencies2 Illustrative Quotes 
Perceived 
Barriers to 
Screening1 
White: Cost (11); Don’t like the 
thought of it/ uncomfortable (6); 
Preparation or dietary changes are 
too difficult (5); Denial/not at risk 
(4); Has a medical issue which she 
believes precludes screening (3); 
Too invasive (2); Taboo 
area/private (2); No symptoms (2); 
Doesn’t think she needs a screening 
(2);  
“… The reason I didn’t go when I was scheduled for it 
[colonoscopy].  I got these marching orders from UNC Hospital, 
“Be here at this time, $500 in your hand, or we won’t even look at 
you.”   
 
“Well, I just wonder if there’s something that, like for diabetics, that 
there’s a liquid that you could take so that you would keep your 
sugar levels when you’re not... ‘cause you can’t fast when you’re a 
diabetic.”   
African American: Don’t want to 
wait/ don’t have the time (5); Don’t 
want to know/Scared about what 
they might find (3); Denial/faith 
they won’t get cancer (3); 
Preparation or dietary changes are 
too difficult (2); Other health issues 
take precedence (2); Cost/Insurance 
concerns (2); Don’t want to undress 
(2);  
“I just didn’t want to have to deal with anything - not that I had to 
deal with anything there, ‘cause I don’t... I just didn’t feel like it, to 
be honest about it.  I have so many doctors’ appointments.  I mean, 
not that many.  It’s just that, you know, I’m trying to be faithful in 
going to them, because I found out about breast cancer in my very 
first mammogram.  So I know these things are important.” 
 
“Also, I’m trying to keep insurance for my eyes, too, ‘cause I’d 
rather have my vision.  When I leave this world, I’d rather be able 
to see where I was, as opposed to being blind.” 
Perceived 
Benefits of 
Screening 
White: Can see inside colon/ find 
problems (2); Early detection (1); 
Look for polyps (1); Peace of mind 
(1) 
 
“I wanted to have it because of the fear, you know, just to remove 
the fear, and not have to wonder.  That’s a really good reason I 
wanted to go because I wanted to know that, well, they’ve done 
this, and now I can feel pretty sure that I don’t have to worry about 
this.  Then they say, after you have the colonoscopy, and you know 
that you don’t have a cancer, then you can just do a blood test.  
That, you know, can give you some signs, but it’s not as good as the 
colonoscopy.  So I just really wanted to make sure that I did it, just 
to remove the fear.”  
African American: Remove fear/ 
not have to wonder (1); Test for 
blood in stool (1) 
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Perceived 
Susceptibility 
(Compared to 
your other 
women your 
age, how likely 
are you to get 
CRC in the 
future?) 
 
White: Less (3);  
Equal (2)  
Don’t know (2);  
More (1) 
“Well, I mean, granted, I don’t take my drugs like I should and take 
care of that kind of stuff.  I still try to eat right and eat healthy.  And 
I’m a very active person.  I have two hours of horses and dogs that I 
take care of every morning, before I come to work; and then, three 
hours of doing it every evening, and training and showing and 
things like that.  I’m a very active person, and I do try to eat a 
healthy diet.”  
African American:  “I’m not getting 
it” (3) 
Less (1) 
More (1) 
“I don’t believe that I’m gonna get it [cancer] as opposed to the next 
person.  And, like she said, I’m a born-again Christian, so, I truly 
believe that I won’t get it. I just believe that.  And then, it has a lot 
to do with why I’m not really worried about the fact that I haven’t 
had the screening?  Because I know that they’re not gonna find 
anything?”  
1Due to high numbers of perceived barriers, only those which were cited 2 or more times are included in the chart. 
2Frequencies of each theme are listed in parentheses
 
 
 
 
 
CHAPTER VI 
TARGETED COLORECTAL CANCER PREVENTION MESSAGES FOR 
OBESE WOMEN: RESULTS OF AN INTERNET-BASED MESSAGE TESTING 
PILOT STUDY 
VI.A. Abstract 
Obese women are at higher risk for multiple cancers, but less likely than normal 
weight women to engage in cancer prevention behaviors such as screening and physical 
activity (PA). Research indicates that higher perceived barriers and lower perceived 
benefits to screening/PA may affect behavior. In order to address these disparities, we 
proposed using weight-targeted messages to improve colorectal cancer (CRC) prevention 
among obese women.  Messages were tested online with women age 50 and older 
(N=181).  Participants were stratified by weight (obese vs. non-obese) and randomized to 
receive either 10 weight-targeted or 10 generic messages. Targeted messages were 
written for obese women based on pre-study focus groups and addressed Health Belief 
Model constructs such as benefits and barriers to CRC screening/PA which were relevant 
to that population. After reading the messages, women were asked to evaluate them using 
an Elaboration Likelihood Model (ELM) scale. We hypothesized that obese women who 
received targeted messages would have higher ELM scores than those who received 
generic messages; we did not expect higher scores among non-obese women who 
received targeted messages. We rejected our hypothesis and found that obese women had 
higher ELM scores than non-obese women regardless of which messages they read 
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(p=0.02).  Specifically, obese women had higher scores on two ELM subscales: 
motivation to thoughtfully read and evaluate the messages (p=0.01) and favorable 
thoughts about the quality of the information presented (p=0.02) Obese women also 
found the online messages to be more believable (p=0.047) and more personally relevant 
(p=0.005) than non-obese women did.  Women were also asked to list thoughts or 
questions that came to mind while reading the messages.  Qualitative findings supported 
ELM sub-group outcomes.  Message testing results indicate that Internet messages may 
be an effective way to reach obese women, however, weight-targeted messages do not 
appear to increase central processing or potential for behavior change. 
VI.B Introduction 
Colorectal cancer (CRC) is the 3rd leading cause of cancer mortality among 
women in the United States.1  As with many diseases, colorectal cancer 
disproportionately affects certain high risk subgroups, including obese women.  
Compared to normal weight women, obese women have higher CRC incidence and 
mortality rates.2, 90  While there is a physiological link between excess bodyweight and 
cancer, 110 lower rates of cancer prevention behaviors may also contribute to this 
relationship.  Obese women, particularly white women, have lower usage rates of several 
cancer screening tests, 91 including colonoscopy,105 the most widely used CRC screening 
test.  They are also less likely to engage in regular physical activity.36, 47  A recent meta-
analysis estimated that higher physical activity levels, independent of weight, could 
reduce colorectal cancer risk by 14%.30 
There is limited research examining the relationship between CRC screening and 
obesity in women.  Focus group discussion with obese women revealed that obese 
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women may face barriers to screening which are not faced by non-obese women. 
(Chapter 5)  For example, obese women have a higher number of co-morbid conditions, 
such as diabetes or heart disease, which may take precedence over cancer screening.  
Treatment of these conditions may monopolize women’s clinic time and exhaust 
healthcare dollars leaving little resources for cancer prevention.  Certain conditions may 
also make screening more difficult for obese women.  Focus groups indicated that obese 
women had poor knowledge of screening benefits and did not believe that their weight 
put them at higher risk for cancer (Chapter 5). 
  Obese women also report more difficulties starting and maintaining regular 
physical activity.  Many factors may contribute, but injuries which are related to or 
exacerbated by excess body weight are among the most commonly cited (Chapter 5).  
Obese women also differ from non-obese women in their reasons for exercise.  Obese 
women are more likely to only engage in exercise when they are trying to lose weight and 
may not recognize that exercise can provide benefits (such as disease prevention) even if 
it does not produce weight loss.   They are also more likely to report feeling 
uncomfortable while exercising and less likely to say that they enjoy it (Chapter 5). 
Interventions are needed to increase cancer prevention behaviors among obese 
women.  While many CRC prevention programs and messages have been developed, they 
may not be effectively reaching obese women; different methods or messages may be 
necessary.  One study indicated that tailored information was more effective at increasing 
physical activity among obese women than a lay health advisor intervention. 80 Several 
other studies have also successfully employed tailored messages to increase screening 
behavior.82, 83  Tailored communications are formal individual communications in which 
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the content and/or style of the materials have been created based on data specific to the 
individual and informed by health behavior theory.  Research and theory suggest that 
tailored communications are more likely to be effective than generic materials because 
they provide personally relevant information that meets the exact information needs of 
readers and excludes irrelevant or superfluous facts.84, 85  It follows that when these needs 
are more closely met, an individual will be more likely to make desired changes in 
knowledge, beliefs, and attitudes and to move towards behavior change.  However, some 
studies have shown that well designed targeted materials can be just as effective at 
changing health behaviors.86  
This paper describes a pilot study designed to test the acceptability and utility of 
targeting health messages to obese women.  If weight targeting proves useful, it could 
justify the use of weight-targeted messages in future intervention studies. Best practice 
for intervention design is to pre-test messages prior to conducting a randomized 
controlled trial.86, 87 The Elaboration Likelihood Model (ELM)88 explains the rationale for 
using targeted and tailored messages making it an appropriate model to guide the 
evaluation of the messages.  The ELM states that an individual with high motivation and 
ability to process a message will have higher elaboration, and thus persuasion will occur 
through a central route.  Persuasion which occurs through the central route is thought to 
be enduring, resistant to change, and predictive of future behavior.89  
For this study we compared weight-targeted messages designed for obese women 
to generic messages about colon cancer prevention.  We hypothesized that obese women 
who read the weight-targeted messages would show greater elaboration compared to 
obese women who read the generic messages.  Additionally, the differences in 
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elaboration scores between women who read the weight-targeted messages and those 
who read the generic messages would be higher among obese women than non-obese 
women.  
VI.C Methods 
Message Testing Website 
Participants were recruited to the study using two main Internet-based methods: 
mass e-mails and postings/advertisements on social networking sites.  Advertisements 
directed interested individuals to a website which gave them further information about 
the study.  If they still wanted to participate, they were asked to complete an eligibility 
questionnaire.  To be eligible, participants had to be female, age 50 or older, have a BMI 
> 18.5 (as assessed by self-reported height and weight), and identify as white/Caucasian.  
Potential participants were not made aware of the eligibility criteria so that there would 
be no incentive to falsify data. Ineligible individuals were told that they could not 
participate in the study, but were offered information about colon cancer prevention.   
Next, eligible individuals were asked to view a consent form with information 
about the study.  In order to proceed they had to check a box saying that they had read 
and agreed to the information in the form.  They also had the option to print the form.  At 
this point they were asked to provide an e-mail and password so that their information 
could be saved in the event that they were unable to complete the entire study at once.  
Once they provided an e-mail and password, women were considered to be officially 
enrolled in the study.  To ensure adequate enrollment of obese (BMI 30+) women, we 
stratified the sample based on weight group (obese vs. non-obese).  A total of 207 women 
enrolled in the study (109 obese and 98 non-obese). 
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After enrolling in the study, women were asked to complete a baseline survey 
which included questions on screening, physical activity behavior and related 
psychosocial variables.  The survey also included questions on health status and health 
care experiences.   After the baseline survey, women within each stratum were 
randomized to view either the intervention or control messages.  Each condition reviewed 
10 messages about colon cancer prevention.  Each message was followed by four open-
ended questions assessing women’s thoughts and opinions about the messages.  After 
reading the messages, women completed a follow-up survey where they were asked to 
assess the messages as a whole using the Elaboration Likelihood Model Scale and were 
asked to answer some of the same psychosocial questions that they did at baseline.  
Women were encouraged to complete the entire study at one time, but had the option to 
save their answers and return at a later date.  Prior to beginning enrollment, we conducted 
a usability test of the study website with women from the target population.  We found 
that the majority of women were able to complete the entire study in less than 1 hour. 
The study website was available online for approximately 6 months.  Within that 
time a total of 181 women completed the study (93 non-obese and 88 obese).  Women 
who enrolled but did not complete the study received 2-4 e-mails asking them to return to 
the website and complete the study.  Three weeks before the study ended, everyone who 
had not yet completed the study received an e-mail notifying them of the last possible day 
for completion.  Of those enrolled, non-obese women were more likely to complete the 
study than obese women (94.9% vs. 80.7%, p=0.002).  Completers were also more likely 
to be up-to-date with screening than non-completers (70.7 vs. 46.1, p=0.01).  All 
individuals who completed the entire study received either a check or an Amazon gift 
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card for $25.  This study was approved by the University of North Carolina at Chapel 
Hill’s Public Health- Nursing Institutional Review Board.      
Messages 
Participants who were randomized to the targeted message group received weight-
targeted messages which were created to meet the informational needs of obese women.  
The messages were created based on results from focus groups with the target population 
and were based on constructs from the health belief model and other relevant theories.  
Topics addressed by each of the 10 intervention and control messages are shown in Table 
1; actual messages are included in Appendix F.  Intervention messages addressed the 
screening and physical activity related constructs which were most salient among obese 
women.  Control messages were selected to address the same general topics included in 
the intervention messages, but were taken from the Centers for Disease Control and 
Prevention’s (CDC) Screen for Life Fact Sheet and CDC’s physical activity website.    
Quantitative Measures 
 Our primary outcome for this study was Elaboration as measured by the 
Elaboration Likelihood Model (ELM) Scale.  Secondary outcomes included 
trustworthiness and relevance of the messages, changes in intentions, knowledge, 
perceived susceptibility and self-efficacy for CRC cancer screening and exercise.  The 
ELM and relevance/trustworthiness questions were only administered at follow-up (after 
reading the messages) since they assessed thoughts about the messages which 
participants received.  Intentions, perceived susceptibility, knowledge and self-efficacy 
were measured at both baseline and follow-up.  Some additional personal characteristics 
were measured only at baseline and included: demographics, CRC screening and physical 
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activity behaviors, health status, healthcare experiences and perceived barriers and 
benefits to screening and physical activity.       
Elaboration Likelihood Model (ELM) Scale. We used an adapted version of the 
scale created by Heppner et al. to measure Elaboration Likelihood.111  The questionnaire 
consists of 12 items assessing three main areas: motivation to thoughtfully evaluate the 
message (Subscale A: six questions), ability to think about and understand the message 
(Subscale B: three questions), and favorable thoughts about the quality of information 
tested (Subscale C: three questions).  All questions are on a 7-point likert scale with 
ranging from 1 (strongly disagree) to 7 (strongly agree).  Three negatively worded 
questions (ex., “It was difficult to understand the information in the messages”) were 
reverse coded so that a higher score would indicate more elaboration.  The ELM scale is 
designed to be summed so that the highest possible score a person could get is 84.  
Higher scores indicate greater central route processing.  The ELM Questionnaire has 
been shown to be an effective measurement for changes in elaboration and other 
constructs in the ELM.111 For this study, the scale was modified to reflect the format of 
the messages and answer scales were modified based on survey pre-tests with the target 
population.  Internal consistency reliability for the modified scale remained high 
(Cronbach’s alpha= 0.81). 
Trustworthiness and Relevance. After reading all of the messages, participants 
were asked to rate the trustworthiness and relevance of the messages using an adapted 
version of questions asked in the NC Strides Study Trustworthiness and relevance of the 
message were shown to be related to behavior change in the NC STRIDES study.112  
Both constructs were each measured using a likert scale ranging from 1 (strongly 
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disagree) to 7 (strongly agree): Relevance was measured as the sum of the following two 
items:  “The messages were written especially for someone like me” and “the information 
in the messages applied to my life.”  Trustworthiness was measured with one question 
item: “I believed the information in the messages.” 
Intention: CRC screening and exercise intentions were measured by 1 item each: 
“how likely are you to get a CRC screening test within the next 6 months” and “how likely 
is it that you will exercise regularly over the next 2 weeks,” respectively. Each item was 
measured on a 10 point likert scale ranging from 1 (not at all likely) to 10 (very likely).  
Colorectal cancer screening.  To measure screening behavior we used a selection 
of validated questions developed by Vernon and others113, 114 to assess CRC screening.  
Survey items assessed whether participants have ever had any of the following tests to 
check for colorectal cancer within the recommended timeframe: stool cards in the past 
year, flexible sigmoidoscopy within the past five years, colonoscopy within the past 10 
years, and/or double contrast barium enema within the past five years.  Marcus and others 
have shown reasonably good validity of self-reported CRC testing.115 A woman was 
considered up-to-date with screening if she reported having one or more CRC screening 
tests within the recommended timeframe.  
Physical Activity.  Physical activity was assessed using this self-administered 
version of the IPAQ short form.  This questionnaire is designed to separate individuals 
into three levels of physical activity: low, moderate and high.  The IPAQ has been shown 
to have reasonable reliability and validity in diverse populations.116   
Demographic Measures.  Age was measured as a continuous variable while 
education (high school/GED, some College/trade school, college graduate, more than 
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college), income (<30,000, 30,000-49,999, 50,000-74,999, 75,000-99,999, 100,000+), 
and health insurance status (yes/no) were all categorical.  Only 10 women stated that they 
did not have any form of health insurance coverage.   
Health Status:  Self-reported health was measured as excellent, very good, pretty 
good, or fair.  No one in the sample indicated that their health was poor.  Participants 
were asked if they were actively trying to lose weight, gain weight, or maintain their 
current weight.  From this question we created a dichotomous variable: weight loss 
practices (trying to lose weight vs. not trying to lose weight).  Only one person indicated 
that she was trying to gain weight; thus she was categorized as not trying to lose weight.  
.  We asked participants if they had any of the following co-morbidities: high blood 
pressure, heart disease, diabetes (type I or II), arthritis, Crohn’s disease, ulcerative colitis, 
cancer or other.  For the other category, participants could list their illness, and each 
additional illness not mentioned previously was counted as a separate co-morbidity 
(range was 0-4).  This number was added to the total number of reported illnesses to 
create a co-morbidity variable (range 0-6).   Since over three-quarters of participants 
reported fewer than 3 co-morbidities, answers of 3 or more were collapsed into one 
category for the final analysis. 
Psychosocial Constructs.  Knowledge about colorectal cancer was measured using 
six questions which were drawn from previous literature and pre-intervention focus 
groups.  Items addressed important facts regarding CRC risk (gender, age, weight) and 
prevention (screening, physical activity, symptoms).  Possible answers included: agree, 
disagree and don’t know.  A knowledge score was created by summing all the correct 
answers so that the highest possible score was six.  Perceived barriers and benefits to 
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CRC screening and exercise were measured using a 4-point likert scale (agree a lot, agree 
a little, disagree a little, disagree a lot).  Items were created based on previous research 
and pre-intervention focus groups.  Result for perceived benefits and barriers are 
presented elsewhere (Appendix G). 
Healthcare Variables:  Patient Provider Communication was measured using a 
modified version of a scale which was previously shown to correlate with CRC screening 
behavior.57  Questions were added based on pre-study focus groups resulting in a total of 
eight questions (Cronbach’s alpha= 0.95).  A question assessing health care visits in the 
past year was categorized to reflect those used in Aim 1 (0, 1, 2-3, 4-5, 6 or more). 
Healthcare satisfaction was measured using a single item taken from the Medical 
Expenditure Panel Survey (MEPS), cosponsored by the Agency for Health Care Research 
and Quality and the National Center for Health Statistics.  This survey has been used in 
previous studies looking at the association between weight and patient satisfaction.77  
Results for the healthcare variables are reported elsewhere (Appendix G). 
Statistical Analysis 
All analyses were conducted using SAS version 9.2 (Cary, NC).  Baseline 
characteristics were calculated for all study completers.  To examine the differences at 
baseline between obese and non-obese participates we used chi-square tests (categorical 
variables) and two-sided t-tests (continuous variables).  Two-sided t-tests were also used 
to look at unadjusted differences between control and intervention change scores within 
each weight group for the outcome variables and behavioral constructs.  Change scores 
were created by subtracting the baseline value for each variable from the follow-up 
variable.   
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We also created linear regression models with an interaction term (obesity status * 
condition) to determine if weight moderated the change in outcome variables between 
control and intervention groups.   If no interaction was present, we eliminated the 
interaction term from the model and reported results based on obesity status and 
condition alone.  We used PROC GLM to calculate adjusted means for each subgroup 
based on covariates in the model.  Potential confounders were selected by completing t-
tests of the association between each outcome variable and all sample characteristics 
found to be associated with obesity.  Any variable found to be associated (p<0.1) with a 
given outcome variable was included in that variables adjusted model.  Additionally, all 
models included intervention condition as a covariate.  
Lastly we completed sub-group analyses to examine the relationship between the 
main outcome variable (ELM) and certain sub-groups.  Sub-groups were created based 
on their answers to certain psychosocial and behavioral questions.  These analyses were 
used to determine if there were certain groups for which the messages might be more 
appropriate.  Results are reported elsewhere (Appendix G).  
Qualitative Measures and Analysis 
 After reading each message, women were asked to answer 4 open-ended 
questions about the message they just read.  The first questions asked women: “what 
thoughts or questions came to mind while reading this message?”  This question allowed 
us to measure elaboration in a qualitative manner.  Subsequent questions focused on ways 
in which the message could be improved.  All comments made were coded using an 
inductive coding process with each statement receiving a unique code.   Codes were 
grouped into the following themes: 1.) related to/agreed with/acknowledged the 
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importance of the information in the message or did not relate/agree; 2.) found 
information to be novel or already knew information in message; 3.) information 
increased intentions to engage in CRC screening or physical activity/perceived 
susceptibility to CRC or decreased intentions/perceived susceptibility; 4.) positive 
thoughts/benefits related to the message or negative thoughts/barriers; 5.) message 
quality (what was liked or needed to be changed).   
 For each set of codes, we compared the proportion of occurrences within selected 
subgroups based on obesity status and intervention condition.  For example, we 
calculated the percentage of comments coded as “related to/agreed with message” which 
were made by obese women versus non-obese women.  We then noted if less than 40% 
(or more than 60%) of the comments coded came from one group or the other; these cut-
offs were used to identify potential differences between groups. 
VI.D. Results 
Sample Characteristics 
 Table 6.2 shows the baseline characteristics of the sample stratified by obesity 
status.  There were statistically significant differences in age, education, physical activity 
level, self-reported health, co-morbidities and weight-loss status.  Compared to obese 
women, non-obese women were older and more likely to have a post-graduate degree, 
have a high level of physical activity, report their health as excellent and have no co-
morbidities.  A majority of the women in the sample stated that they were actively trying 
to lose weight, but the percentage was higher (p<0.0001) among obese women (88.9%) 
compared to non-obese women (54.4%).  Obese women also reported lower rates of CRC 
 83 
 
screening than non-obese women (65.9%, vs. 75.3%, p=0.17), but these differences were 
not statistically significant. 
Baseline Psychosocial Measures  
 Few differences were seen in baseline psychosocial measures between obese and 
non-obese women (Table 6.3).  Obese women reported lower exercise self-efficacy than 
non-obese women (5.2 vs. 6.3, p=0.005).  Obese women also had lower scores for 
exercise intentions (5.5 vs. 6.7 for non-obese women, p=0.06).  Perceived susceptibility 
to CRC was higher among obese women (6.0 vs. 5.3 for non-obese women, p=0.06), 
however as a group they did not perceive their risk to be much higher than that of other 
women their age; a score of 5-6 out of 10 indicated that they thought they were about as 
likely as other women their age to get colon cancer.  There were no notable differences in 
CRC screening intentions, CRC knowledge or CRC screening self-efficacy between 
weight groups. 
Within Weight Group Comparisons 
We compared cognitive processing scores between the women in the control and 
intervention conditions to determine if weight-targeted messages could increase cognitive 
processing (Table 6.4).   We found no statistically significant differences between 
conditions for either weight group.  Contrary to what we had hypothesized, ELM scores 
of obese women who received the weight-targeted messages did not significantly differ 
from those of obese women who received the control generic messages (73.8 vs. 74.3, 
p=0.80).  The intervention messages did produce increases in intention to engage in CRC 
screening or exercise in specific subgroups, but the statistical power of the comparisons 
were limited by the small number of women in these groups. Among non-obese 
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participants, those who read the intervention messages had a greater increase in intention 
to get screened than those who read the control messages (1.8 vs. 1.1, p=0.30).  CRC 
screening intentions also increased more among obese individuals who were not up-to-
date with screening when they read the intervention messages (2.7 vs. 1.7 for the control, 
p=0.27).  A similar pattern was also seen for exercise; non-obese individuals in the 
intervention condition increased their exercise intentions by 1.2 points compared to only 
0.5 points for the control (p=0.16).  Among obese individuals who did not currently 
engage in regular exercise, exercise intentions increased more when they read the 
intervention messages (2.9 vs. 1.2 for the control, p=0.06).  For the other psychosocial 
measures there were few notable differences between the conditions for either weight 
group.  Colonoscopy self-efficacy was increased slightly more in the intervention 
condition for the obese group (p=0.12).  Non-obese women, on the other hand, had lower 
colonoscopy self-efficacy after reading the intervention messages (p=0.09). 
Between Weight Group and Condition Comparisons 
Intervention outcomes stratified by weight group are shown in Table 6.5.  Obese 
women had significantly higher elaboration scores (p=0.02) than non-obese women.  
Obese women had an average ELM score of 74.0 compared to 70.6 for non-obese 
women.  Relevance and trustworthiness scores were also higher for obese women 
(p=0.005 and 0.047, respectively).  Average relevance score was 11.7 for obese women 
compared to 10.4 out of a possible 14 for non-obese women.  Trustworthiness scores 
were high for both groups; 6.2 and 6.6 out of 7 for non-obese and obese women, 
respectively.  There were no significantly different outcomes scores between weight 
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groups for any of the other outcome measures.  In addition, there were no outcome 
measure score differences between intervention and control groups as a whole.   
Adjusted Analysis 
We had hypothesized that the weight-targeted intervention messages would 
increase changes in outcome variables more in the obese women than in the non-obese 
women.  We did not find any evidence for moderation on the primary outcome, however, 
we found that ELM scores were still higher in obese women as a group (p=0.03), even 
after controlling for intervention condition, education and age (Table 6.6).  Similar results 
were seen for the relevance and trustworthiness variables; weight-group did not moderate 
the intervention effects, however obesity remained significantly related to both relevance 
(p=0.02) and trustworthiness (0.047) when controlling for confounders (data not shown). 
Weight-group moderated the relationship between intervention group and change 
in colonoscopy and FOBT self-efficacy (p=0.02 and p=0.05 respectively). Obese women 
who received the intervention messages increased their adjusted colonoscopy self-
efficacy by 1.0 points compared to an increase of 0.27 in the control group.  The opposite 
was true in the non-obese individuals who increased their adjusted colonoscopy self-
efficacy by 0.71 in the control group, but only by 0.05 in the intervention group.  An 
identical pattern was also seen for FOBT self-efficacy (p=0.02).  Obese individuals in the 
intervention group increased adjusted FOBT self-efficacy by 0.19 points compared to a 
0.10 decrease in the control group.  Non-obese women decreased their FOBT self-
efficacy by 0.13 points in the control group and 0.89 points in the intervention group.  
We found no moderation effects for the intention, perceived susceptibility or knowledge 
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variables, nor were there any primary effects of obesity or intervention condition on any 
of those outcomes. 
ELM Subscales 
To better understand what was driving the higher ELM scores in obese women, 
we examined the relationship between weight group and each of the three ELM 
subscales.  Obese women had significantly higher scores for subscale A (p=0.01) and 
subscale C (p=0.02), but not for subscale B (p=0.55).  For ELM subscale A (motivation 
to thoughtfully hear and evaluate the message) obese women had an average score of 
30.4 compared to 29.1 for non-obese women.  Obese women also had more favorable 
thoughts about the quality of the information presented; their subscale C score was 19.1 
vs. 17.7 for non-obese women.  There were no significant differences in women’s ability 
to think about and understand the message (subscale B). 
Comments on Messages 
We coded a total of 452 separate comments written in response to the question 
“what thoughts or questions came to mind while you were reading this message?”  We 
compared women’s responses to the open-ended questions to elucidate the main 
outcomes.  After coding the responses, we found differential rates of certain types of 
comments based on weight status.  Obese women were more likely to comment on 
whether or not they were familiar with the information in the messages; 62.1% of the 
comments indicating that they learned something new or wished the information 
provided was more widely available came from obese women.  Additionally, 60.7% of 
the comments coded as “nothing new” also came from obese women.  Notably, most 
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(64.8%) of obese women’s comments about the newness of the information were from 
women in the intervention group. 
Non-obese women were more likely to comment on the quality of the message.  
Of all comments listing something that was not liked or should be changed about the 
messages, 62.8% of them came from obese women.  A majority (60.5%) of the comments 
stating that they did not relate to/agree with message came from non-obese women.  
Among those comments from non-obese women reflecting disagreement with the 
message, 71.2% of them were made about the intervention messages.  Similarly, 81.8% 
of comments stating that the messages reduced their intentions (for screening or exercise) 
or susceptibility to CRC came from non-obese women.   
Next we compared comments made by women in the intervention to those made 
by women in the control group.  Overall, women in the intervention group were more 
likely to comment that they didn’t relate to or disagreed with the message (67.4%), or 
that the information in the message was new (68.0%).   The message describing 
colonoscopy as a screening method elicited the most disagreement; many women felt that 
the description did not reflect their own experience.  Women who read the intervention 
messages were less likely (36.4% of comments) to state that they decreased their 
susceptibility.  Additionally, only 39.6% of comments coded as questions (related to or 
about the information in the message) were from women in the intervention group.  
Lastly, intervention messages were more likely to elicit positive thoughts or recognition 
of benefits (of screening and physical activity) than the control messages (64.2% of 
comments). 
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VI.E. Discussion 
Targeting or tailoring of intervention messages is thought to increase elaboration 
of the reader.  We hypothesized that obese women who received messages that were 
targeted to the informational needs of obese readers would have higher elaboration 
scores.  We rejected this hypothesis and found instead that obese women had higher 
elaboration than non-obese women regardless of whether they received the generic or 
targeted messages.  There are several possible explanations for why obese women may 
have had higher elaboration.  First, obese women may be more engaged by the message 
medium Internet-based information); previous research has shown tailored messages to 
be more effective for increasing physical activity among obese women compared to an 
in-person lay health advisor intervention.80  In the same study, normal weight women in 
the tailored message intervention actually decreased their physical activity compared to 
control when they received the tailored messages.  Focus groups conducted with obese 
women showed that they overwhelmingly preferred to receive health information through 
the Internet.  This may not be the case for non-obese women.  Non-obese women rated 
the messages lower on trustworthiness and relevance than obese women did.  Although 
non-obese women were aware that the messages were coming from a university cancer 
center, they may be less likely to trust Internet-based information as opposed to that 
which comes from a doctor or healthcare provider.  While the underlying reason for this 
is unknown it may be related to differences in patient-provider communication or trust of 
the healthcare system.  Differences in relevance and trustworthiness scores persisted even 
after we controlled for relevant confounders such as education. 
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Analysis of the ELM sub-scales indicated that two aspects of elaboration were 
significantly different between the obese and non-obese women.  Based on their scores, 
obese women were more motivated to read the messages (subscale A) and had more 
favorable thoughts about the quality of the information in the messages (subscale C).  
There were not, however, any differences by weight in women’s reported ability to 
understand the messages.  Women’s answers to the open-ended responses support these 
findings as well.  Obese women made more comments indicating that the information in 
the messages was novel and should be more widely known.  They also were more likely 
to indicate that they already knew the information in the messages.  In both cases these 
responses might translate into higher motivation to read the messages.  New information 
may hold their interest; on the other hand, if they already know the information it may be 
because the topic is important to them.  Items in subscale A measure both ability of the 
messages to hold the readers interest and interest in the topic.    
Non-obese women were more likely to point out problems with the messages or 
make suggestions for improvements.  This reflects their lower scores on subscale C.  It is 
unclear why non-obese women were more likely to comment on improvements which 
could be made to the messages.  All women who participated in the study were told that 
we needed their help to improve the messages for other women and to be candid in their 
comments about them.  It is possible that non-obese women had more experience with 
the topics addressed (i.e., they had higher rates of physical activity and cancer screening) 
and felt more qualified to evaluate the information in the messages. 
 This study is unique in that it proposes a systematic way for testing health 
messages.  The field of health communication emphasizes the importance of pre-testing 
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messages,87 but there are few established protocols for doing so.  This was a relatively 
inexpensive way to test messages prior to using them in a larger trial.  Qualitative data 
from the open-ended questions provides extremely useful information on how messages 
can be improved.  There were, however, a few weaknesses in this protocol.  First, we 
chose to compare intervention messages to established CDC messages.  Intervention 
messages were reviewed by several women in the target population and minimally edited 
by our staff prior to testing, but may not have been as polished as the CDC messages.  
Additionally, intervention messages used a more familiar tone, similar to that of a 
popular magazine, as opposed to the more factual tone used by the CDC messages.  
Differences in message tone and quality may have been more noticeable to women than 
the content differences that we were attempting to study.  However, there were no 
differences in the number of message improvement comments made based on 
intervention condition. 
 Another shortcoming of our study is that unscreened and obese women were less 
likely to complete the study.  This is unfortunate since these are the groups which are 
most in need of information about colon cancer prevention.  Overall, our sample was 
highly educated, reflecting the demographics of the university community from which 
almost half of the women were recruited.   The women who chose to participate in the 
study are probably more inclined to seek out cancer prevention information.  This was 
reflected in their high elaboration scores; scores may have been lower on average had we 
been able to retain more unscreened women.  Women in the study also had high rates of 
screening compared to the general population.105  This, combined with limited sample 
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size, may explain why we did not see significantly different rates of screening between 
obese and non-obese women in the study.   
While we did not see significant differences in ELM scores between intervention 
and control, we did see some positive results of the intervention messages for obese 
women.  The intervention messages improved screening self-efficacy more in obese 
women than non-obese women.  Intervention messages also elicited more positive 
thoughts and recognition of benefits although we did not quantitatively measure changes 
in perceived benefits.  Focus groups revealed that there was limited knowledge of the 
benefits of colon cancer screening.  Women also did not recognize a connection between 
physical activity and colon cancer.  Intervention messages highlighted both of these 
benefits.   
It is possible that tailored messages may be preferable to weight-targeted 
messages.  Topics for the messages were chosen based on results to focus groups with a 
small number of unscreened obese white women.  However, obese women were more 
likely to more likely to express disagreement with or say that they did not related to the 
intervention messages than they did for the control messages.  The weight-targeted 
intervention messages made assumptions about the issues that would be most salient for 
obese women; however, those topics may not have resonated with all obese women.  
Conversely, they may have resonated with some non-obese women.  We would 
recommend that cancer prevention messages address some of the topics which are salient 
for many obese women, but not assume that they are important to all of them.  Future 
research should examine whether or not adding these topics to a tailoring algorithm might 
improve message evaluation for obese women.  Improving the delivery of cancer 
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prevention information to obese women has the potential to increase CRC screening and 
physical activity for this high risk population.
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Table 6.1 Topics and Psychosocial Constructs Addressed by Intervention and Control Messages. 
Message Topic Intervention Message (Weight-
Targeted) 
Control Message (Generic) 
Colorectal Cancer Importance CRC knowledge 
Perceived Susceptibility to CRC 
(gender, age) 
CRC Knowledge 
Perceived Susceptibility to CRC 
(gender, age) 
Colon Cancer Risk Perceived Susceptibility (family 
history, age, weight, activity 
level), Perceived Barriers (no 
family history) 
Perceived Susceptibility 
(gender, age, high risk) 
CRC Screening Screening Knowledge 
(colonoscopy), Screening 
Benefits (polyp removal/cancer 
prevention) 
Screening Benefits (polyp 
removal/cancer prevention) 
Colonoscopy Screening Knowledge, Perceived 
Barriers (pain). Colonoscopy 
Benefits (peace of mind) 
Screening Knowledge, 
Perceived Barriers (pain), 
Colonoscopy Benefits (direct 
view of colon) 
FOBT Screening Knowledge, Screening 
Benefits (lower cost, less time), 
Perceived Barriers (no 
symptoms) 
Screening Knowledge 
Patient-Provider 
Communication 
Perceived Barriers to PPC 
(delaying care, impersonal 
healthcare), Self-efficacy (to 
improve PPC and ask for 
screening) 
Perceived Benefits of PPC 
(healthcare satisfaction), Self-
efficacy (to improve PPC) 
Exercise Benefits Knowledge (colon cleanse), PA 
Benefits (colon health, decreased 
CRC risk) 
PA Benefits (decreased risk for 
cancer) 
Exercise Benefits Perceived Barrier (exercise is 
only important for weight loss), 
PA Benefits (disease prevention) 
PA Benefit (weight 
management), PA Knowledge 
Exercise Benefits PA Benefits (disease prevention, 
disease treatment, less healthcare 
visits and costs) 
PA Benefits (disease prevention, 
disease treatment); Perceived 
Barrier (not everyone can 
benefit from PA) 
Exercise Tips PA Self-Efficacy, Perceived 
Barriers (nowhere to exercise, 
uncomfortable exercising, safety) 
Risks of PA, PA Barriers 
(injury, disease) 
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Table 6.2 Baseline Characteristics of Study Completers 
 
Table 6.3 Baseline Values for Psychosocial Constructs Related to CRC, CRC Screening and Physical 
Activity 
† Limited to participants who did not report being up-to-date with screening at baseline (Non-obese: n=25, 
Obese: n=33). 
‡ Limited to participants who reported that they did participate in any regularly scheduled activity and did 
not report that they were unable to do physical activity (Non-Obese: n=44, Obese: n=41). 
Variable Non-Obese (n=93) Obese (n=88) P-value 
Age, mean (SD) 57.4 (5.4) 55.6 (5.2) 0.03 
Income, %  
<30,000 
30,000-49,999 
50,000-74,999 
75,000-99,999 
100,000+ 
 
7.1 (7) 
17.2 (16) 
26.9 (25) 
21.5 (20) 
26.9 (25) 
 
20.5 (18) 
18.2 (16) 
29.6 (26) 
11.4 (10) 
20.5 (18) 
 
 
 
 
 
0.06 
Education, % (n) 
 High School/GED 
 Some College/Trade School 
 College 
 More than College 
 
4.3 (4) 
25.8 (24) 
24.7 (23) 
45.1 (42) 
 
18.2 (16) 
25.0 (22) 
22.7 (20) 
34.1 (30) 
 
 
 
 
0.02 
Uninsured, % (n) 3.2 (3) 8.0 (7)  
Up-to-date with CRC Screening, % 75.3 65.9 0.17 
Physical Activity, % 
 Low 
 Medium 
 High 
 
26.2 
38.1 
35.7 
 
42.3 
38.5 
19.2 
 
 
 
0.03 
Self-reported Health, % 
 Excellent 
 Very Good 
 Pretty Good 
 Fair 
 
28.0 
44.1 
22.3 
5.4 
 
9.1 
39.8 
36.4 
14.7 
 
 
 
 
0.001 
Co-morbidities, % 
 0 
 1 
 2 
 3+ 
 
38.9 
30.0 
22.2 
8.9 
 
18.5 
27.2 
28.3 
26.1 
 
 
 
 
0.002 
Currently Trying to Lose Weight, % 54.4 88.9 <0.0001 
Psychosocial Constructs, Mean 
(SD) 
Non-Obese Obese P-Value 
CRC Screening Intentions 
 All Participants 
 Unscreened† 
 
3.6 (3.1) 
4.2 (3.1) 
 
3.4 (3.2) 
4.5 (3.5) 
 
0.76 
0.75 
Physical Activity Intentions 
 All Participants 
 Not regularly active‡ 
 
6.7 (3.2) 
5.6 (2.9) 
 
5.5 (3.1) 
4.7 (2.7) 
 
0.06 
0.12 
CRC Knowledge 4.2 (1.2) 4.1 (1.2) 0.63 
Colonoscopy Self-Efficacy 8.4 (2.8) 8.1 (3.0) 0.57 
FOBT Self-Efficacy 8.5 (2.7) 8.4 (2.7) 0.90 
Exercise Self-Efficacy 6.3 (3.2) 5.2 (2.9) 0.005 
Perceived Susceptibility to CRC 5.3 (2.6) 6.0 (2.6) 0.06 
  
 
Table 6.4 Unadjusted Intervention Outcomes: Within Weight Group Comparisons by Intervention Condition 
 
Outcome Variable, Mean (SD) Non-Obese Obese 
Control 
(n=48) 
Intervention 
(n=45) 
P-value Control 
(n=44) 
Intervention 
(n=44) 
P-value 
Message Evaluation* 
 Elaboration Likelihood Score 
 Relevance 
 Trustworthiness  
 
70.2 (11.8) 
10.7 (3.0) 
6.3 (1.2) 
 
71.0 (9.7) 
10.2 (3.1) 
6.2 (1.4) 
 
0.71 
0.43 
0.65 
 
74.2 (7.3) 
11.8 (2.2) 
6.7 (0.94) 
 
73.8 (9.3) 
11.9 (2.6) 
6.5 (1.1) 
 
0.80 
0.79 
0.34 
Change in CRC Screening Intentions 
 All Participants 
 Unscreened† 
 
1.1 (3.4) 
1.9 (2.5) 
 
1.8 (2.7) 
1.7 (1.6) 
 
0.30 
0.83 
 
1.5 (2.5) 
1.7 (2.1) 
 
1.9 (2.7) 
2.7 (2.8) 
 
0.51 
0.30 
Change in Exercise Intentions 
 All Participants 
 Not regularly active‡ 
 
0.6 (2.2) 
1.4 (1.8) 
 
1.2 (2.3) 
1.4 (2.0) 
 
0.19 
0.98 
 
1.1 (3.0) 
1.2 (2.6) 
 
1.1 (2.3) 
2.9 (2.4) 
 
0.91 
0.06 
Change in CRC Knowledge 1.4 (1.2) 1.6 (1.3) 0.40 1.3 (1.4) 1.5 (1.5) 0.68 
Change in Colonoscopy Self-Efficacy 0.51 (1.9) -0.62 (1.7) 0.09 0.25 (2.1) 0.96 (2.2) 0.12 
Change in FOBT Self-Efficacy 0.15 (2.1) -0.39 (1.9) 0.21 0.23 (1.8) 0.47 (1.5) 0.50 
Change in Exercise Self-Efficacy 0.28 (2.0) 0.27 (1.5) 0.98 0.36 (2.6) 0.84 (2.1) 0.34 
Changes in Perceived Susceptibility -0.30 (2.9) -0.13 (2.7) 0.78 0.23 (3.4) 0.2 (2.8) 0.97 
 
 
* Message Evaluation Measures were only collected at follow-up so mean score at follow-up is reported 
† Limited to participants who did not report being up-to-date with screening at baseline (Non-obese: n=23, Obese: n=31). 
‡ Limited to participants who reported that they did participate in any regularly scheduled exercise and did not report that they were unable to do 
physical activity (Non-Obese: n=40, Obese: n=33). 
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Table 6.5 Unadjusted Intervention Outcomes: Between Weight Group and Condition Comparisons 
 
Outcome Variable, Mean (SD) Weight Group Condition 
Non-Obese Obese p-value Control Intervention p-value 
Message Evaluation* 
 Elaboration Likelihood Score 
 Relevance 
 Trustworthiness  
 
70.6 (10.8) 
10.4 (3.0) 
6.2 (1.3) 
 
74.0 (8.3) 
11.7 (2.4) 
6.6 (1.0) 
 
0.02 
0.005 
0.047 
 
72.1 (10.0) 
11.2 (2.7) 
6.5 (1.1) 
 
72.4 (9.5) 
11.0 (3.0) 
6.3 (1.5) 
 
0.87 
0.68 
0.36 
Change in CRC Screening Intentions 
 All Participants 
 Unscreened† 
 
1.4 (3.1) 
1.8 (2.1) 
 
1.7 (3.1) 
2.2 (2.5) 
 
0.54 
0.94 
 
1.3 (3.0) 
1.8 
 
1.9 (3.2) 
2.3 
 
0.19 
0.45 
Change in Exercise Intentions 
 All Participants 
 Not regularly active‡ 
 
0.80 (2.6) 
1.3 (2.2) 
 
1.2 (2.3) 
2.0 (2.3) 
 
0.33 
0.17 
 
0.86 (2.3) 
1.4 (1.9) 
 
1.1 (2.6) 
2.0 (2.6) 
 
0.51 
0.25 
Change in CRC Knowledge 1.4 (1.3) 1.5 (1.4) 0.39 1.5 (1.2) 1.4 (1.4) 0.67 
Change in Colonoscopy Self-Efficacy 0.38 (2.0) 0.43 (2.0) 0.89 0.21 (1.8) 0.61 (2.2) 0.18 
Change in FOBT Self-Efficacy -0.11 (2.0) 0.35 (1.7) 0.10 0.19 (2.3) 0.05 (1.8) 0.61 
Change in Exercise Self-Efficacy 0.27 (1.7) 0.60 (2.3) 0.28 0.19 (2.0) 0.05 (1.8) 0.61 
Changes in Perceived Susceptibility -0.22 (2.6) 0.21 (3.1) 0.33 -0.04 (3.2) 0.03 (2.7) 0.86 
 
* Message Evaluation Measures were only collected at follow-up so mean score at follow-up is reported 
† Limited to participants who did not report being up-to-date with screening at baseline (Non-obese: n=23, Obese: n=31). 
‡ Limited to participants who reported that they did participate in any regularly scheduled exercise and did not report that they were unable to do 
physical activity (Non-Obese: n=40, Obese: n=33). 
96 
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Table 6.6 Adjusted ELM Scores Stratified by Variables from the Multivariate Model 
Model Variable Average Adjusted 
ELM Score 
p-value 
Weight group 
 Non-obese  
 Obese 
 
71.9 
75.5 
0.02 
Condition 
 Intervention 
 Control 
 
73.5 
73.9 
0.77 
Education 
 High School/GED 
 Some College/Trade School 
 College 
 More than College 
 
77.2 
72.8 
74.2 
70.6 
0.03 
Age 
 50-55 
 55-60 
 60+ 
 
70.9 
74.6 
75.7 
0.02 
 
 
 
 
 
CHAPTER VII 
SUMMARY AND RECOMMENDATIONS 
VII.A. Summary of findings 
The information presented in this dissertation contributes to design and delivery 
of cancer prevention interventions with obese women in four main ways: (1) by 
confirming that obese white women, among other groups, have lower than average 
screening rates making them an important group to target with cancer prevention 
interventions; (2) by increasing understanding of the factors affecting screening and 
physical activity behavior among obese women; (3) by recommending potential 
intervention methods and messages which might help improve cancer prevention 
behaviors in this population; (4) by assessing the usefulness of weight-targeted messages 
among women. 
Taken together, the results of this dissertation suggest that a variety of personal 
and healthcare related factors are contributing to lower rates of screening and physical 
activity among obese women.  Current efforts to promote CRC screening and physical 
activity do not adequately address the psychosocial and informational needs of this 
population.  It is clear that interventions are needed to help increase rates of these and 
other cancer prevention behaviors in high risk populations such as obese women.  
Internet-based messages appear to be an effective way to reach obese women, but like 
many methods this strategy still may not help the most hard to reach populations.  It is 
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also unknown whether or not this method is superior to other methods such as a clinic-
based intervention. 
 In the first aim, studied in chapter 4, we analyzed the relationship between CRC 
screening and obesity in women using nationally representative data.  We found that 
obese white women had lower rates of CRC screening, particularly colonoscopy, than 
non-obese white women (p<0.05); the opposite was true for African American women, 
but results were not statistically significant.  This analysis helped to explain why previous 
studies which examined the relationship between obesity and CRC screening, but did not 
stratify by race or gender, found mixed results.  Our results confirm that obese women, 
particularly white obese women, are an important group to target with cancer prevention 
interventions.  The analysis also concluded that differential rate of doctor 
recommendation was not responsible for weight-related screening disparities.   
 In the second aim, explored in chapter five, we attempted to better understand the 
factors that affect screening and physical activity behavior in obese women.  We found 
that many of the barriers to CRC screening were similar to those found in non-obese 
women (i.e., cost, time, anxiety about preparations or procedures); however, we also 
found that these barriers had different meaning for obese women.  Many of the women in 
the focus groups had one or more co-morbidities which were caused or exacerbated by 
their current weight.  These health concerns were seen as their priority; because these 
concerns took up a great deal of women’s time and healthcare dollars, there were few 
resources left for screening.  While women expressed many barriers to screening, they 
had poor knowledge about CRC prevention and were generally unfamiliar with the 
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benefits of screening.  Most women also did not see a connection between weight and 
CRC.  
     As with weight, women also did not see a connection between physical activity 
and CRC.  While they knew that physical activity was important and could have many 
health benefits, they did not connect it with cancer prevention.  There was also general 
agreement that physical activity was most necessary for women who were overweight; 
however this belief was countered by the belief that physical activity was important for 
general health and did not produce much weight loss.  Women described a vicious cycle 
in which higher weight made it harder for them to exercise, but that exercise was 
important for preventing more weight gain.  They cited many weight-related barriers to 
physical activity including embarrassment about exercising in front of others, getting out 
of breathe easily, not having enough energy to exercise and having physical difficulty 
exercising.  Many women, particularly African American women, noted frustration with 
the fact that often when they started a new exercise program, difficulties or schedule 
changes arose and made it difficult to continue their planned activities.  Women made 
many suggestions for what could be done to increase screening and activity in this 
population and shared their preferences for receiving information about health.  The 
Internet was listed as the most frequently consulted source for health information; some 
women still preferred to receive information from their physicians though they 
recognized the limitations of their physicians’ expertise when it came to diet and 
exercise.  Many women were frustrated by doctors who made general recommendations 
for weight loss, but did not provide them with any specific instructions on how to achieve 
it. 
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 In the third aim, examined in chapter 6, we designed a protocol for pilot testing 
CRC prevention messages among white women.  Participants were stratified by weight 
(obese vs. non-obese) and then randomly assigned to review either weight-targeted 
messages designed for obese women or generic messages written by the CDC. Both sets 
of messages addressed CRC screening, physical activity and patient-provider 
communication.  We assessed several variables including elaboration, behavioral 
intentions, CRC knowledge, self-efficacy and perceived susceptibility.  We had 
hypothesized that the weight-targeted messages would produce greater elaboration and 
more positive changes for obese women than the generic messages would.  We did find 
that the intervention messages improved screening self-efficacy among obese women and 
not in non-obese women.  Weight group did not, however, moderate the relationship 
between intervention condition and any of the other outcomes.  Instead we found that 
obese women had higher ELM scores than non-obese women regardless of which 
message group they were in.   They also rated the messages significantly higher on 
relevance and trustworthiness than the non-obese women did.  Baseline survey data from 
Aim 3 also confirmed that obese women had higher rates of certain barriers to screening 
and physical activity. 
VII.B. Theoretical Implications 
 The results of all three Aims taken together informed a revised model of the link 
between obesity and CRC screening (Figure 7.1).  We have chosen “Likelihood of being 
up-to-date with CRC screening” as the final outcome in this model for several reasons.  
First, data from Aims 1 and 2 both indicate that obesity is more likely to affect the timing 
of screening.  That is to say that while there was no relationship between ever having a 
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screening and obesity, there was a relationship between being up-to-date with screening 
recommendations and obesity.  Timely screening is important as the risk of CRC 
increases after age 50 and current screening guidelines are set to reflect the time it takes 
for the disease to develop and the accuracy of the screening method.  Secondly, women 
in the focus groups talked generally about the effect their weight had on screening and 
preventive care.  They stated that while their weight might not keep them from going to 
the doctor, it might cause them to delay getting care.  We use the word screening 
generally because it is possible that many of the factors linking obesity and screening 
apply not only to colorectal cancer screening, but also may explain some of the weight-
related disparities seen in breast and cervical cancer screening. 
 One factor which stood out in aims 2 and 3 was the effect of competing healthcare 
needs on screening.  Women in the focus groups often stated that they had other health 
concerns (i.e., diabetes, cholesterol) which they believed were more important.  Since 
they did not realize that their weight put them at higher risk for CRC, screening was not a 
top priority.  Baseline survey data from aim 3 confirmed that while time and cost 
involved in CRC screening did not alone seem overwhelming, they became barriers when 
placed in the context of other healthcare concerns faced by obese women.  It is also 
important to note that higher co-morbidities and higher number of healthcare visits were 
associated with greater screening in the adjusted colonoscopy model developed based on 
aim 1 data.  In this model, obesity remained significantly related to screening after 
controlling for both number of co-morbidities and past-year healthcare visits.  This 
suggests that there may be some other unmeasured factor at play, such as body esteem, 
which is causing lower screening rates in obese women. 
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In the model, the arrows linking body esteem and delayed preventive care are 
broken because our data were not able to fully explore this relationship.  Differences in 
body esteem may explain why obesity does not decrease screening rates among African 
American women.  We hypothesize that, compared to their non-obese counterparts; body 
esteem is lower in obese white, but not obese African American women104.  Women with 
low body esteem may be more likely to delay care because they don’t want to face 
weight-related bias or discussion at the doctor’s office.  This phenomenon was discussed 
in Aim 2, but not specifically in relation to CRC screening.  Additionally, women with 
lower body esteem may find screening to be more embarrassing.  In Aim 3, we found that 
obese women were more likely to agree that screening tests were embarrassing.  
Unfortunately our data did not include a measure of body esteem so we were not able to 
confirm these hypotheses.  Further exploration of the relationship between body esteem 
and screening in white and African American women may help explain how race 
moderates the screening-obesity relationship. 
Even though weight-related screening disparities were not seen among African 
American women, they still have lower average screening rates than white women.  
Focus group discussions emphasized the importance of patient-provider communication, 
general healthcare trust, and healthcare satisfaction in the healthcare decision-making 
process. Focus group discussions uncovered significant distrust of the healthcare system 
among African American women.  Past research has also shown higher physician distrust 
among certain groups of African Americans117 which may partially explain their lower 
screening rates..  In Aim 3, we observed that healthcare satisfaction was correlated with 
baseline screening as well as several other outcome variables.  Previous research has 
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shown a relationship between healthcare satisfaction and health status (i.e., illness 
burden).77 We hypothesized that greater co-morbidities and/or more healthcare visits may 
lead to less healthcare satisfaction.  We have left this arrow broken since our study did 
not confirm these results in white women; there was no relationship between obesity and 
healthcare satisfaction or patient-provider communication, even after controlling for 
number of co-morbidities or self-reported health status.  Moreover, we saw a positive 
relationship between number past-year visits and healthcare satisfaction.  Further 
research is needed to better understand how number of co-morbidities, frequency of 
healthcare visits, patient-provider communication and healthcare satisfaction may interact 
to affect screening behavior in different sub-groups.  The pathways drawn are hypothesis 
created based on qualitative data; mediation analyses of quantitative data would assist in 
confirming these relationships.  
  
 
Figure 7.1 Model Linking Obesity with Screening Behavior in Women 
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VII.C. Intervention Recommendations 
Aim 1 
 The results from Aim 1 confirm that obese white women have lower rates of CRC 
screening, particularly with colonoscopy, than non-obese white women.  Analyses such 
as this are important because they allow us to identify disparities in behavior which could 
be addressed with behavioral interventions.  The study also concluded that obesity was 
not significantly associated with lower screening in African American women.  Adjusted 
analyses indicated that when all other covariates are held equal, obese white women have 
the lowest rate of up-to-date colonoscopy (30.2%) and obese African American women 
have the highest rate (41.2%).  While calculating adjusted screening rates, as was done 
for Aim 1, is useful highlighting the effects of a single factor (such as race or obesity) 
independent of other possible confounder (such as age or illness burden) on a particular 
outcome, we must caution against their use in identifying at-risk groups. 
 Adjusted screening rates assume that all participants have average values for all 
covariates except the variables of interest (i.e., obesity and race).  For this reason, it is 
important that when attempting to identify disparities that we rely instead on unadjusted 
analyses.  The unadjusted analyses clearly indicate that African American women have 
significantly lower rates of up-to-date colonoscopy than white women (36.1% vs. 43.0%, 
p=0.002).  Furthermore, the average unadjusted colonoscopy rate for obese African 
American women (38.1%) was lower than the average unadjusted rate for obese white 
women (40.3%).  While the purpose of our analyses was to identify weight-related 
disparities, which appear to exist only for white women, we cannot ignore the fact that 
across weight-groups African American women have lower screening rates than white 
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women.  Additional efforts are needed to increase screening among African American 
women who not only have lower screening rates than white women, but who also have 
the highest CRC mortality of any racial/ethnic group.96 
Aim 2 
The qualitative study conducted for Aim 2 was the first we are aware of to 
examine screening and physical activity knowledge, attitudes, beliefs and behaviors 
among obese women.  One strength of this study was that, at the time of recruitment, 
none of the women in the focus groups was up-to-date with CRC screening.  While this 
allowed us to look more closely at the population of interest, it made it extremely difficult 
to recruit women.  Women who have not had screening may be less inclined to 
participate in a study about colon cancer either because they are not interested in the topic 
or they are afraid to admit that they are not engaging in socially desirable health 
behaviors.  This also may have biased the sample toward younger women who had not 
yet had their first screening.  Nearly two-thirds or the women in the focus groups were 
under the age of 55.  Many of the women felt that they would have a screening 
eventually, but they had not done it yet.  While we did not specifically plan to recruit 
women in this age group it may have been an advantage for the study.  Previous research 
indicates that obese women delay care and this is an ideal population within which to 
study that phenomena.  Older unscreened women are more likely to have developed a 
pattern of non-adherence and may be difficult to reach with behavioral intervention; 
younger women may be more open to new information and initiating new behaviors. 
 When we began recruitment, we asked women to volunteer, but had difficultly 
recruiting women and scheduling them for focus groups.  While many of the women 
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worked in close proximity to the groups, they were not otherwise connected; this made it 
difficult to schedule discussions and get women to attend.  In the past, it has proved 
easier to recruit and retain participants who are part of some common group (housing, 
church etc.), however we did not choose to do this because we felt it would be difficult to 
limit participation on the basis of sensitive topics such as screening or weight. 
We tried an alternative method for recruitment which involved directly calling 
women associated with a large medical practice.  We used a database of information on 
screening behavior to identify women who were not currently meeting CRC screening 
guidelines.  Unfortunately, this database was not updated and many of the women we 
contacted did not meet our recruitment criteria.  We were able to recruit a handful of 
women using this method, however only one or two of them actually attended our focus 
groups.  We abandoned this method for several reasons; first, calling women in the 
database was extremely time intensive and did not yield much result.  Second, the 
Institutional Review Board changed its policies to no longer allow us to identify women 
through medical records.  Third, we felt strongly that we did not want to label women as 
obese based on their BMI.  It is preferable that future studies allow women to self-
identify as overweight (we did not use the word obese when communicating with 
participants).  Women who we contacted directly often had strong feelings about the use 
or misuse of BMI measures or weight class labels.   
For this study, we also debated whether a focus group was an appropriate data 
collection method to use when discussing sensitive topics such as weight.  We found, 
however, that women very much enjoyed the supportive nature of the discussion.  They 
felt comfortable discussing weight-related issues in front of women who were facing the 
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same challenges.  One woman specifically stated that she was relieved to find out that no 
one else had been screened for CRC and that she was not going to be admonished for 
avoiding screening.  The focus groups did not, however, endorse or discourage CRC 
screening.  Still, in many cases women said that they came to the discussion to learn more 
about CRC prevention and left with intentions of getting screened.  Although this was not 
the goal of the focus group, it is important to note.  As noted earlier, our previous 
research had shown that a social support interventions was not be as effective at reaching 
obese women for CRC prevention as a tailored message intervention80.  We hypothesized 
that obese women may have felt uncomfortable discussing health issues with non-obese 
women or vice versa.  Reactions to these focus groups suggest future promise for social 
support interventions that are homogenous with respect to weight.  Conversely, the 
majority of women felt that the internet was the best way for them to get health 
information.  While a few women mentioned group discussions as a possible method, 
some felt that group activities were too time consuming.   
Aim 3 
For Aim 3, we did not see higher ELM scores for obese women reading the 
targeted messages compared to the generic messages, but we did see higher ELM scores 
overall in obese women.  The ELM posits that higher elaboration leads to greater central 
processing and thus greater potential for behavior change.  If this is true, then these 
results are promising; the group with lower screening/physical activity rates had higher 
ELM scores and more potential for change.  This result may support our focus group 
finding that messages received through the Internet are a potentially effective way to 
reach obese women.  Unfortunately, we did not see significantly higher screening or PA 
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intentions in obese women.  This leads us to questions whether the ELM scale is the best 
way to evaluate messages.  It is possible that there was not enough time between reading 
and evaluating the messages for women to reevaluate their intentions and that we would 
see different results had these messages been used, as intended, in the context of a larger 
intervention trial. 
To better gauge the utility of the ELM scale for message testing, we looked at the 
association between ELM scores and changes in behavioral intentions.  Overall, ELM 
scores were more highly correlated with changes in intentions to engage in physical 
activity (r=0.23, p=0.002) than changes in intentions to have a CRC screening (r=0.11, 
p=0.13).  Interestingly, these correlations were also much stronger in non-obese women 
than obese women; the relationship between ELM score and changes in physical activity 
intentions was significant among non-obese women (r=0.33, p=0.001), but not obese 
women (r=0.11, p=0.29).  There was also positive a correlation between changes in 
physical activity intentions and relevance/trustworthiness scores.  Contrary to previous 
research stating that relevance and trustworthiness predict behavior,112 believing the 
information in the messages was not correlated with screening intentions (r=0.00, 
p=0.97); there was a non-significant positive correlation between relevance and screening 
intentions (r=0.12, p=0.09).  Again, these correlations were confined to non-obese 
women.  It is unclear why these associations would differ by obesity status.  It is possible 
that higher ELM scores among obese women do not indicate greater potential for 
behavior change, but may reflect some other latent difference between obese and non-
obese women.  Qualitative measures may prove more indicative of actual elaboration and 
potential for the messages to prompt future behavior change. 
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While this study did not find evidence for weight-targeting messages, it did 
confirm some of the weight-related barriers that we found in the focus groups.  For 
screening, we saw that a larger proportion of obese women agreed that other health 
concerns were a priority when it came to their time and healthcare dollars.  We also 
confirmed that obese women were more likely to agree that they only exercise when they 
are trying to lose weight and that their weight makes it difficult for them to exercise.  The 
weight-targeted messages addressed all of these weight specific barriers.  Consequently, 
women who expressed agreement with the weight-related barriers had higher ELM scores 
when they read the intervention messages than when they read the control ones.  These 
findings indicate that these messages may be motivating for the sub-group of women who 
express weight-related barriers.  However, not all obese women face these barriers and 
some non-obese women do.  Including these messages in a tailoring algorithm could be 
more beneficial than a weight-targeted message intervention.  
VII.D. Future Research  
Based on the findings described above, we would recommend additional inquiry in the 
following areas: 
1) Focus group discussions were conducted with both white and African American 
women, but since aim 3 data was only collected with white women, we were not able 
to compare psychosocial variables for screening or physical activity by race and 
weight group.  We are in the process of collecting these data with African American 
men and women.  Making comparisons between weight, gender and race groups we 
allow us to better understand which factors might be responsible for the screening 
disparities we see between sub-groups.  To more accurately confirm the hypotheses 
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set forth in the conceptual model linking screening and weight, we would need to 
conduct a longer term intervention study to address potential psychosocial mediators 
and perform formal mediation analyses and/or structural equation modeling.  
2) We were unable to fully explore the effect of body esteem on screening behavior.  
Research indicates that this may play a role in weight-related disparities in breast and 
cervical cancer screening, but women in the focus groups did not believe that their 
weight kept them from getting CRC screenings specifically (thought they did admit to 
delaying preventive care because of their weight).  It is possible that the focus group 
setting was not the proper method for exploring the relationship between screening 
and latent variables such as body esteem.  Future studies could include quantitative 
measures of body esteem and look at their relationships with cancer screening.  
Currently our research does not provide a good explanation for why obesity does not 
affect cancer screening rates in obese men or African American women.  Our 
explanation of the obesity-screening relationship focused on co-morbidities and 
healthcare satisfaction, but we have no reason to believe that these issues would 
differentially affect obese white women.  More research is need to explore whether or 
not racial differences in weight acceptance, body esteem or other related factors are 
better explanatory variables for the differential effects we see by race and gender. 
3) An important finding from the focus groups was that obese women had poor CRC 
knowledge and were unfamiliar with the benefits of screening.  They also believed 
that they had average or below average risk for CRC because they did not have a 
family history of cancer.  Emerging research indicates that doctors spend the majority 
of their time discussing screening logistics and little or no time is spent discussing the 
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risk factors for CRC or the purpose/benefits of screening.2
4) Focus group data and preliminary results from the message testing study indicate that 
messages which focus on CRC risk and prevention may be better able to increase 
intentions in women.  Women expressed interest in more information about general 
cancer prevention and colon health (including the benefits of weight loss and physical 
activity). Unfortunately, they did not have confidence that their doctors could/would 
give them information about how to increase physical activity or manage their 
weight.  From a health communications perspective, we may be doing women a 
disservice by framing the cancer prevention discussion in terms of a choice between 
screening tests rather than a choice to screen or not to screen.  Additionally, we may 
be missing opportunities to discuss risk factors for and prevention of CRC.  In regards 
to physical activity, messages which promote exercise outside the context of weight-
loss may be needed to change obese women’s attitudes and beliefs about exercise.  
Further analysis of the qualitative message testing data will allow us to better 
understand which types of cancer prevention messages would best resonate with 
women.  Pilot studies are needed to test the effectiveness of benefit-focused messages 
compared to conventional messages about screening tests.  It is unclear if these types 
of messages can increase the importance of CRC prevention among groups who face 
multiple health issues.   
  Data from actual patient-
physician conversations can be used to confirm our hypothesis that conversation 
about obesity-related co-morbidities are taking precedence over cancer prevention.   
5) We hypothesized that obese women had higher ELM scores because they were more 
accepting of the intervention method.  However, we do not know if giving screening 
                                               
2 Data presented by Dr. Elston Lafata at UNC (12/8/2009) 
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messages online is more effective than a clinic-based or other type of intervention.  
Previous research suggests that the method of delivery may be just as important as the 
message when it comes to reaching different population sub-groups.  Pilot studies 
could test preference for online messaging versus other methods to see if it differs by 
weight group, race or gender.  Targeted intervention delivery methods may be 
integral to reaching groups with the lowest rates of cancer prevention behaviors. 
In summary, this research has provided insight into potential ways to improve CRC 
screening and physical activity rates among older obese women. This research prompts 
us to rethink the way we provide information about cancer prevention behaviors, 
especially in clinical settings.  It suggests that targeting interventions methods and 
tailoring messages may better reach some of the most at-risk populations.  Further 
research is still needed to understand all the factors that are affecting cancer screening in 
obese women, however we can still begin to address the factors which are better 
understood such as the influence of competing medical demands.  While the main focus 
of this research was colorectal cancer prevention, its findings may be applicable to the 
prevention of other cancers such as breast and cervical cancer. 
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APPENDIX A 
SUMMARY TABLE OF WEIGHT AND CRC SCREENING STUDIES 
Author, 
Date  
Data 
Source 
Screening 
Outcome 
Measurement 
Weight 
Categories  
Results/OR Adjustment for 
Confounding 
Limitations 
1.) 
Rosen 
et al. 
(2004) 
 
BRFSS 
1999 
(Only 
results for 
women are 
reported) 
Self Report:  
FOBT in last year 
or Endoscopy in 
last 5 years 
Normal (18.5- 
24.9); 
Overweight 
(25.0-29.9); 
Obese (30-
34.9); Morbidly 
Obese (≥35) 
Morbidly obese 
women had a 
significantly 
lower rate of  
screening than 
normal weight 
women 
Any On-time: 
37.1 vs. 42.7 
FOBT: 18.7 vs. 
22.4 
Endoscopy: 
25.9 vs. 30.8 
Age, ethnicity, 
income, education, 
marital status, 
insurance status, 
region, self-reported 
health status, 
smoking status, and 
time of last medical 
visit. 
Cannot 
differentiate 
between 
colonoscopy and 
sigmoidoscopy, 
some people may 
be misclassified.  
Did not stratify by 
race. 
2. 
Ferrante 
et al. 
(2006) 
Chart 
Abstraction 
in 22 Family 
Medical 
Practices in 
N.J. and 
P.A. 
Documentation in 
Chart of: FOBT 
in past year, 
sigmoidoscopy in 
last 5 years; 
colonoscopy in 
last 10 years; 
DCBE in last 5 
years 
Obese (BMI ≥ 
30) vs. Non-
Obese 
Men and 
Women:  OR 
0.75 (0.62- 
0.91) 
No interaction 
with obesity and 
gender. 
Age, gender, 
number of visits in 
the last 2 years, 
number of co-
morbidities, number 
of years at practice 
Did not separately 
examine different 
tests.  Did not 
control for or 
stratify by race. 
3.) Heo 
et al. 
2004 
BRFSS 
2001 (only 
results for 
Self Report:  
FOBT in last year 
or Flex Sig in last 
Normal (18.5-
<25); 
Overweight (25- 
Flex Sig: Obese 
I OR 0.86  
(0.78-0.94) 
Age, health 
insurance, race and 
smoking. 
Did not stratify by 
race.  Ignored 
colonoscopy 
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women are 
reported) 
5 years <30); Obesity 
class I (30-<35); 
Obesity class II 
(35-<40): 
Obesity class III 
(≥ 40) 
(normal weight 
as referent) 
Obese II OR 
0.88 (0.79-0.99 
FOBT: No 
association 
which is included 
in the flex sig 
question on the 
BRFSS 
questionnaire. 
4.) 
Chao et 
al. 2004 
Cancer 
Prevention 
Study II 
Nutrition 
Cohort 
 97,786 
Women 
(only results 
for women 
are 
reported) 
Self Report: 
Screening 
Sigmoidoscopy 
or Colonoscopy 
Ever 
BMI:  <18.5; 
18.5-24.9; 25.0-
29.9; 30.0-39.9; 
≥40 (normal 
weight as 
referent) 
Overweight OR 
0.89 (0.85-0.93) 
Obese OR 0.86 
(0.81-0.91) 
Morbidly Obese 
OR 0.71 (0.59-
0.85) 
Age, race, 
education, work 
status, occupation, 
recent doctors visit, 
health insurance 
coverage, ever 
diagnosed with 
cancer, ever 
diagnosed with 
other health 
conditions, personal 
history of polyps, 
number of relatives 
with CRC, vitamin 
usage, fiber laxative 
usage, other laxative 
usage, physical 
activity level, 
cigarette smoking, 
alcohol usage  
Did not look at 
FOBT, did not 
look at tests in 
recommended 
time frame.  Did 
not stratify by 
race. 
5.) 
Seeff et 
al. 2004 
NHIS 2000 Self- report: 
FOBT within the 
past year, 
Endoscopy in last 
10 years. 
Normal (<25); 
Overweight (25-
29); Obese 
(≥30) 
Any On-time: 
Overweight OR 
1.07 (0.96-1.20) 
Obese OR 1.11 
(0.98-1.27) 
Gender, race, 
ethnicity, age, 
education, marital 
status, health care 
coverage, usual 
Endoscopy 
includes 
proctoscopy 
which is not a 
recommended 
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FOBT: 
Overweight OR 
0.99 (0.87-1.14) 
Obese OR 1.07 
(0.92-1.25)  
Endoscopy: 
Overweight OR 
1.10 (0.98-1.23) 
Obese OR1.09 
(0.95-1.25) 
 
source of care, 
number of 
physicians visits in 
the last year, general 
health status, 
personal history of 
cancer, family 
history of CRC, 
family history of 
other cancers, 
physical activity, 
cigarette smoking, 
alcohol use 
screening 
modality.  Normal 
weight includes 
underweight 
individuals who 
tend to have 
lower screening 
rates.  Did not 
stratify by gender 
or race. 
6.) Wee 
et al. 
2005 
NHIS 2000 Self Report: 
FOBT in past 
year, 
sigmoidoscopy in 
last 5 years; 
colonoscopy in 
last 10 years 
BMI <18.5; 
18.5-<25.0; 
25.0-<30.0; 
30.0-<35.0; 
35.0-<40.0; 
40.0+ 
No significant 
results: All odds 
ratios between 1 
and 1.2 
Age, sex, 
race/ethnicity, 
education, insurance 
coverage, region, 
usual source of care, 
health status, 
smoking, family 
history of colon 
cancer, and marital 
status 
Study not 
designed to look 
at weight and 
screening.  Did 
not stratify by 
race or gender 
7.)  
Menis 
et al. 
2006 
2002 
Maryland 
Cancer 
Survey,  a 
population-
based 
statewide 
survey on 
cancer 
screening 
Self-report 
telephone survey: 
FOBT 
within the last 
year, 
sigmoidoscopy 
within the last 5 
years, or 
colonoscopy 
within the last 10 
Normal weight 
or underweight 
(BMI 
<25); 
Overweight 
(BMI 25–29.9); 
Obese (BMI 
>30) 
Overweight OR 
1.05 (0.83-1.33)  
Obese OR 0.84 
(0.65-1.09) 
Sex, race, age, 
marital status, 
education, 
employment, 
geographic area, 
health insurance, 
having had a 
physical 
examination in the 
last 2 years, and 
Normal weight 
category includes 
underweight 
individuals.  The 
interaction terms 
between sex and 
BMI were 
excluded from the 
final models 
because the 
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and 
behavioral 
risk factors 
among 
people aged 
40 and older 
(3,436 50+ 
respondents) 
years CRC screening 
recommendation. 
overall modifying 
effect by sex was 
not significant 
after controlling 
for all other 
covariates in the 
logistic regression 
model.  
Compared with 
the U.S. 
population in 
2000, adults aged 
50 and older who 
lived in Maryland 
had a much 
higher up-to-date 
CRC screening 
rate (34.0% for 
the U.S. 
population vs. 
64.9% for 
Marylanders).   
Did not stratify by 
race. 
8.) 
Slattery 
et al. 
2004 
Case 
Control 
Study 
conducted 
with Kaiser 
Permanente 
Medical 
Care Group 
of 
Self- report: 
Sigmoidoscopy 
within past 10 
years 
BMI < 25; 25-
29; >30 
Overweight OR 
2.3 (1.5-3.5) 
Obese OR 1.8 
(1.2-2.8) 
Education level, 
marital status, 
family history of 
colorectal cancer, 
physical activity, 
NSAID use, dietary 
supplement use, 
Western/Prudent 
Diet, cigarette 
Study not 
designed to look 
at weight and 
screening.  
Referent category 
includes 
underweight 
individuals.  
Sigmoidoscopy 
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California 
(1,231 
women age 
30+) 
smoking history, 
HRT, alcohol intake 
time frame is not 
recommended 
frame.  Does not 
include other 
recommended 
tests.  Individuals 
40+ were 
included if they 
had a family 
history of colon 
cancer. 
9.) 
James 
et al. 
2008 
Baseline 
data from 
Rural 
African 
American 
Church 
Members in 
NC 
Self-report:  
Screening in the 
past year 
Normal (18.5-
<25); 
Overweight (25- 
<30); Obesity 
class I (30-<35); 
Obesity class II 
(≥35-) 
 
In women, 
weight was 
significantly 
associated with 
having had any 
CRC screening 
test in the past-
year (n=278, 
p=.05).  
Screening rates: 
Normal 44.8% 
Overweight 
28.1% 
Obese I 22.8% 
Obese II 28.9% 
None Only looked at 
screening in the 
past year, not 
adherence to 
recommendations; 
however, FOBT 
was the 
predominant test.  
Small numbers 
made it difficult 
to control for any 
confounders. 
 
 
 
 120 
APPENDIX B 
FOCUS GROUP PARTICIPANT INFORMATION SHEET 
Please answer the following questions before we begin the focus group discussion: 
1. What is the highest grade of school or amount of college you have completed? (check 
one) 
  Eighth grade or less 
  Some high school  
  High school graduate or GED 
  Trade or beauty school graduate  
  Some college 
  College graduate  
  More than college (some post graduate, post graduate, or professional degree) 
 
2. Which of the following best describes your yearly household income? (check one) 
  less than $10,000       
  $10,000 - $19,999      
  $20,000 - $29,999  
  $30,000 - $49,999  
  $50,000 - $74,999  
  $75,000 – $99,999  
  $100,000 - $124,999  
  $125,000 – $149,999  
  more than $150,00     
 
3.  How do you pay for your health insurance?  (check all that apply) 
  I have Medicaid  
  I have Medicare 
   I have Veterans benefits  
  My employer [or previous employer] and I share health insurance costs 
  I pay for my own health insurance 
  Other  
  I don’t have any health insurance 
 
5.  What is your marital status? (check one) 
  Married or living with a partner  
  Never been married    
  Divorced  
  Separated   
  Widowed  
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  Other 
 
4. What is your age?  ____ 
5. What is your height?   ____ ft.   _____  in. 
6. What is your weight in pounds?  ______ 
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APPENDIX C 
FOCUS GROUP MODERATOR’S GUIDE 
Introduction 
 
Hello and welcome, my name is _______.  (Introduce other team members and roles) I 
thank you for taking time to join us in this research focus group session today.  We are 
researchers from the University of North Carolina.  We want to learn more about the best 
ways to help prevent colon cancer in women.  We are having focus group discussions 
with several groups of women in the triangle area to help us better understand why 
women choose to have colon cancer screening test and be physically active.  The overall 
goal of this research is to understand how a woman’s weight affects whether or not she 
does physical activity or gets a screening test for colon cancer.  We know that in the U.S. 
we tend to gain weight as we age, so we want to make sure that programs designed to 
help prevent colon cancer and increase physical activity  are acceptable to all women . 
 
The session should last between an hour and a half and two hours.  At the end of that 
time you will receive a check for $30 for your time.  Feel free to help yourself to 
refreshments at any time.  If you need to use the ladies room it is [give directions]   
 
Forms  
 
You have in front of you a few different documents.  First, you have two identical copies 
of a consent form.  I ask that you review the information in the consent form and then 
sign the last page stating that you understand what is involved in this research study and 
that you agree to participate.  Please return the signed copy to me and keep the other 
copy for yourself. 
 
The second document is a Participant Information Sheet.  I also ask that you fill this out 
and return it to me before we start. 
 
Before we begin, does anyone have any questions about the study or anything listed in the 
consent form? 
 
Collect Consent Forms and Participant Information Sheets 
 
 
 
Focus Group Conduct Issues  
 
1. We would like to tape record the discussion today to make sure we don't miss any 
of your comments.  We take notes but often they are not as complete as when we 
tape the discussion.  Is that OK with everyone? Any objections? If you want to 
make a comment that you don’t want recorded, just tell us that and we’ll turn off 
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the tape and re-start it when you finish making your comment. Is that OK? (Check 
for nods, agreement) Try to speak up so the tape recorder picks up your answers.   
 
TEST TAPE AND START RECORDING 
 
2. Everything we say here today is confidential. We will only be using first names on 
the recording.  Individual names or answers will not be shared with anyone. Only 
a summary of all the focus groups we are doing will be used.  We also ask that 
you do talk about what people in this group say today to anyone outside the 
group. What is said in the room should stay in the room. Can everyone agree to 
this?  As researchers, we commit to keeping confidential the information you 
share with us. However, we can’t control what happens outside of the group.  If 
there is anything that you don’t want known outside the group, don’t talk about it 
in the discussion. If you have something you want us to know but don’t want to 
talk about in the group, , I will stay  around after the group and will be happy to 
talk with you privately.  
 
3. Please feel free to share your ideas and opinions even if they are different from 
others.  All views and ideas are important.  There are no right or wrong answers.  
We would like to get as many different points of view as we can.  Since this is a 
group discussion you do not have to wait for me to call on you to speak, but 
please try to speak one at a time.  If everyone starts talking at once I may ask you 
to stop so that we can hear everyone on the tape recorder. 
 
4. To help our note taker, I am going to ask you all for your first and last initial. 
 
Begin Discussion 
 
To start the focus group session, we’ll first discuss some issues around health and cancer 
screening, take a break, and then discuss physical activity and intervention preferences.  
When we are done, you will sign a receipt and receive your check. 
 
To begin, I would like to go around the (table, room) and have each of you tell us your 
first name, and if you like, share why you were interested in participating in this focus 
group. 
 
Take about a minute or so to do this. 
 
I. Health Issues 
As we have this discussion I would like you to keep in mind that we are trying to learn if 
weight has an effect – or not – on women’s concerns about their as well as on the health 
choices they make.   
 
Let's start with a general discussion about your health.  
 
1. What concerns you most about your health? 
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Probe:  What about weight?   
 
2. What kind of things do you normally do to take care of your health?   
Probe:   Are there any regular check-ups or screening tests you get? 
 
3. Have you ever delayed getting a screening test or any other preventive health care 
that you knew you should get? [By preventive healthcare I mean anything you see 
a health care provider about when you are not sick such as regular check-ups, 
cholesterol tests, blood sugar tests, vaccines or cancer screenings] 
Probe:  Can you tell me about what happened? 
 
4. Some women have said that they delay going to get screenings because they don’t 
want to be weighed or be told to lose weight.  Has this ever been a concern for 
you? 
 
5. Has your weight ever prevented you from visiting a health care provider for any 
other reason? 
 
6. How do you decide whether or not you should get medical tests or screenings? 
a. Which tests do you think are most important to get? 
b. What role does your health care provider have in your decision to get a 
test or screening?  Who else influences your decision? 
 
7. How satisfied are you with your current healthcare provider? 
Probe for reasons 
a. Have you ever been dissatisfied with a health care provider? Why?  
 
II. Knowledge of colon cancer 
 
The next questions are about colon cancer.  
 
1. What’s the first thing you think of when you hear the words “colon cancer”?  
 
2. What do you know about colon cancer?  
Probe:  What do you think are reasons people get colon cancer? 
 
3. Compared to other women your age, do you think you are more or less likely to 
get colon cancer? 
Probe:  What puts you at higher/lower risk? 
If not mentioned:  What about weight? 
 
4. What can be done to help prevent women from getting colon cancer? 
 
 
III. Colon Cancer Screening 
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1. What colon cancer screening tests have you heard of? 
 
2. What do the tests look for?   
 
Describe Screening Tests and Purpose  
 
3. Have you ever had a colon cancer screening test? 
 
4. If you were to get a(nother) colon cancer screening test, what would be the 
reason? 
 
5. What are some reasons why women don’t get colon cancer screenings? 
Probe: Earlier we discussed how weight might affect the healthcare that 
women receive.  Is there any connection between weight and a woman’s 
decision to get a colon cancer screening? 
 
6. Has your doctor told you that you should have a colon cancer screening? 
 
a. If so, what kind of screening? 
 
b. If not, if your doctor recommended it, how likely would you be to get a 
colon cancer screening? 
 
7. Have any of your friends or family been screened for colon cancer? 
 
a. What have they told you about screening? 
 
8. What could be done that would help you to get a(nother) screening test for colon 
cancer?  
Probe:  Is there information that you would like?  Who would help you? 
 
 
BREAK 
 
Welcome back.  In the first part of the session we discussed you your thoughts about 
health issues, colon cancer and cancer screening.  Now we are going to talk about 
physical activity and how you best like to receive health information. 
 
V.  Physical Activity 
 
1. How would you define physical activity?    
Probe:  What kinds of things do you consider to be physical activity? 
 
2. What kind of physical activity do you currently do? 
Probe for those who are active:  How often do you do it? 
How long have you been doing this activity? 
 
 
 
 126 
 
a. How has your physical activity changed over time?  
 
b. Does your weight have any effect on your activity level? 
 
3. What motivates you (or would motivate you) to be physically active? 
 
4. What gets in the way of being active?  
 
Probe:  Do you consider any of these barriers to be weight-related? 
 
5. What do your friends and family members say to you about physical activity? 
Probe:  What role does weight play in these conversations, if any?   
 
a. How do friends and family affect how much physical activity you do? 
Probe:  Do they make it harder for you to be active?  Do they encourage 
you to be active? 
 
b. Do you have friends or family members who are active on a regular basis? 
 
6. How comfortable do you feel talking to your doctor about physical activity? 
 
a. What does your doctor say to you about physical activity? 
Probe:  What role does weight play in these conversations, if any?   
 
b. How do your health care providers affect your decision about how much 
physical activity you do? 
 
7. If you were going to be more physically active, what would help you most to do 
that? 
Probe:  Is there information that you would like?  Who would help you? 
 
 
VI. Best ways to get health information 
 
1. There are lots of ways that people get information about colon cancer and 
physical activity. Here are three:  
i. talking to someone like you who had been trained to talk to others 
about health 
ii. receiving information over the internet or through e-mail,  
iii. receiving print information sent to you home 
 
a. Where do you usually get your health information? 
 
b. Which way do you prefer?  Why? 
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c. Is there another way of getting this information that I haven’t mentioned 
that you would prefer? 
 
2. Is there anything that annoys you in health messages?  
 
3.  What types of health messages have been able to encourage you in the past?  
 
That’s the end of the questions.  Is there anything else you would like to add? 
 
Thank you very much for your time. 
 
(Name of note taker) will give you each a check for $30 for your participation today.   
 Thanks for your help today.  
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APPENDIX D 
FOCUS GROUP RESULTS FOR PHYSICAL ACTIVITY 
Women in the focus groups were asked what type of exercise they currently do.  
For white women, the most common type of current physical activity was walking and 
doing yard work/outdoor activities.  Others stated that they were just trying to always be 
active (e.g. “always moving”).  Also, some women indicated that they were either too 
pressed for time or that medical problems prohibited them from exercising.  For black 
women, walking was also the most frequently cited physical activity.  However, they also 
indicated that their current PA fluctuates between periods of high to moderate activity to 
relatively none at all.  These changes were generally related to changes in personal 
routines, schedules or weather.          
Next we asked about other factors, such as weight, which might affect 
participants’ exercise behaviors.  Perceived benefits and barriers to participating in 
physical activity are shown in Table D.1.  For white women, the most common barrier to 
exercise was physical injuries, many of which were aggravated by excess body weight.  
Lack of time and “weight-related” barriers and were also frequently cited; women stated 
that their weight made it more difficult for them to exercise and made activity physically 
uncomfortable.  “Weight-related” barriers were also common among African American, 
several of whom expressed discomfort with how they looked while they were exercising.  
Many African American women were discouraged from exercising because it did not 
produce significant changes in their weight.   
White and African American women sighted similar motivations for engaging in 
physical activity.  For both groups, the health benefits were cited as being the most 
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motivating factor for engaging in any form of physical activity.  Women also reported 
using exercise as a way to develop and maintain a social network.  While few women 
cited weight lose as a motivation for exercise, most women believed that exercise was 
most important for women who were trying to lose weight.   
“I never had to exercise in my young life to stay in shape.  It never was even a 
thought in my head.  And so, like I said, it’s not something I’m used to.” (White 
Woman) 
We also discussed potential strategies which might help women to increase their current 
exercise level.  Strategies included exercising in a motivating setting (i.e. beach or other 
pleasant scenery), seeking encouragement via a social group or having an exercise 
partner.   
While women recognized the health benefits of exercise, some of them associated 
these benefits with weight loss.  If obese women who do not see significant weight loss 
resulting from exercise participation they may not believe exercise is benefiting their 
health.  This coupled with the increased difficulty of exercise for larger women may 
discourage them from continuing regular exercise.  Future exercise promotion programs 
targeted to obese women should emphasize that the benefits of exercise can be achieved 
even at moderate levels, which may not produce weight loss.  
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Table D.1. Perceived Benefits and Barriers to Physical Activity among Obese Women 
Construct Common Codes and Frequencies Illustrative Quotes 
Perceived 
Barriers to 
Physical Activity 
(General)*  
White: Injury or surgery (9); 
Time (5); Life gets in the way/ you 
get distracted (3); Chronic condition 
(3); Environment/safety issues (2); 
Don’t want to exercise in front of 
others (2) 
 
African American: “Life situations” 
i.e. events which cause schedule 
changes (6); Exercising doesn’t 
cause enough weight loss (4); Don’t 
have place/don’t know how to 
exercise (4); Lack of Time (3); Too 
tired/old (3); Injury (2); Weather 
(2); Don’t enjoy exercise (2); Lost 
group or partner (2); Fatalism (2); 
Lack energy/ motivation (2) 
“The knees.  And the hips, too, right now.  Yeah I used to go to 
the gym but the knees are now going, “Don’t do that!”  So I have 
to accommodate them, now.”  (White Woman) 
 
“When my blood sugar’s low, I can’t go out and walk because it’s 
gonna drop, and then I’ll be lying around somewhere, half dead! 
(Laughs) So... you know, it’s a constant balancing act.”  (African 
American Woman) 
 
“I went back in the group, got me a walking partner, we would go 
to South Point every morning and [then] we had an emergency 
with one of my daughters... what put me into that situation, and I 
haven’t gotten back yet, find my group back there.” (African 
American Woman) 
 
“But when you pass a certain age, it’s just not as, um... 
advantageous to you, ‘cause you can exercise, and you can eat 
less, and you don’t change.  And it takes six/ eight months before 
anything happens, and then, like I said, there’s other little 
problems coming in between that make you either slow down or 
you just can’t keep that routine.” (African American Woman)   
Perceived 
Barriers to 
Physical Activity 
(Weight-related) 
 
 
White: Weight, general (3); 
Physically Uncomfortable while 
exercising (3) Short of breath (1); 
Uncomfortable with appearance 
while exercising (1) 
 
African American: Other’s 
perception that larger women can’t 
“…the weight goes down and then I feel better about exercising, 
because who wants to be, you know, big, fat, tight clothes, that 
kind of thing, getting out of breather earlier or something like 
that, although my breath really is pretty good.” (White Woman) 
 
“I think the reason I don’t exercise is... I want to exercise by 
myself, but the only reason I don’t want to join a club, or anything 
like that is because everybody in there is like a size 2!” (African 
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do certain things (2); 
Uncomfortable with appearance 
while exercising (2); Weight makes 
you tire easily; Short of breath; 
Exercise harder when you are 
overweight 
 
American Woman) 
Perceived 
Benefits of 
Physical Activity 
White: Improve Health/Quality of 
life (7); Weight management (6); 
Disease prevention (6); Improve 
physical health (5); Treat 
conditions/ Avoid medication (5); 
Improve mental health (4); Social/ 
Fun (2) 
 
African American: 
Weight management (5); Improve 
mental health (5); Social/Fun (4); 
Improve physical health (3); 
Manage diabetes (1); Take time for 
self (1); Improve skin (1) 
“My physical activity drops off as I gain weight.  And then it 
increases as I lose weight.  And so, losing weight, seeing the 
numbers go down on the scale, feeling as though my clothes are 
fitting better or I get into, you know, my smaller size clothes and 
that sort of thing, that motivates me to work out, to be more 
purposeful in doing physical activity. I also don’t want to hurt I 
don’t want to have heart disease and so, when I’m doing what I 
need to be doing, those also help reinforce being active.” (White 
Woman) 
 
“Walking to me is therapeutic, as well as the exercise. I’ve solved 
a lot of problems walking.  I can really tell the difference in 
everything - my skin, my weight, my temperament and that works 
for me.” (African American Women) 
*Due to high numbers of perceived barriers, only those which were cited 2 or more times are included in the chart.
APPENDIX E 
ONLINE MESSAGE TESTING SURVEYS 
Eligibility Questionnaire 
Please only complete the eligibility questionnaire once. 
1. What is your gender? 
  Male  
  Female  
2. What is your age? ___ 
3. What is your height ?  _______  ft.  ______ in. 
4. What is your weight in pounds? _______        
5. What is your race? (select one) 
  White (not Hispanic)/ European American  
  African American/ Black  
  Native American    
  Asian/ Pacific Islander 
  Hispanic 
  Multi-racial 
  Other 
6. What is the highest grade of school or amount of college you have completed? 
  Eighth grade or less 
  Some high school  
  High school graduate or GED 
  Trade or beauty school graduate  
  Some college 
  College graduate  
  More than college (some post graduate, post graduate, or professional degree) 
7. Which of the following best describes your yearly household income? 
a. Less than $10,000 (5)      
b. $10,000 - $19,999 (7)     
c. $20,000 - $29,999 (16) 
d. $30,000 - $49,999 (37) 
e. $50,000 - $74,999  (58) 
f. $75,000 – $99,999 (37) 
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g. $100,000 - $124,999  (26) 
h. $125,000 – $149,999 (10) 
i. More than $150,00   (11) 
Baseline Survey 
Colon Cancer Questions 
These questions are about tests which you may have had to screen for colon cancer. 
1. A stool blood test, also known as a Fecal Occult Blood Test or FOBT is a test to 
check for colon cancer.   It is done at home using a set of three cards to determine 
whether the stool contains blood. You smear a sample of your fecal matter or stool on 
a card from three separate bowel movements and return the cards to be tested.  Before 
reading this description, had you ever heard of FOBT? 
 
a. Yes → Continue to Question 1b. 
b. No → Continue to Question 2 
c. Not sure/ Don’t know→ Continue to Question 2 
1b. Have you ever had and FOBT? 
a. Yes → Continue to Question 1c. 
b. No → Continue to Question 2 
c. Not sure/ Don’t know→ Continue to Question 2 
1c.  When was your last FOBT? 
a. A year ago or less 
b. More than 1 but not more than 5 years ago 
c. More than 5 years ago but not more than 10 years ago 
d. More than 10 years ago 
e. Not sure/ Don’t know 
2. On a scale of 1 to 10, how confident are you that you can complete a(nother) stool card 
test?  A 1 means that you are not at all confident, a 10 means that you are very confident. 
1  2  3  4  5  6  7  8  9  10 
Not at all confident (goes under the 1)   very confident (goes under 
the 10) 
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The following questions are about sigmoidoscopy and colonoscopy, two other tests to 
check for colon cancer.  Both tests examine the colon using a narrow, lighted tube that is 
inserted in the rectum. Sigmoidoscopy only examines the lower part of the colon, while 
colonoscopy examines the entire colon.  
With the sigmoidoscopy: 
• You are awake. 
• You are able to drive yourself home. 
• You are able to resume your normal activities.  
With the colonoscopy: 
• You are given medicine through a needle in your arm to make you sleepy. 
• You need someone to drive you home. 
• You may need to take the rest of the day off from your usual activities. 
 
3.  Before reading this description, had you ever heard of a sigmoidoscopy? 
a.  Yes → Continue to Question 3 b. 
b. No → Continue to Question 4 
c. Not sure/ Don’t know→ Continue to Question 3 
3b. Have you ever had a sigmoidoscopy? 
a.  Yes → Continue to Question 3 c. 
b. No → Continue to Question 4 
c. Not sure/ Don’t know→ Continue to Question 4 
3c. When was your last sigmoidoscopy? 
a. A year ago or less 
b. More than 1 but not more than 5 years ago 
c. More than 5 years ago but not more than 10 years ago 
d. More than 10 years ago 
e. Not sure/ Don’t know 
4.  Before reading the description above, had you ever heard of a colonoscopy? 
a. Yes → Continue to Question 4 b. 
b. No → Continue to Question 5 
c. Not sure/ Don’t know→ Continue to Question 5 
4b. Have you ever had a colonoscopy? 
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a.  Yes → Continue to Question 4 b. 
b. No → Continue to Question 5 
c. Not sure/ Don’t know→ Continue to Question 5 
4c. . When was your last colonoscopy? 
a. A year ago or less 
b. More than 1 but not more than 5 years ago 
c. More than 5 years ago but not more than 10 years ago 
d. More than 10 years ago 
e. Not sure/ Don’t know 
5.  On a scale of 1 to 10, how confident are you that you can schedule and complete 
a(another) colonoscopy?  A 1 means that you are not at all confident, a 10 means that you 
are very confident. 
1  2  3  4  5  6  7  8  9  10 
Not at all confident (goes under the 1)   very confident (goes under 
the 10) 
6.. Barium enema, or a lower gastrointestinal series, is another test to check for colon 
cancer. X-rays are taken of the colon after barium or barium and air are given by enema. 
The day before the test, you are asked to drink a lot of liquids and to take laxatives. No 
solid food is permitted.  Before reading this description, had you ever hear of a 
barium enema? 
a. Yes → Continue to Question 6 b. 
b. No → Continue to Question 7 
c. Not sure/ Don’t know→ Continue to Question 7 
6b. Have you ever had a barium enema? 
a. Yes → Continue to Question 6 b. 
b. No → Continue to Question 7 
c. Not sure/ Don’t know→ Continue to Question 7 
6c.  When was your last barium enema? 
a. A year ago or less 
b. More than 1 but not more than 5 years ago 
c. More than 5 years ago but not more than 10 years ago 
d. More than 10 years ago 
e. Not sure/ Don’t know 
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7. Please tell us whether you agree or disagree with the following statements about 
colorectal cancer.   
        Agree       Disagree  DK 
1          2                3 
a. The risk of colorectal cancer is higher in men than women.  
b. Physical activity decreases the risk for colorectal cancer.   
c. Individuals at average risk for colon cancer should start regular screenings at age 50. 
d. You only need to have a colorectal cancer screening test if you are having symptoms.    
e. Being overweight may increase your chances of getting colon cancer.  
f. If a polyp is removed during a colonoscopy it can prevent colon cancer from 
developing.     
 
8. Thinking about getting a screening test to check for colon cancer, please tell me how 
much you agree or disagree with the following statements. 
Agree       Agree       Disagree   Disagree  
              a lot       a little       a little    a lot 
1          2              3      4 
a. The benefits of colon cancer screening outweigh the discomforts. 
b. No one in my family has had colorectal cancer, so I have nothing to worry about 
c. I have faith that I will not get colon cancer, so I don’t need to get screened 
d. My doctor or health care provider has never recommended a colon cancer screening 
test. 
e. I don’t have symptoms of feel sick, so there is no reason for me to get a colorectal 
cancer screening test 
f. Colon Cancer Screening Tests are too embarrassing 
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9. Thinking only about getting a colonoscopy to check for colon cancer, please tell me 
how much you agree or disagree with the following statements.  
              
Agree       Agree       Disagree   Disagree  
              a lot       a little       a little    a lot 
1          2              3      4 
a. It would be painful      
b. The preparations I would have to do are too difficult (such as changing my diet or 
taking laxatives).  
c. It would be too expensive.     
d. I have too many other health costs right now and can’t afford to have a colonoscopy. 
e. I don’t have time to get a colonoscopy. 
f. I have other health concerns which are more important right now than getting a colon 
cancer screening. 
 
10. On a scale of 1 to 10, how likely are you to get a colon cancer screening test within 
the next 6 months? A 1 means that it is very unlikely, a 10 means that it is very likely. 
1  2  3  4  5  6  7  8  9  10 
Very unlikely (goes under the 1)   very likely (goes under the 10) 
 
11. Compared to others your age, how likely is it that you will get colon cancer at some 
time in the future? Please answer on a scale of 1 to 10.  A 1 means that you a much less 
likely to get colon cancer than other people your age, a 10 means that you are much 
more likely to get colon cancer  than other people your age . 
1  2  3  4  5  6  7  8  9  10 
Much less likely (goes under the 1) about as likely (middle) much more likely 
(goes under the 10) 
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Physical Activity  
12. Do you have any injuries or medical conditions that have kept you from being 
physically active over the last 7 days?      
a. yes  → 12. b What is your condition? ______________________    
     
b. no 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much 
harder than normal.  Think only about those physical activities that you did for at least 10 
minutes at a time. 
13. During the last 7 days, on how many days did you do vigorous physical activities 
like heavy lifting, digging, aerobics, or fast bicycling?  
_____ days per week  
 
   13b. No vigorous physical activities  Skip to question 3 
 
14. How much time did you usually spend doing vigorous physical activities on one of 
those days? 
_____ minutes per day  
 
  14b. Don’t know/Not sure  
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal.  Think only about those physical activities that you did for 
at least 10 minutes at a time. 
15. During the last 7 days, on how many days did you do moderate physical activities 
like carrying light loads, bicycling at a regular pace, or doubles tennis?  Do not 
include walking. 
_____ days per week 
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   15.b No moderate physical activities  Skip to question 5 
16. How much time did you usually spend doing moderate physical activities on one of 
those days? 
_____ minutes per day 
 
  16. b Don’t know/Not sure  
 
Think about the time you spent walking in the last 7 days.  This includes at work and at 
home, walking to travel from place to place, and any other walking that you might do 
solely for recreation, sport, exercise, or leisure. 
17. During the last 7 days, on how many days did you walk for at least 10 minutes at 
a time?   
_____ days per week 
  
   17b. No walking     Skip to question 7 
 
18.  How much time did you usually spend walking on one of those days? 
_____ minutes per day  
 
  18. b Don’t know/Not sure  
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time.  
This may include time spent sitting at a desk, visiting friends, reading, or sitting or lying 
down to watch television. 
19.  During the last 7 days, how much time did you spend sitting on a week day? 
_____ hours per day 
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  19 b. Don’t know/Not sure  
 
20. Please tell me how much you agree or disagree with the following statements about 
exercise. 
               Agree       Agree       Disagree    Disagree  
              a lot       a little       a little    a lot 
1          2  3      4 
 
 a. I usually only exercise if I am trying to lose weight 
 b. I don’t have any one to exercise with.     
 c. I don’t have any place to exercise.      
 d. I don’t have the energy to exercise.    
 e. I am uncomfortable with how I look while exercising or while wearing exercise 
clothing.   
f. My current weight makes it difficult for me to exercise 
 g. I will have more energy if I exercise.    
 h. I will control my weight if I exercise.    
 i. I will improve my health if I exercise.   
j. Exercising will decrease my chances of getting some diseases.  
k. I enjoy exercising 
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21. On a scale of 1 to 10, how confident are you that you can exercise at least five times 
per week for 30 minutes or more? A 1 means that you are not at all confident, a 10 means 
that you are very confident. 
1  2  3  4  5  6  7  8  9  10 
Not at all confident (goes under the 1)  very confident (goes under the 10) 
 
22. Do you currently participate in any regularly scheduled exercise? 
a. yes 
b. no →  23. In the past 6 months, have you participated in any regularly scheduled 
exercise? 
a. no 
b. yes →   24. Why did you stop your exercise routine? 
a.  Because of an injury 
b.  Something more important conflicted with my exercise routine 
c.  Other 24a. Please specify: 
 
25. On a scale of 1 to 10, how likely is it that you will exercise regularly over the next 2 
weeks.  A 1 means that it is very unlikely, a 10 means that it is very likely. 
1  2  3  4  5  6  7  8  9  10 
Very unlikely (goes under the 1)   very likely (goes under the 10) 
 
26.  Are you actively trying to: (select one)  
a. Lose weight→ If selected:   What are you doing to try and lose weight (select all that 
apply) 
    26a.  I’m exercising more 
    26b. I’m eating less 
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    26c. Other 26d.(please specify) _______ 
b. Gain weight 
c. Maintain your current weight 
d. Don’t know/Unsure 
 
These next questions are about your health and going to the doctor or other health care 
provider. 
 
27. Overall, is your health:  (select one) 
a. excellent   d. fair 
b. very good   e. poor 
c. pretty good 
 
28. Have you been diagnosed with any of the following illnesses? 
a) High Blood Pressure    yes  no don’t know 
b) Heart disease     yes  no don’t know 
c) Diabetes (Type I or Type II)   yes  no don’t know 
d) Arthritis     yes  no don’t know 
e) Crohn’s Disease    yes  no don’t know  
f) Ulcerative colitis    yes  no don’t know 
g) Cancer      yes  no don’t know    
If yes, what kind of cancer? ______________________________________  
      h)    Other health problem:  _______________________ 
 
29. In the last 12 months (not counting times you went to an emergency room), how any 
times did you go to a doctor’s office or clinic to get care for yourself? 
a) None 
b) 1 
c) 2-3 
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d) 4-5 
e) 6 or more 
f) Don't know 
 
30. When your doctor or healthcare provider recommends that you get a test or screening, 
how do you decide whether or not you should get it?  For this question, test or screening 
means a procedure that is used to find out whether or not you have a certain health 
condition.  It is not used to treat a health condition.   
Please check all that apply to you. 
a) I usually get all of the tests that my doctor/healthcare provider 
recommends. 
b) I usually only get the test if I am having pain or other symptoms 
c) I usually only  get the test if it is covered by insurance 
d) I usually read up on the test before I decide if I will get it 
e) I usually talk to my friends or family about the test before I decide if I 
should get it 
f) Other ft. (please specify)  _____________ 
 
31. Thinking about the doctor or health care provider that you currently see most often,  
please tell me how much you agree or disagree with the following statements. 
      Agree       Agree       Disagree  Disagree  
              a lot       a little       a little  a lot 
1          2              3  4 
a. The nurses and office staff at my doctor’s office treat me with respect. 
b. I receive enough understandable information from my doctor/ health care provider to 
make good decisions about my health.         
c. My doctor/ health care provider involves me in decisions about my health care.  
  
d. My doctor/health care provider understands my health needs.      
  
e. My doctor/ health care provider listens carefully to me 
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f. My doctor/ health provider explains things in a way I can understand 
g. My doctor/ health provider shows respect for what I have to say 
h. My doctor/ health provider spends enough time with me 
 
32. On a scale of 1 to 10, how would you rate all of the health care you received in the 
last 12 months? 
A 1 means that you received the worst possible healthcare, a 10 means that you received 
the best possible healthcare. 
1  2  3  4  5  6  7  8  9  10 
Worst possible health care (goes under the 1) Best possible healthcare (goes under the 10) 
 
33. How do you pay for your health insurance?   
a. I have Medicaid  
b. I have Medicare. 
c.  I have Veterans benefits  
d. My employer [or previous employer] and I share health insurance costs 
e. I pay for my own health insurance 
f. I don’t have any health insurance 
g.  I don’t know 
h. Other 
Follow-up Survey  
Please respond to each question by selecting the number on the scale which bet 
corresponds to your response. For example, an answer of 1 would mean strongly disagree 
and an answer of 7 would mean strongly agree. You can also choose any number between 
1 and 7.  
Strongly Disagree  1  2  3  4  5  6  7  Strongly Agree 
1.. The topic of colon cancer prevention is important to me personally. (pos) 
2.. I was motivated to read the messages. (pos) 
3.  The information in the messages held my attention. (pos) 
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4.  It was difficult to understand the information in the messages. (neg) 
5. While reading the messages, I was distracted from thinking about the topic. (neg) 
6. The messages took a reasonable amount of time to read (pos) 
7. The messages made good points about the topics. (pos) 
8. I tried hard to think about the information in the messages. (pos) 
9. The messages were organized and easy to follow. (pos) 
10. It was difficult to concentrate on reading the messages. (neg) 
11. The information in the messages was logical and accurate. (pos) 
12. The messages were written especially for someone like me.  (pos) 
13. The information in the messages applied to my life. 
14. I believed the information in the messages. 
15. Overall, the quality of the messages was excellent. 
16.  Knowledge Questions 
Please tell us whether you agree or disagree with the following statements about 
colorectal cancer.           
        Agree       Disagree  DK 
1          2                3 
a. The risk of colorectal cancer is higher in men than women.  
b. Physical activity decreases the risk for colorectal cancer.   
c. Individuals at average risk for colon cancer should start regular screenings at age 50. 
d. You only need to have a colorectal cancer screening test if you are having symptoms.    
e. Being overweight may increase your chances of getting colon cancer.  
f. If a polyp is removed during a colonoscopy it can prevent colon cancer from 
developing.     
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Colon Cancer Questions 
17. On a scale of 1 to 10, how confident are you that you can schedule and complete a 
(another) colonoscopy? A 1 means that you are not at all confident, a 10 means that you 
are very confident.  
1  2  3  4  5  6  7  8  9  10 
 
18. On a scale of 1 to 10, how confident are you that you can complete a (another) stool 
card test? A 1 means that you are not at all confident, a 10 means that you are very 
confident.  
1  2  3  4  5  6  7  8  9  10 
19. On a scale of 1 to 10, how likely are you to get a colon cancer screening test within 
the next 6 months? A 1 means that it is very unlikely, a 10 means that it is very likely.   
1  2  3  4  5  6  7  8  9  10 
 
20. Compared to others your age, how likely is it that you will get colon cancer at some 
time in the future? Please answer on a scale of 1 to 10. A 1 means that you a much less 
likely to get colon cancer than other people your age, a 10 means that you are much more 
likely to get colon cancer than other people your age.  
1  2  3  4  5  6  7  8  9  10 
 
Physical Activity Questions 
21. On a scale of 1 to 10, how confident are you that you can exercise at least five times 
per week for 30 minutes or more? A 1 means that you are not at all confident, a 10 means 
that you are very confident.  
1  2  3  4  5  6  7  8  9  10 
22. On a scale of 1 to 10, how likely is it that you will exercise regularly over the next 2 
weeks. A 1 means that it is very unlikely, a 10 means that it is very likely.  
1  2  3  4  5  6  7  8  9  1  
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APPENDIX F 
INTERVENTION AND CONTROL MESSAGE
Weight-targeted Messages 
 
1. What should you know about colon 
cancer? 
 
Many women are surprised to hear that 
colon cancer is the third leading cause of 
cancer deaths among women in the 
United States.  Information about breast 
cancer is everywhere.  And most women 
have known since they were young that 
they need to get a yearly pap smear to 
check for cervical cancer.  But many of 
us don’t hear anything about colon 
cancer until we turn 50 and the doctor 
surprises us with a long list of tests that 
we should do.  It can be hard to figure 
out which things really need to be done.  
Colon cancer screening is one test you 
should not breeze over.  Here are some 
reasons why: 
• Women are as likely to get 
colon cancer as men.   
• Colon cancer is responsible for 
over 26,000 deaths in women 
each year, compared to only 
about 4,000 deaths from 
cervical cancer. 
• The American Cancer Society 
recommends that everyone age 
50 or older should have regular 
colon cancer screening tests. 
 
 
 
 
 
 
 
 
 
Generic Messages 
 
 
1. What is Colorectal Cancer?  
 
Colorectal cancer is cancer that occurs in 
the colon or rectum. Sometimes it is 
called colon cancer, for short. As the 
drawing shows, the colon is the large 
intestine or large bowel. The rectum is 
the passageway that connects the colon 
to the anus. Colorectal cancer is the 
second leading cancer killer in the 
United States, but it doesn’t have to be. 
If everybody age 50 or older had regular 
screening tests, at least one-third of 
deaths from this cancer could be 
avoided. So if you are 50 or older, start 
screening now.  
 
Colorectal Cancer Facts and Figures  
• It’s the 2nd leading cancer killer in the 
U.S. (after lung cancer).  
 
• Both men and women are at risk.  
 
• 93% of cases occur in people age 50 
and older.  
 
• The risk of developing it increases with 
age.  
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2. Why should you care about colon 
cancer? 
Some people think that if no one in their 
family has had colon cancer that they 
don’t have to worry about getting it.  
This is not necessarily true.  Only 
between 5 and 10 percent of all colon 
cancers are genetic (i.e. they run in your 
family).   The large majority of colon 
cancer cases are related to lifestyle and 
other factors such as: 
• Older Age: Your risk goes up 
the most after age 50.   
• Exercise:  Women who exercise 
are less likely to get colon 
cancer.   
• Higher Weight:  Risk for colon 
cancer is higher in women who 
are overweight.  The more you 
weigh, the higher your risk will 
be.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Who Gets Colorectal Cancer?  
 
• Both men and women can get 
colorectal cancer.  
 
• Colorectal cancer is most often found 
in people 50 and older.  
 
• The risk for getting colorectal cancer 
increases with age.  
 
Your risk for colorectal cancer may be 
higher than average if:  
 
• You or a close relative have had 
colorectal polyps or colorectal cancer.  
 
• You have inflammatory bowel disease.  
 
People at high risk for colorectal cancer 
may need earlier or more frequent tests 
than other people. Talk to your doctor 
about when you should begin screening 
and how often you should be tested. 
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3. What can you do about colon 
cancer? 
The good news is that most cases of 
colon cancer can be prevented.  Colon 
cancer screening can help prevent colon 
cancer or find it early -- when it can be 
cured more easily.  Unlike most 
illnesses, you don’t have to wait until 
you have symptoms to go the doctor.  In 
fact, most cases of colon cancer have no 
symptoms.  Even women who are in 
touch with their bodies will probably not 
be able to tell that colon cancer is 
developing.  A screening test can help let 
you know what is going on inside your 
body. 
 
The most common screening test is 
called a colonoscopy.  This test uses a 
lighted tube inserted through the anus to 
find small growths called polyps in the 
colon.  If left alone, these polyps could 
develop in to cancer.  During a 
colonoscopy, the doctor can remove the 
polyps and stop colon cancer from 
developing.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Screening Saves Lives  
If you’re 50 or older, getting a screening 
test for colorectal cancer could save your 
life. Here’s how:  
 
• Colorectal cancer usually starts from 
polyps in the colon or rectum. A polyp is 
a growth that shouldn’t be there.  
 
• Over time, some polyps can turn into 
cancer.  
 
• Screening tests can find polyps, so they 
can be removed before they turn into 
cancer.  
 
• Screening tests can also find colorectal 
cancer early. When it is found early, the 
chance of being cured is good.  
 
Several tests are available to screen for 
colorectal cancer. Some are used alone, 
while others are used in combination 
with each other. Talk with your doctor 
about which is best for you.    
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4. Don’t Delay! 
Let’s face it.  Most of us do not like the 
idea of getting a colonoscopy.  The test 
sounds invasive and the thought of 
spending the night before going to the 
bathroom to clean out your colon may 
make you feel uncomfortable.  In the 
end, knowing that this test saves lives 
convinces most women to do it.  And the 
truth is that they feel relieved after they 
get it.  It is never as bad as you imagine.  
Here’s why: 
• You are given a medicine to 
make you sleepy and 
comfortable- most women say 
that they didn’t feel anything 
during the procedure.   
• The anxiety leading up to the 
test is all gone when you get the 
results- it’s better to know you 
are healthy than to worry and 
wonder. 
• If the doctor doesn’t find any 
polyps, you will probably only 
need to have a colonoscopy 
once every 10 years.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. What are the colon cancer 
screening tests?  
One screening test is called a 
colonoscopy.  For this test, the doctor 
examines the lining of your rectum and 
entire colon using a thin, flexible, lighted 
tube called a colonoscope.  It is inserted 
into your rectum and colon. The doctor 
can find and remove most polyps and 
some cancers.  This test should be 
completed once every 10 years starting 
at 50 for people with no family or 
personal history of polyps, and no 
symptoms.   
Here are some things you should 
consider before you have this test: - It provides direct view of rectum 
and entire colon.  - Before the test, your doctor will 
recommend that you restrict your 
diet and use laxatives and/or 
enemas to clean out your colon 
and rectum.  - You may feel discomfort during 
or after exam.  - You’re given medication to help 
make the exam more comfortable 
for you and are advised not to 
drive or work on the day of the 
exam.  - There is a slight risk of 
perforation, infection, bleeding. 
   
 
  151 
5. Another doctor visit? 
Going to the doctor can be both costly 
and time consuming.  Even if you have 
insurance, the co-pays and deductibles 
alone can make you think twice about 
going to the doctor.  If you have any 
type of condition for which you need to 
go to the doctor more regularly, it can 
seem overwhelming to think about going 
back for anything else.  If getting a 
colonoscopy to check for colon cancer, 
when you don’t have any symptoms, 
seems like too much for you to do right 
now, there are other options.  Stool card 
tests (sometimes called FOBT or FIT) 
are very inexpensive and can be done at 
home.  Here’s what you should know 
about stool card tests: 
• FIT is a newer version of the 
FOBT which is more 
accurate and does not require 
you to change your diet.   
• Stool card tests can be 
returned to your doctor 
through the mail, so don’t 
have to go in unless you have 
a positive result.   
• The doctor will test your 
stool for hidden blood which 
could indicate that you have 
colon cancer or an advanced 
polyp.   
• Because this test is not as 
good at finding polyps as a 
colonoscopy, it should be 
repeated every year. 
 
You can have peace of mind without all 
the waiting or financial worry.   
 
 
 
 
 
 
5. The Fecal Occult Blood Tests 
(FOBT) 
Sometimes called stool cards, this test 
checks for occult (hidden) blood in the 
stool. You receive a test kit from your 
doctor or health care provider. At home, 
you place a small amount of your stool 
from three bowel movements in a row 
on test cards. You return the cards to 
your doctor’s office or a lab, where the 
stool samples are tested for hidden 
blood.   This test should be completed 
once a year starting at 50.Here are some 
things you should consider before you 
have this test:  - You receive the test kit from 
your doctor or health care 
provider and do the test yourself 
at home.  - -Your doctor will probably 
recommend that you avoid some 
foods and medicines before and 
until stool samples are collected 
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6. Talking to the doctor 
We all have different reasons for why 
we delay going to the doctor: “I just 
want to lose 5 more pounds before I go 
back” or “I don’t want to tell my doctor 
that I haven’t been doing the exercises 
she recommended.”  While many 
women report that they have a good 
relationship with their doctor, they may 
have had a bad experience in the past.  
Doctors have a reputation for rushing, 
not listening to patients, and making 
impersonal recommendations.  Still, 
most women trust their doctors to help 
them make important decisions about 
their health.  Having a doctor you feel 
comfortable with can make a huge 
difference.  Here are some tips for 
improving your communication with 
your doctor. 
• Let your doctor know what your 
needs are.  Most health care 
providers consider it their job to 
bring up anything they think is a 
health priority, but if you disagree 
or have other priorities be sure to 
let him/her know. 
• Show up prepared with a list of 
questions or concerns so you don’t 
waste time or forget to ask certain 
things  
• If you are over 50 and your doctor 
has not brought up colon cancer 
screening, be sure to ask about it.  
Ask as many questions as needed 
to help make a decision about 
getting screened. 
• If you think of more questions 
later, you may not be able to reach 
the doctor, but you can ask to 
speak to a knowledgeable nurse or 
other staff member.   
 
 
 
 
6. Talking to the doctor 
Research has shown that patients who 
have good relationships with their 
doctors tend to be more satisfied with 
their care—and to have better results. 
Here are some tips to help you and your 
doctor become partners in improving 
your health care. 
 
Give Information. Don't Wait to Be 
Asked!  
You know important things about your 
symptoms and your health history. Tell 
your doctor what you think he or she 
needs to know.  
 
Get Information  
• Ask questions. If you don't, your 
doctor may think you understand 
everything that was said.   
• Write down your questions before 
your visit. List the most important 
ones first to make sure they get 
asked and answered.   
• You might want to bring someone 
along to help you ask questions. 
This person can also help you 
understand and/or remember the 
answers.  
 
Once You Leave the Doctor's Office, 
Follow Up  
• If you have questions, call.   
• If your symptoms get worse, or if 
you have problems with your 
medicine, call.   
• If you had tests and do not hear 
from your doctor, call for your 
test results.   
• If your doctor said you need to 
have certain tests, make 
appointments at the lab or other 
offices to get them done.   
If you and your doctor just don’t see 
eye-to-eye, it is okay to look for 
someone who fits your needs better.  
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Your relationship with your doctor 
should help (not hinder) you from 
getting the healthcare that you deserve.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• If your doctor said you should 
see a specialist, make an 
appointment.  
 
Remember, quality matters, especially 
when it comes to your health. 
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7. A truly natural colon cleanse 
Everybody has seen at least one 
advertisement for a colon cleanse.  
Based on those ads you would think that 
everyone needs a pill or procedure to 
clean their colon out.  The reality is that 
the colon does a pretty good job of 
removing waste from the body.  In fact, 
frequent colon cleanses, even the so-
called “natural” ones, can reduce your 
body’s ability to remove waste on its 
own.  If you still feel like you need some 
help getting your colon to work there is 
one great thing you can do:  Be Active!  
Exercise is the original, natural colon 
cleanse.  It can help your body eliminate 
waste more quickly and efficiently.  This 
may be one reason why people who are 
active have a lower risk of colon cancer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. The Benefits of Physical Activity 
Regular physical activity is one of the 
most important things you can do for 
your health.   For example, being 
physically active lowers your risk for 
two types of cancer: colon and breast. 
Research shows that: 
 
• Physically active people have a 
lower risk of colon cancer than do 
people who are not active.  
• Physically active women have a 
lower risk of breast cancer than do 
people who are not active.  
• Although the research is not yet 
final, some findings suggest that 
your risk of endometrial cancer and 
lung cancer may be lower if you get 
regular physical activity compared to 
people who are not active.   
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8. Why do you exercise? 
There are many reasons why women 
exercise, but let’s face it, for most of us 
the biggest reason why we exercise is to 
manage our weight.  Unfortunately, this 
leads to the misconception that thin 
people are healthy and don’t need to 
exercise.  However, your weight is not 
always an indicator of how healthy you 
are.  There are plenty of thin women 
with high blood pressure and cholesterol 
and plenty of larger women without any 
health problems.  Active people know 
that exercise can improve your health no 
matter what your weight is.  Even if you 
are not losing weight, being active can 
help prevent many diseases, including 
some types of cancer. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. Control Your Weight 
Looking to get to or stay at a healthy 
weight? Both diet and physical activity 
play a critical role in controlling your 
weight. You gain weight when the 
calories you burn, including those 
burned during physical activity, are less 
than the calories you eat or drink.  When 
it comes to weight management, people 
vary greatly in how much physical 
activity they need. You may need to be 
more active than others to achieve or 
maintain a healthy weight.  
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9. Need some more motivation? 
You already know that being more 
active may decrease your risk of colon 
and other cancers, but it can also help 
with other health problems as well.  
Exercise can decrease your likelihood of 
getting heart disease and diabetes.  It can 
also improve your cholesterol levels and 
help reduce chronic pain, not to mention 
help you reduce stress and improve your 
sleep.  Additionally, women who already 
have a chronic disease (like heart 
disease, diabetes, arthritis or cancer) can 
use exercise to improve their condition 
and quality of life.  Fewer health 
problems can mean fewer trips to the 
doctor, lower health care costs, and a 
better quality of life.  No matter what 
you health is like, you can benefit from 
exercise.  Talk to your doctor about 
which type of exercise would be best for 
you. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9. Need some more motivation? 
In addition to the benefits mentioned 
earlier, exercise can also help you to: 
• Reduce your risk of 
cardiovascular disease  
• Reduce your risk for type 2 
diabetes and metabolic syndrome  
• Strengthen your bones and 
muscles  
• Improve your mental health and 
mood  
• Improve your ability to do daily 
activities and prevent falls, if 
you're an older adult  
• Increase your chances of living 
longer 
 
Everyone can gain the health benefits 
of physical activity - age, ethnicity, 
shape or size do not matter. 
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10. I want to be more active, now 
what? 
Starting to exercise can be intimidating.  
You may feel uncomfortable exercising 
in front of others, especially if you are 
new to an activity.  Here are some tips to 
help you exercise with confidence: 
• Chose something you enjoy.  
Exercise doesn’t have to be 
complicated or involve expensive 
equipment or a gym membership.  
It can be as easy as walking or 
biking around your neighborhood.  
If you are new to exercise start by 
making small changes like taking 
the stairs instead of the elevator or 
by doing activities around the 
home like cleaning and yard work.   
• Choose comfortable clothes 
which fit your body type and that 
you can move easily in. 
• Ask for help.  If you are visiting a 
gym or community center for the 
first time, ask if someone can give 
you a tour and show you how to 
use the equipment.  Even if they 
don’t offer, there is usually 
someone whose job it is to do this.  
• Safety first.  Walking or biking on 
busy streets can be dangerous.  
Instead pick a quieter, more scenic, 
route where you won’t be 
bothered.  If you enjoy exercising 
with others, an exercise partner can 
make you feel more comfortable 
and safe as well as help keep you 
motivated.  And most importantly, 
always remember to check with 
your doctor before you start a new 
exercise program. 
 
 
 
 
 
 
10. Getting Started 
If you're not sure about becoming active 
or boosting your level of physical 
activity because you're afraid of getting 
hurt, the good news is that moderate-
intensity aerobic activity, like brisk 
walking, is generally safe for most 
people.  
• Start slowly. Cardiac events, 
such as a heart attack, are rare 
during physical activity. But the 
risk does go up when you 
suddenly become much more 
active than usual.  
• If you have a chronic health 
condition such as arthritis, 
diabetes, or heart disease, talk 
with your doctor to find out if 
your condition limits, in any 
way, your ability to be active. 
Then, work with your doctor to 
come up with a physical activity 
plan that matches your abilities.  
 
The bottom line is - the health benefits 
of physical activity far outweigh the 
risks of getting hurt. 
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APPENDIX G 
ADDITONAL BASELINE SURVEY RESULTS 
Colorectal Cancer Screening Barriers 
 Colorectal Cancer (CRC) Screening barriers are listing in Table G.1.  More 
women expressed agreement with the barrier “screening tests are too embarrassing” than 
any other barrier.  Moreover, a significantly higher proportion (p=0.03) of obese women 
(41.1%) agreed with this statement than non-obese women (28.6%). Obese women were 
also more than twice as likely as non-obese women to agree that they would not need a 
screening if they did not have symptoms (p=0.04); however a only a small proportion of 
obese women agreed with this statement (13.8%).  Overall, a higher percentage of 
women agreed with the colonoscopy specific barriers than agreed with the general CRC 
screening barriers.  Obese women were more likely than non-obese women to agree that 
they had too many other health costs (p=0.049) or more important health concerns that 
took precedence over colonoscopy (p=0.045).  There were no significant differences by 
weight group in agreement with the more general statements about cost or time as 
barriers to getting a colonoscopy. 
Physical Activity Benefits and Barriers 
 Physical activity benefit and barrier results are listed in Table G.1.  Agreement 
with listed benefits was above 95% for all but one benefit: “I enjoy exercising.”  A 
significantly lower percentage (p=0.01) of obese women reported that they enjoy 
exercising (56.9%) compared with non-obese women (73.5%).  Obese women also 
reported greater agreement with every possible barrier, most notably the statement “my 
current weight makes it difficult for me to exercise.”  They were more than twice as 
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likely as non-obese women to agree that they usually only exercise when trying to lose 
weight (p<0.0001). 
Healthcare Quality 
The association between healthcare quality measures [patient-provider 
communication (PPC) and healthcare satisfaction] and selected variables is shown in 
Table G.2.  Obesity was not significantly associated with either variable, but screening 
status was.  Individuals who were up-to-date with screening rated their both their PPC 
(p=0.03) and healthcare satisfaction higher (p<0.001).  Both healthcare quality variables 
were significantly and positively associated with past-year healthcare visits and screening 
self-efficacy.  Healthcare satisfaction was also positively associated with physical activity 
self-efficacy (r=0.17, p=0.02) and physical activity intentions among women who were 
not currently active (r=0.26, p=0.04).  Finally, both healthcare quality variables were 
significantly associated with the main outcome.  Baseline patient-provider 
communication (r=0.25, p<0.001) and healthcare satisfaction scores (r=0.18, p=0.01) 
were positively correlated with elaboration at follow-up (data not shown). 
Sub-group Analyses 
 We conducted sub-group analyses to determine if the messages increased 
elaboration more in people with certain psychosocial characteristics.  Specifically we 
looked at ELM scores of women who were more likely to agree with weight-related 
screening and physical activity barriers (discussed above).  For all barriers examined, 
women who expressed these barriers had higher elaboration in the intervention group 
then in the control (Table G.3).  We found that the intervention effect was moderated by 
three of the weight-related barriers (p<0.05 for the interaction): having other health 
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concerns that were more important than CRC screening, having other health costs, and 
only exercising when trying to lose weight.  Along with the symptoms barrier (i.e. I don’t 
have symptoms so I don’t need screening), these barriers were specifically addressed in 
the intervention messages, but not the control messages.  These findings indicate that 
tailoring messages to these weight-related barriers may be an effective way to reach 
women who express these barriers. 
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Table G.1 Barriers and Benefits of CRC Screening and Physical Activity by Obesity Status  
Barrier/Benefit  
(% who agree with each statement) 
Non-
Obese Obese p-value 
CRC Screening Barriers 
a. No one in my family has ever had colon cancer so I have 
nothing to worry about 
b. I have faith that I will not get colon cancer, so I don’t need to 
get screened  
c. My doctor or health care provider has never recommended a 
colon cancer screening  
d. I don’t have symptoms or feel sick, so there is no reason for me 
to get a colorectal cancer screening test 
e. Colon Cancer Screening Tests are too embarrassing  
 
9.18 
 
7.14 
 
16.3 
 
5.1 
 
28.6 
 
15.6 
 
12.84 
 
24.8 
 
13.8 
 
43.1 
 
0.16 
 
0.17 
 
0.13 
 
0.04 
 
0.03 
Colonoscopy Barriers 
a. It would be painful 
b. The preparations I would have to do are too difficult (such as 
changing my diet or taking laxatives). 
c. It would be too expensive. 
d. I have too many other health costs right now and can’t afford 
to have a colonoscopy. 
e. I don’t have time to get a colonoscopy. 
f. I have other health concerns which are more important right 
now than getting a colon cancer screening. 
 
40.8 
54.1 
 
46.9 
26.5 
 
26.5 
21.4 
 
45.0 
51.4 
 
51.4 
39.5 
 
29.4 
33.9 
 
0.55 
0.69 
 
0.52 
0.049 
 
0.65 
0.045 
Physical Activity Benefits 
a. I will have more energy if I exercise.    
b. I will control my weight if I exercise.    
c. I will improve my health if I exercise.   
d. Exercising will decrease my chances of getting some diseases.  
e. I enjoy exercising 
 
 
95.9 
96.9 
98.9 
97.9 
73.5 
 
95.4 
95.4 
100 
97.2 
56.9 
 
0.86 
0.57 
* 
* 
0.01 
Physical Activity Barriers 
a. I usually only exercise if I am trying to lose weight 
b. I don’t have any one to exercise with.    
c. I don’t have any place to exercise.     
d. I don’t have the energy to exercise.    
e. I am uncomfortable with how I look while exercising or while 
wearing exercise clothing.   
f. My current weight makes it difficult for me to exercise 
 
 
 
19.4 
41.8 
14.3 
42.9 
26.5 
 
8.16 
 
 
47.7 
53.2 
19.3 
57.8 
49.5 
 
51.4 
 
 
<0.0001 
0.10 
0.34 
0.03 
0.0007 
 
<0.0001 
 
*Number of people who disagree with the statement is too low to compute an accurate p-value 
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Table G.2 Correlates of Healthcare Quality 
Correlate Patient-Provider 
Communication 
p-value Healthcare 
Satisfaction 
p-value 
Obesity, mean (SD) 
 Non-obese 
 Obese 
 
19.2 (4.9) 
19.7 (5.0) 
0.52  
8.2 (1.6) 
8.2 (1.7) 
0.72 
CRC Screening, mean (SD) 
 Up-to-date 
 Out-of-date 
 
21.0 (4.4) 
19.1 (5.7) 
0.03  
8.5 (1.5) 
7.6 (1.8) 
<0.001 
 
Co-morbidities*, r 0.11 0.12 0.09 0.25 
Past-year Medical Visits*, r 0.16 0.03 0.21 <0.01 
FOBT Self-Efficacy, r 0.15 0.03 0.21 <0.01 
Colonoscopy Self-Efficacy, r 0.37 <0.0001 0.40 <0.0001 
Physical Activity Self-Efficacy, 
r 
0.13 0.06 0.17 0.02 
CRC Screening Intentions, r 
 All Participants 
 Unscreened‡ 
 
0.05 
0.12 
 
0.51 
0.26 
 
0.09 
0.26 
 
0.21 
0.04 
Physical Activity Intentions, r 
 All Participants 
 Inactive Participants‡ 
0.08 
0.11 
0.26 
0.30 
0.12 
0.13 
0.10 
0.25 
* Variables treated as continuous for this analysis 
† Limited to participants who did not report being up-to-date with screening at baseline (Non-obese: n=25, 
Obese: n=33). 
‡ Limited to participants who reported that they did participate in any regularly scheduled activity and did 
not report that they were unable to do physical activity (Non-Obese: n=44, Obese: n=41). 
 
 
Table G.3 ELM Scores for Selected Sub-Groups of Women 
Barrier (p for interaction*) Agree with Statement Disagree with Statement Intervention Control Intervention Control 
**I have other health concerns which 
are more important right now than 
getting a colon cancer screening (0.04) 
71.2 65.1 72.9 73.8 
**I have too many other health costs 
right now and can’t afford to have a 
colonoscopy (0.05) 
71.8 67.1 72.6 74.1 
**I don’t have symptoms or feel sick, 
so there is no reason for me to get a 
colorectal cancer screening test (0.07) 
71.4 58.3 72.4 72.6 
Colon cancer screening tests are too 
embarrassing (0.55) 
71.3 69.6 73.1 73.2 
**I usually only exercise if I am trying 
to lose weight (0.02) 
76.0 70.5 70.8 72.7 
I don’t have the energy to exercise 
(0.16) 
73.5 71.1 71.2 72.9 
I am uncomfortable with how I look 
while exercising or while wearing 
exercise clothing (0.90) 
72.6 72.1 72.2 2.2 
My current weight makes it difficult for 
me to exercise (0.63) 
74.1 72.7 71.7 71.9 
*Interaction between barrier and Intervention condition in the model predicting ELM score 
**Barriers addressed in the intervention messages 
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